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Abstract  
 
Cyclic di-GMP (c-di-GMP) has emerged as a bacterial second messenger that regulates a variety of 
cellular processes, in particular those associated with the switch between a motile and a sessile 
lifestyle. At low levels of c-di-GMP the motile lifestyle is favoured whereas at high levels of c-di-GMP 
the formation of biofilms is promoted.  
In Pseudomonas aeruginosa, over 50 genes encoding proteins involved in the synthesis, hydrolysis or 
sensing of c-di-GMP are found and many remain uncharacterized. Herein, an analysis of a collection 
of mutants was performed and supported the idea that the sophisticated c-di-GMP network 
operates at high specificity. 
In addition to c-di-GMP, P. aeruginosa has a regulatory pathway, the Gac pathway, that is known to 
control the bacterium lifestyle switch. By investigating a particular mutant affected in this pathway, 
a link between the Gac pathway and c-di-GMP was established.  
Furthermore, the Gac pathway not only influences biofilm formation, but it is also crucial in 
determining the bacterium mode of infection. In other words, biofilm formation correlates to a 
chronic mode of infection where the bacterium has an active type VI secretion system (T6SS), and a 
motile phenotype correlates to an acute infection where the type III secretion system (T3SS) is 
active. Interestingly, by artificially modulating the levels of c-di-GMP it was demonstrated that c-di-
GMP regulation goes beyond the control of the motile/sessile phenotypes and is able to inversely 
regulate the T3SS and T6SS.  
Finally, the link between c-d-GMP and the Gac pathway was consolidated by showing that the Gac 
system impacts the expression of a few c-di-GMP related proteins and one protein, SadC, was 
identified as a central component of the network. Overall this work largely contributed to reconcile 
two independent concepts involved in the regulation of the P. aeruginosa lifestyle. 
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Chapter 1 – Introduction 
 
Bacteria are ubiquitous unicellular microorganisms. Not only they are abundant, they are also 
widespread in the environment, thriving in the most diverse ecosystems including extreme 
conditions or the organisms of other forms of life. The success of bacteria relies on a combination of 
factors and the ability to sense what surrounds them and quickly adapt is one of them. Fascinated by 
this, my work focussed on the molecular mechanisms used by bacteria to sense, signal and change 
their behaviour. This chapter starts with a general overview of Pseudomonas aeruginosa, a versatile 
opportunistic human pathogen that was used as model organism. It then explains how bacteria use 
regulatory cascades to adapt to the environment and further depicts an important pathway, the Gac 
pathway. Last but not least, this chapter gives a state of the art review of the c-di-GMP signalling 
network and presents the aims of the study. 
 
1.1 Pseudomonas aeruginosa, an opportunistic pathogen 
 
Pseudomonas aerugionsa is the type species of the Pseudomonas genus (Palleroni & Moore, 2004). 
These are rod-shaped, polarly flagellated, aerobic Gram-negative microorganisms that belong to the 
class of Gammaproteobacteria where many medically relevant bacteria are grouped. In P. 
aeruginosa, the species epithet “aeruginosa” is reminiscent of blue/green colour, an attribute 
observed in the pus of P. aeruginosa infected wounds and in laboratory cultures of the bacterium. 
This colour derives from its ability to produce and secrete two pigments, pyocyanin which is blue 
and pyoverdin which is fluorescent green (Gessard, 1984). 
Since its discovery, P. aeruginosa has been extensively used as a model organism to study key 
aspects of bacterial biology, from basic metabolism to host/pathogen interaction. To date, the 
complete genome sequence of eleven P. aeruginosa strains is available in the Pseudomonas 
database (www.pseudomonas.com) (Winsor et al., 2009) and three strains are most widely used in 
laboratories for research purposes: PAO1 (wound isolate), PA14 (burn isolate, more virulent than 
PAO1) and PAK (also a clinical isolate) (Liberati et al., 2006; Stover et al., 2000).  
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1.1.1 Acute versus chronic infections 
 
Pseudomonas species are ubiquitous and can be found in soil, water, plants and animals. In humans, 
P. aeruginosa can be part of the normal microbiome (mainly in stools but occasionally in the skin, 
nasal mucosa, and throat) where it lives without being noticed (Morrison & Wenzel, 1984). However, 
in hospital patients and in people with a genetic disease called cystic fibrosis, infections of P. 
aeruginosa are prevalent and constitute a major public health concern. Even though the prevalence 
of nosocomial infections is lower in high-income countries compared to low-income countries 
(WHO, 2011), an average of 4 million people acquire an infection in hospitals every year in Europe 
(ECDC, 2012). Overall, P.aeruginosa is among the most common causative agents of hospital 
acquired pneumonia, urinary tract infections, catheter and surgery derived infections, and 
septicaemia (ECDC, 2012; Gaynes et al., 2005). In addition to these acute-like infections, P. 
aerugionsa chronically colonizes the lungs of people with cystic fibrosis who have impaired ability of 
clearing their airways from inhaled microorganisms, and becomes the major causative agent of 
morbidity and mortality in these patients (Emerson et al., 2002; Folkesson et al., 2012; Williams & 
Davies, 2012).  
The biology behind the ability of P. aeruginosa to cause both acute and chronic infections is complex 
and dependent on many factors but is known to rely in its capacity to adopt distinct lifestyles and 
control the production of different virulence factors (Figure 1.1). On the one hand, acute infections 
are associated with a motile lifestyle and involve the secretion of toxins via the type II and type III 
secretion systems (Bleves et al., 2010; Mahenthiralingam et al., 1994; Woods et al., 1986). On the 
other hand, chronic infections are linked to a sessile lifestyle in which the bacterial cells produce 
exopolysaccharides and express the type VI secretion system (Costerton et al., 1999; Hoiby et al., 
2001; Mougous et al., 2006).  
Sometimes during the long-term colonization of the lung in cystic fibrosis patients, P. aeruginosa 
undergoes genetic adaptation which results in the appearance of different colony morphotypes, 
specifically the mucoid colonies and the small colony variants (Damkiaer et al., 2013; Smith et al., 
2006). The mucoid phenotype is mainly due to the production of an exopolysaccharide called 
alginate (Govan & Deretic, 1996) whereas the small colony variants are characterized by slow growth 
and have an autoaggregative phenotype that is dependent on the production of the Pel and Psl 
exopolysaccharides (Haussler et al., 1999; Haussler et al., 2003; Kirisits et al., 2005). Curiously, the 
molecular origin of these phenotypes varies and can be under both negative and positive selective 
pressure over the course of an infection (Malone et al., 2012; Starkey et al., 2009).  
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Figure 1.1 Simplified diagram of the virulence determinants of P. aeruginosa. 
Acute infections are associated with a motile lifestyle and the secretion of toxins via the T2SS and 
T3SS. Swimming motility is driven by the polar flagellum and twitching motility is mediated by the 
production of type 4 pili (T4P). The T2SS secretes toxins to the extracellular medium like the 
elastases LasA and LasB or the exotoxin A. The T3SS secretes the exoenzymes S, T, Y and U into host 
cells. Chronic infections have been associated with the formation of biofilms which are sessile 
communities of bacteria. The formation of biofilms is facilitated by the production of fimbriae and 
adhesins that allow surface attachment and in P. aeruginosa it is strongly associated with the 
production of the Pel and Psl exopolysaccharides which are major components of the extracellular 
matrix of the biofilms. Sometimes, clinical isolates from chronically infected cystic fibrosis patients 
have a mucoid phenotype and in this case the exopolysaccharide alginate is produced. Also 
associated with chronic infections is the expression of the T6SS as high titers of antibodies against it 
are found in the serum of cystic fibrosis patients (Mougous et al., 2006). 
 
Below, the most important biological attributes that contribute for the definition of a P. aeruginosa 
infection, including the formation of biofilms and the expression of secretion systems, are described.  
 
1.1.2 Biofilm development: from formation to dispersal 
 
Scientists routinely cultivate bacteria in suspensions where a planktonic and free swimming mode of 
growth is favoured. However, in nature, it is more likely that bacterial cells live attached to a surface, 
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forming a cooperative and highly dynamic structure called biofilm. The ability of bacteria to attach to 
surfaces was first noticed by Claude Zobell in 1943 (Zobell, 1943) but the same observation only 
reappeared in the literature and was extensively studied much later by William Costerton (Costerton 
et al., 1978; Costerton et al., 1987; Hall-Stoodley et al., 2004). Today, the biofilm developmental 
cycle is the focus of many studies and Pseudomonas spp. have been used as one main model 
organism. However, most of these studies have been carried out in in vitro conditions and one 
should bear in mind that during infection the dynamics of biofilm development may vary.  
For P. aeruginosa, the study of biofilms is of clinical relevance for two main reasons. Firstly, the 
formation of biofilms in the lungs of cystic fibrosis patients is associated with the establishment of a 
chronic infection (Singh et al., 2000). Secondly, the growth of biofilms on the surfaces of medical 
devices such as catheters or ventilators is a major cause of nosocomial infections worldwide 
(Donlan, 2001).  
Based on microscopic, genetic and biochemical studies, the biofilm developmental cycle is 
consensually divided in five different stages: (i) reversible attachment, (ii) irreversible attachment, 
(iii) formation of microcolonies, (iv) macrocolony and biofilm maturation, and (v) biofilm dispersal 
(Sauer et al., 2002; Tolker-Nielsen et al., 2000; Webb et al., 2003). A more detailed insight on the 
peculiarities of each stage follows and is illustrated in Figure 1.2. 
 
 
Figure 1.2 Stages of biofilm development. 
The biofilm developmental cycle is divided into five stages: (1) reversible attachment, (2) irreversible 
attachment, (3) formation of microcolonies, (4) macrocolony and biofilm maturation and (5) biofilm 
dispersal. Initial reversible attachment occurs via the cell pole when planktonic cells enter in contact 
with a surface. Then, reorientation of the attached cells and loss of swimming motility contribute to 
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a more stable association with the surface. Following this irreversible attachment, clusters of cells 
start to appear and are referred to as microcolonies. Growth of these microcolonies forms 
macrocolonies. An extracellular matrix composed of exopolysaccharides, proteins and extracellular 
DNA helps maintaining the biofilm structure and protects the cells from external threats. The biofilm 
life cycle comes full circle when cells from the biofilm revert to a motile state and are released to the 
environment. Phage induced cell death is indicated by the bacteria coloured in red and has been 
associated with the progression to dispersal.  
 
Stage1: Reversible attachment 
The planktonic cells enter in contact with a surface (biotic or abiotic) and establish an initial polar 
and reversible attachment. 
Stage2: Irreversible attachment 
Following the first contact with a surface, the lateral reorientation of the attached cells, loss of 
swimming motility and expression of adhesins contribute to a more stable association of the 
bacterial cells with the surface. 
Stage 3: Formation of microcolonies 
Clusters of cells start to be visible and are referred to as microcolonies. The formation of 
microcolonies can occur either by clonal growth of the attached cells or by active translocation of 
cells across the surface (twitching motility). 
Stage 4: Macrocolony and biofilm maturation 
Growth of the microcolonies into mushroom-like structures forms macrocolonies which are 
separated by aqueous channels. An extracellular matrix composed of exopolysaccharides, 
extracellular DNA (Whitchurch et al., 2002) and proteins maintains the biofilm structure and protects 
the cells against harmful compounds or adverse conditions.  
Stage 5: Biofilm dispersal 
The biofilm developmental cycle comes full circle when cells from the biofilm revert to a motile 
lifestyle and are released to the environment where they can colonize new areas (McDougald et al., 
2011). During biofilm maturation, phage-induced death of cells within the biofilm is part of the 
natural course of development and promotes biofilm dispersal (Webb et al., 2003). 
 
Both the biofilm formation and dispersal stages of the biofilm developmental cycle constitute critical 
moments that are potential targets to prevent or eradicate an infection. For instance, biofilm 
formation could be prevented through the development of compounds that hamper the attachment 
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of the bacteria (Valle et al., 2006); or eradication of established biofilms could be induced by 
promoting dispersal (Christensen et al., 2013). For this reason, understanding the regulatory 
cascades underlying biofilm development, as well as of other key traits of P. aeruginosa biology, is of 
pivotal relevance.  
 
1.1.3 Extracellular appendages and exopolysaccharides 
 
Regardless of the lifestyle that P. aeruginosa adopts (motile versus sessile), this bacterium is able to 
assemble a number of extracellular appendages that are involved in motility or adhesion. These 
include a unipolar flagellum, type IV pili (T4P), Cup fimbriae or the CdrA adhesin. In addition to these 
and during the sessile mode of growth, P. aeruginosa produces a range of extracellular polymeric 
substances such as the alginate, Pel and Psl exoplysaccharides.   
 
The unipolar flagellum – swimming and swarming motility 
Many bacteria can swim in liquid environments due to the presence of flagella. In general, this 
flagella-driven swimming motility is due to the rotation of long flagellin polymers (FliC, PA1092) that 
are hooked to the cell surface and are controlled by a flagellar motor. Rotation of the flagella is 
powered by a proton flux across the cytoplasmic membrane and depends on the interaction 
between proteins of the rotor (rotating part) and the stator (non-rotating, membrane associated 
part) that constitute the flagellar motor.    
In P. aeruginosa, a single flagellum at one cell pole is found and approximately 50 genes are involved 
in its assembly and function (Dasgupta et al., 2003). Curiously, two sets of stator proteins instead of 
just one, MotAB (PA4953-PA4954) and MotCD (PA1460-PA1461), are found in the PAO1 genome 
(Toutain et al., 2005). Besides driving swimming motility in liquid environments, and upon 
production of the rhamnolipid surfactant, the P. aeruginosa flagellum also drives swarming motility 
in semisolid surfaces (Overhage et al., 2008).  
 
The Type IV Pili (T4P) – twitching motility 
T4P are common extracellular appendages in bacteria that can serve different functions. In P. 
aeruginosa there are three types of T4P – T4Pa, T4Pb and Flp – which differ in function and assembly 
system. One of them, the T4Pa (here referred to as T4P for simplicity reasons), is associated with 
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twitching motility and assembles at the flagellated pole of the cells. This type of surface associated 
motility mediated by T4P is independent of the presence of a functional flagellum and results from 
the repeated extension, tethering and retraction of long and thin pili (Burrows, 2012).     
Like for the flagellum, more than 50 genes in the genome of P. aeruginosa PAO1 strain are involved 
in the regulation, expression or function of the T4P. For its biogenesis, at least four different 
complexes of proteins are required: the pilus complex, the outer membrane complex, the inner 
membrane motor complex and the alignment complex (Burrows, 2012).  
The pilus complex forms the actual surface appendage and is composed by the major pilin subunit 
PilA (PA4525) and the minor pilins FimU (PA4550), PilE (PA4556), PilV (PA4551), PilW (PA4552) and 
PilX (PA4553). The minor pilins have been proposed to form the initiation platform for pilus 
assembly and are thought to sit at the tip of each pilus. For pili to exit the cell, the outer membrane 
complex is required. This is composed by the secretin PilQ (PA5048) that forms outer membrane 
channels and the lipoprotein PilF (PA3805) that mediates PilQ oligomerization and ensures its 
correct localization. At the inner membrane, the motor complex is responsible for the continuous 
assembly and disassembly of the pilus complex and comprises the PilB (PA4526), PilC (PA4527), PilD 
(PA4528), PilT (PA0395) and PilU (PA0396) proteins. Finally, the alignment complex is composed of 
FimV (PA3115), PilM (PA5044), PilN (PA5045), PilO (PA5046) and PilP (PA5047) and serves to align 
the outer and inner membrane complexes for proper pilus biogenesis.  
The twitching motility resulting from the function of T4P has been shown to be important for biofilm 
development at two different stages: the initial stages where it provides the bacteria with the ability 
to attach to a surface, and the later stages where it plays a role in biofilm differentiation (piliated 
cells are seen at the cap portion of the mushroom-like biofilms whereas nonpiliated cells localize to 
the stalk portion) (Klausen et al., 2003a; Klausen et al., 2003b).  
 
The Cup fimbriae 
Cup (chaperone usher pathway) fimbriae result from the polymerisation of fimbrial subunits at the 
cell surface via a chaperone usher pathway (Vallet et al., 2001). In P. aeruginosa PAO1 strain, there 
are four gene clusters encoding for Cup fimbriae: cupA (PA2128-PA2132), cupB (PA4081-PA4086), 
cupC (PA0992-PA0994) and cupE (PA4648-PA4653). An additional cupD cluster is encoded in a 
pathogenicity island in the PA14 strain.  
Although the cup gene clusters in P. aeruginosa show some variability, a typical cup cluster encodes 
(i) a pilin subunit; (ii) a chaperone that binds the pilin subunits in the periplasm; (iii) an adhesin that 
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is presented at the tip of the fimbriae; and (iv) an outer membrane usher responsible for the 
translocation of the pilin subunits across the membrane. 
Some observations suggest that Cup fimbriae are important surface appendages during biofilm 
development. For instance, CupA fimbriae have been shown to be required at the early stages of 
attachment, CupB and CupC play a role in microcolony formation and CupE is involved in shaping the 
biofilm structure during macrocolony maturation (Giraud et al., 2011; Ruer et al., 2007; Vallet et al., 
2001).     
 
The CdrA adhesin 
Not much is known about the CdrA (PA4625) adhesin but it has been shown that it binds the Psl 
exopolysaccharide. It is encoded in an operon with its outer membrane transporter, CdrB (PA4624), 
and expression of CdrA promotes auto-aggregation in liquid cultures and biofilm formation on 
surfaces (Borlee et al., 2010). 
 
The alginate, Pel and Psl exopolysaccharides  
Exopolysaccharides are major components of the extracellular biofilm matrix. In P. aeruginosa 
isolates from cystic fibrosis lungs, the mucoid phenotype is dependent on the production of alginate 
whereas in other isolates, including the small colony variants, the formation of biofilm is dependent 
on Pel or Psl exopolysaccharides (Figure 1.3).  
Alginate is a polymer of D-mannuronic acid residues randomly modified by acetylation and 
epimerization. The genes for the production and export of alginate are encoded by the alg operon 
composed of twelve genes (PA3540-PA3551) and by algC (PA5322). In total, this involves the 
enzymes required for the synthesis of the polymer precursors in the cytoplasm, AlgA, AlgC and AlgD; 
the membrane proteins required for the polymerization and transport of the D-mannuronic acid 
polymer to the periplasm, Alg8 and Alg44; the enzymes required for its periplasmic modification, 
AlgF, AlgG, AlgI, AlgJ and possibly, AlgX; a periplasmic alginate lyase, AlgL; a periplasmic scaffold 
protein, AlgK; and an outer membrane porin, AlgE, responsible for the export of alginate to the 
extracellular medium (Franklin et al., 2011; Mann & Wozniak, 2012).  
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Figure 1.3 The biosynthetic complexes of Pel, alginate and Psl exopolysaccharides. 
Figure retrieved from Franklin et al. (2011). (A) Genetic organization of the pel, alg and psl operons, 
coloured according to the description shown on the right. (B) Models of the organization of the 
biosynthetic complexes of the Pel, alginate and Psl exopolysaccharides, coloured as depicted in A. 
 
The Pel exopolysaccharide is a glucose-rich polymer whose precise chemical composition or 
biosynthetic pathway is not known. The genes involved in its biogenesis however, are encoded in the 
pel operon (PA3058-PA3064) and based on structural homology analysis, a model for its production 
and export has been proposed (Coulon et al., 2010; Franklin et al., 2011; Friedman & Kolter, 2004a). 
In this case, the polymer precursors are thought to derive from the central carbon metabolism of the 
cells and the cytoplasmic PelF protein is involved in the polymerization process. After, the 
membrane proteins PelD, PelE and PelG are thought to be required for the transport of the polymer 
to the periplasm; PelA may be involved in the periplasmic modification and/or degradation of the 
polymer; and PelB and PelC are putative proteins associated with the outer membrane that serve as 
scaffold proteins and/or secretion platform for the exclusion of the Pel exopolysaccharide.  
Finally, the Psl exopolysaccharide is a polymer composed of a repeating pentamer containing D-
mannose, L-rhamnose, and D-glucose, and anchored to the cell surface in a helical pattern (Ma et al., 
2009). The genes required for the production and export of Psl are encoded in the psl operon which 
is composed of twelve genes (PA2231-PA2242). These include one cytoplasmic enzyme involved in 
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the synthesis of the mannose precursor, PslB; four cytoplasmic proteins that participate in the 
synthesis of the pentamer, PslC, PslF, PslH and PslI; five membrane proteins involved in the 
polymerazition and transport of the polymer to the periplasm, PslA, PslE, PslJ, PslK and PslL; a 
periplasmic protein for the modification and/or degradation of the polymer, PslG; and a protein 
associated with the outer membrane for the export of the Psl exopolysaccharide, PslD (Franklin et 
al., 2011; Friedman & Kolter, 2004b). Curiously, part of the psl exopolysaccharide cluster is missing in 
the PA14 strain.    
 
1.1.4 Secretion of proteins across the membrane 
 
Like other Gram-negative bacteria, P. aeruginosa uses an array of different multiprotein complexes, 
called secretion systems, to translocate proteins to the extracellular medium or to target cells. 
Overall, these secretion systems play a crucial role in modulating the interactions between the 
bacteria and the environment or the bacteria and other organisms (like competitor microorganisms 
or host cells). A total of six different types of secretion systems have been recognized in Gram-
negative bacteria and are named type I secretion system (T1SS) to type VI secretion system (T6SS). In 
the Gram-positive bacteria belonging to the Mycobacterium genus, a seventh type of secretion 
system has also been described for the translocation of proteins across the highly impermeable cell 
wall (Abdallah et al., 2007) but it should be kept in mind that the nomenclature of the secretion 
systems is relative to Gram-negative bacteria and the translocation across the outer membrane. 
In the Gram-negative P. aeruginosa, all but the T4SS are found (Bleves et al., 2010). Generally, 
secretion systems are divided according to the mode of transport across the cell envelope: in one 
step, when the proteins are translocated directly from the cytoplasm to the extracellular medium or 
target cells (T1SS, T3SS, T4SS and T6SS); or in two steps, when the proteins are first transported to 
the periplasm and only after to the extracellular medium (T2SS and T5SS). A brief description of the 
secretion systems found in P. aeruginosa follows (Figure 1.4).     
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Figure 1.4 Secretion systems found in P. aeruginosa.  
P. aeruginosa has five of the six secretion pathways found in Gram-negative bacteria. In the T1SS, 
T3SS and T6SS the effector proteins are translocated directly from the cytoplasm to the extracellular 
medium or target cells. In the T2SS and T5SS, the effector proteins are translocated from the 
periplasm to the outside and the translocation across the inner membrane is carried out by the Sec 
or Tat systems. The T3SS is known to transport toxins into the cytosol of eukaryotic cells. The T6SS is 
known to transport toxins into the periplasm and cytoplasm of bacterial cells and into the cytosol of 
eukaryotic cells. Figure retrieved from Bleves et al. (2010). 
 
Type I secretion system (T1SS) 
T1SSs are composed of an inner membrane ABC (ATP-binding cassette) transporter, an outer 
membrane protein and an adaptor protein that connects the first two. A total of four T1SSs have 
been found in P. aeruginosa but only the proteins secreted by two of them are known (Ma et al., 
2003). In the Apr(D-F) system (PA1246-1248), the alkaline protease and virulence factor AprA 
(PA1249) is secreted. In the Has(D-F) system (PA3404-PA3406), the haem acquisition protein HasA 
(PA3407) is secreted (Wandersman & Delepelaire, 2004).  
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Type II secretion system (T2SS) 
T2SSs involve two steps. Initially, the proteins need to be translocated across the inner membrane 
by the means of the widespread Sec or Tat systems. Secondly, the proteins in the periplasm are 
exported through a large protein complex, the T2SS, to the extracellular medium. 
In P. aeruginosa, the Sec system is composed of three inner membrane proteins that form a channel, 
SecE (PA4276), SecG (PA4747) and SecY (PA4243); one cytoplasmic ATPase that provides the energy 
for the translocation, SecA (PA4403); one chaperone that presents the unfolded protein to the 
ATPase, SecB (PA5128); and several other proteins that participate in the translocation process, 
cleavage of signal peptides or insertion of transmembrane domains in the inner membrane. On the 
other hand, the Tat system is composed of only three inner membrane proteins, TatA (PA5068), TatB 
(PA5069) and TatC (PA5070), and is responsible for the specific translocation of folded proteins that 
have an N-terminal signal peptide with a double arginine (RR) motif (Ma et al., 2003). 
Once in the periplasm, a complex of at least ten proteins is involved in the transport of the proteins 
across the outer membrane. Two complete sets of these proteins are found: the Xcp system 
(PA3095-PA3105), involved in the secretion of many proteolytic enzymes and virulence factors like 
the LasB elastase (PA3724) and the ToxA exotoxin A (PA1148); and the Hxc system (PA0677-PA0687), 
involved in the specific secretion of the LapA alkaline phosphatase (PA0688) under phosphate 
limiting conditions (Bleves et al., 2010).  
Interestingly, the T2SS machinery resembles the T4P assembly system in such a way that a similar 
protein arrangement is visible: a pseudopilus complex composed of a major pseudopilin (XcpT) is 
capped with minor pseudopilins (XcpU, XcpV, XcpW and XcpX) and spans the periplasm; an inner 
membrane and alignment complex comprises the ATPase motor XcpR and the proteins XcpP, XcpS, 
XcpY and XcpZ; and an outer membrane complex composed of the XcpQ secretin forms a channel 
(Filloux, 2004). Mechanistically, the XcpP protein is seen as a platform that recruits the periplasmic 
proteins to be exported and the pseudopilus is likely to work as a piston that pushes the recruited 
proteins through the channel formed by the XcpQ secretin (Douzi et al., 2011).    
 
Type III secretion system (T3SS) 
T3SSs are responsible for the assembly of a needle structure that allows the injection of bacterial 
effectors directly into the cytosol of host cells. A total of 42 genes involved in the assembly and 
regulation of the T3SS are encoded in the P. aeruginosa PAO1 genome. Most of them are arranged 
in five operons that cluster together, except the three known secreted effectors (ExoY, PA2191; 
ExoS, PA3841; and ExoT, PA0044) and the cytoplasmic effector chaperone (SpcS, PA3842) which are 
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encoded elsewhere. In the PA14 strain, the additional effector ExoU and its chaperone SpcU are 
found (Hauser, 2009).  
All the structural components of the T3SS are thought to be encoded within the five-operon cluster, 
including the inner membrane associated baseplate complex, the outer membrane complex and the 
needle complex. Briefly, at the baseplate, the cytoplasmic ATPase PscN (PA1697) is likely to energize 
the system; at the outer membrane complex, the secretin PscC (PA1716) allows the passage of the 
needle; and at the needle complex, PscF (PA1719) is the building block of the needle. Once 
assembled, three proteins at the tip of the needle, PopB (PA1708), PopD (PA1709) and PcrV 
(PA1706), are involved in the formation of a pore in the membrane of the host cells. The subsequent 
injection of the effector proteins helps the bacteria to evade the host immune system and is highly 
cytotoxic, promoting the establishment of an acute infection (Hauser, 2009).  
 
Type V secretion system (T5SS) 
Like T2SSs, T5SSs operate in two steps. First, the Sec system translocates the proteins across the 
inner membrane. Second, an autotransporter or a two-partner secretion pathway exports the 
proteins to the extracellular medium. There, they can remain associated to the cell surface or be 
released to the environment. 
In an autotransporter pathway, the protein that exits the cell assists its own passage through the 
outer membrane. Three autotransporters are found in P. aeruginosa (PA0328, PA3535, PA5112) and 
they are characterized by the following modular organization: an N-terminal signal peptide that 
allows its translocation via the Sec pathway to the periplasm; a central domain that is the actual 
effector domain to be secreted; and a C-terminal domain that alone or upon oligomerization forms a 
β-barrel at the outer membrane and allows the secretion of the effector domain (Bleves et al., 
2010). 
In a two-partner secretion pathway, the domain forming the outer membrane pore is in a different 
protein. These two proteins are encoded in an operon and the secreted protein has an additional N-
terminal motif that is recognized by the outer membrane component (Ma et al., 2003). In P. 
aeruginosa, five two-partner secretion pathways have been identified and one of them corresponds 
to the CdrA adhesin and the CdrB outer membrane protein. 
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Type VI secretion system (T6SS) 
Like T3SSs, T6SSs are responsible for the translocation of proteins directly into target cells. However, 
the activity of the T6SS in P. aeruginosa is commonly associated with the chronic mode of infection 
rather than acute, and with the ability of the bacterium to defend itself against other bacteria, at 
least in the case of the best characterized cluster so far (Hood et al., 2010; Potvin et al., 2003).  
In P. aeruginosa PAO1, three clusters encoding for three T6SS machineries have been identified (H1, 
H2 and H3). Most of the available literature focuses on the understanding of the machinery encoded 
by the H1 cluster (PA0070-PA0095) (Coulthurst, 2013; Filloux, 2013). Structurally, the H1-T6SS 
machinery resembles an inverted bacteriophage with a contractile tail and a puncturing device at 
the tip of the tail tube. Encoded in the H1 cluster are twenty five genes involved in the assembly and 
function of the T6SS. This includes the components IcmF1 (PA0077) that anchors the system to the 
membrane; Hcp1 (PA0085) which forms the tail tube that extends to the target cell; VgrG1 (PA0091) 
which sits at the tip of the tube to form the puncturing device (Hachani et al., 2011; Pukatzki et al., 
2006); TssB1 (PA0083) and TssC1 (PA0084) which form the contractile tail sheath at the the 
baseplate of the system (Lossi et al., 2013); and ClpV1 (PA0090), a cytoplasmic ATPase involved in 
the disassembly of the sheath (Mougous et al., 2006).    
Mechanistically, the contraction of the TssB1/TssC1 sheath allows the pushing of the Hcp1 tube 
which displays the VgrG1 puncturing device on top and perforates the membrane of target cells. 
Subsequently, the delivery of effector proteins to the targeted cells is thought to contribute to their 
killing. So far, three toxins that are delivered to the periplasm or the cytoplasm of the recipient cells, 
Tse1 (PA1844), Tse2 (PA2702), and Tse3 (PA3484), have been identified as H1-T6SS effectors (Hood 
et al., 2010). Interestingly, each one of these toxins has a corresponding antitoxin that prevents the 
killing of the donor cell and constitutes a toxin-antitoxin system. 
 
1.2 Regulatory cascades in P. aeruginosa 
 
Bacteria respond to variations in the environment by sensing extracellular signals that are translated 
across the membrane into an intracellular readout and lead to a biological output. Signal 
transduction pathways are the regulatory cascades of reactions that drive this signalling and allow 
the integration of extracellular signals (or first messengers) into intracellular messages. Generally, 
signal transduction pathways involve either (i) direct binding to an effector protein, (ii) a cascade of 
phosphorylation reactions or (iii) a combination of phosphorylation and methylation reactions 
(Figure 1.5). Ultimately, regulatory cascades result in the modulation of gene expression at the 
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transcriptional, posttranscriptional or posttranslational/allosteric level, helping bacteria to shape 
their biological behaviour.  
 
 
Figure 1.5 Signalling transduction pathways in bacteria.  
Three categories of regulatory cascades are considered based on their complexity: direct binding of a 
signal to an effector protein (one-component systems), a cascade of phosphorylation reactions (two-
component systems), and a combination of phosphorylation and methylation reactions (chemotactic 
pathways). One-component systems are typically cytoplasmic proteins with a sensory domain and an 
output domain that can either be a DNA-binding domain or an enzymatic domain. Two-component 
systems involved two proteins, one sensor and one response regulator. Upon sensing of a stimulus, 
the sensor undergoes autophosphorylation in an H (histidine) residue of the kinase domain and 
transfers the phosphoryl group into a D (aspartate) residue in the REC domain of the response 
regulator. Sometimes, the kinase domain in the sensor is followed by a REC domain. In these cases, 
the two-component systems are referred to as hybrid if a third component which is a Hpt domain 
protein exists, or unorthodox if the Hpt domain follows the REC domain in the sensor protein. The 
signal transduction pathway involved in chemotaxis comprises phosphorylation and methylation 
reactions. In the canonical chemotactic pathways there is a receptor protein (MCP) that sits in the 
inner membrane, an adaptor protein (CheW, represented by W), a kinase (CheA), a 
methyltransferase (CheR), and two response regulators (CheY and CheB). CheB functions as a 
methylesterase and together with CheR resets the system. CheY consists of only the REC domain and 
goes to the flagellum proteins to modulate motility.    
 
1.2.1 Regulation by direct binding to effector proteins 
 
Proteins that exert their regulatory action upon direct sensing of a signal are abundant in bacterial 
genomes and can be referred to as one-component systems (Ulrich et al., 2005). Usually, these 
proteins have two domains, an N-terminal input domain involved in binding to small molecules, and 
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a C-terminal output domain. This is either a helix-turn-helix DNA binding domain or, less frequently, 
an enzymatic domain (Figure 1.5).  
 
The majority of one-component systems lack transmembrane domains and are therefore more likely 
to be involved in sensing signals directly from the cytoplasm (Ulrich et al., 2005). These signals can 
be extracellular signals that diffuse or are transported across the membrane, or intracellular signals 
originated after sensing of an extracellular stimulus, i.e. second messengers. 
 
A typical example of a one-component system is LasR (PA1430) or RhlR (PA3477), proteins involved 
in quorum sensing signalling in P. aeruginosa. Quorum sensing is the bacterial adaptive response to 
cell density and an important signalling mechanism in bacteria that will not be discussed in detail in 
this thesis. Both LasR and RhlR have a modular organization where the input domain is an 
autoinducer binding domain and the output domain is a DNA binding domain. Autoinducers are the 
signals used in quorum sensing mediated regulation and binding of those signals promotes 
conformational changes (usually homodimerization) of the receptor proteins, resulting in binding of 
the output domain to its DNA targets. In the case of LasR and RhlR, the autoinducers are 3-oxo-C12-
homoserine lactone and C4-homoserine lactone, respectively, and they act as a signal that activates 
transcription of a large number of DNA targets (Suarez-Moreno et al., 2012).  
 
Despite the fact that one-component systems are usually cytoplasmic proteins, there are some 
examples of one-component systems that are membrane associated (but not necessarily involved in 
direct sensing of signals in the extracellular medium). Two such examples in P. aeruginosa are RbdA 
(PA0861, Table 1.5) and MucR (PA1727, Table 1.5).  
 
In RbdA, the N-terminus harbours an input PAS domain just after a predicted transmembrane 
domain, and the C-terminus contains two output domains with putative enzymatic activities (see 
section 1.4.2 for more details). PAS domains (named after the proteins where they are commonly 
found) are very common in bacteria and have a three-dimensional structure where small molecules 
like haem, flavin or adenine, bind to a ligand-binding pocket and respond to the presence of factors 
like oxygen or light (Table 1.1) (Galperin, 2004). In the characterization of RbdA, the protein was 
shown to be involved in biofilm dispersal via the activity of only one of its enzymatic domains and an 
intact PAS domain was essential for the catalytic activity (An et al., 2010; Roy et al., 2012). It was 
suggested that RbdA senses oxygen and that binding of oxygen to the PAS domain suppresses the 
activity of the output domain, preventing biofilm dispersal.  
 34 
 
In the case of MucR, the N-terminus contains a MHYT domain and the C-terminus has two output 
domains with putative enzymatic activities (see section 1.4.3 for more details). A MHYT domain 
consists of six transmembrane regions with cytoplasmic loops rich in arginine residues and 
periplasmic loops rich in charged amino acids. MHYT domains have been bioinformatically predicted 
to bind metals and sense oxygen, carbon monoxide or nitric oxide, but this is still largely unexplored 
(Table 1.1) (Galperin et al., 2001). Even for MucR, the signal or impact of the MHYT domain in the 
enzymatic activity of the output domains is unknown but the protein has been shown to be involved 
in alginate production and biofilm dispersal (Hay et al., 2009; Li et al., 2013).  
 
Another input domain often found in membrane associated one-component systems is the CHASE 
domain that is bioinformatically predicted to have an extracellular input domain and is found 
associated with enzymatic output domains (Table 1.1) (Zhulin et al., 2003). A total of four proteins 
with this domain are found in P. aeruginosa, namely PA0847 (Table 1.5), PA2072 (Table 1.5), PA4036 
and PA4112, but up to now they remain uncharacterized. 
 
 
Table 1.1 Input domains relevant for this study. 
Domain Description Reference 
PAS  
Domain found in Per, Arnt and Sim proteins. Internal 
sensor of oxygen, redox potential and light. 
Taylor & Zhulin, 1999 
Galperin, 2004 
REC 
Domain found in response regulators. Contains a 
phosphoacceptor site. Usually, the phosphoryl group is 
received from a cognate sensor.   
Pao & Saier, 1995 
HAMP  Linker domain found in H kinases, ACs, MCPs.  
Aravind & Ponting, 1999; 
Parkinson, 2010 
GAF  
Domain found in cGMP-specific PDEs, ACs and FhlA. Can 
serve as an interface for protein interactions or binding to 
ligands including cyclic nucleotides in eukaryotic cells, 
chromophores in plants or sodium in cyanobacteria.  
Aravind & Ponting, 1997; 
Cann, 2007; Heikaus et 
al., 2009 
MHYT  
Named based on its conserved amino acid pattern. 
Predicted to bind metals and sense oxygen, carbon 
monoxide or nitric oxide. Consists of six transmembrane 
regions connected by short arginine-rich cytoplasmic loops 
and periplasmic loops rich in charged amino acids. Three 
of the transmembrane regions have highly conserved 
methionine and histidine residues located near the outer 
face of the cytoplasmic membrane.  
Galperin et al., 2001 
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Domain Description Reference 
CHASE  
Cyclase/histidine kinase-associated sensing extracellular 
domain.   
Zhulin et al., 2003 
MASE  Membrane associated sensory domain. Nikolskaya et al., 2003 
PBPb or 
SBP_bac_3 
Periplasmic substract-binding protein domain found in 
bacteria 
Bermejo et al., 2010; 
Tam & Saier, 1993 
CBS  Intracellular modules that pair together and bind ligands. 
Bateman, 1997;  
Scott et al., 2004 
7TMR-DISM 
Consists of seven transmembrane segments with a 
periplasmic ligand-binding domain. 
Anantharaman & 
Aravind, 2003 
Cache 
Frequently found in animal calcium channels and 
prokaryotic chemotaxis receptors. It is an extracellular 
domain that is predicted to have a role in small-molecule 
recognition. 
Anantharaman & 
Aravind, 2000 
 
 
1.2.2 Regulation by phosphorylation  
 
Regulatory cascades that use phosphorylation as a means of information transfer are usually 
composed of two proteins and are therefore called two-component systems. In bacteria, they are 
less abundant than one-component systems but are more complex, allowing a more versatile 
signalling, and are evolutionary younger (Ulrich et al., 2005). In highly adaptable microorganisms like 
P. aeruginosa, the prevalence of these systems is generally high and indeed, in the complete 
genome sequence of P. aeruginosa PAO1, a total of 135 two-component system genes are found 
(more than double the average of other bacterial species) (Barakat et al., 2011; Capra & Laub, 2012; 
Rodrigue et al., 2000; Stover et al., 2000). Among the 135 genes, 84 form a recognizable pair and the 
remaining are either atypical or orphan sensors and response regulators.      
 
In two-component systems, the input and output domains are located in two different proteins, the 
sensor kinase and the response regulator (Figure 1.5). The sensor kinase is usually a membrane 
protein with an extracellular N-terminal input domain and a C-terminal transmitter domain able to 
bind ATP (adenosine triphosphate) and undergo autophosphorylation. The response regulator is a 
cytoplasmic protein with an N-terminal REC domain (receiver domain) and a C-terminal output 
domain that can bind DNA or, less frequently, have enzymatic activity (Galperin, 2010a).  
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In a classical two-component system, binding of a signal to the input domain of the sensor triggers 
autophosphorylation (i.e. the attachment of a phosphoryl group from ATP to an amino acid) of a 
histidine (H) residue in the transmitter domain. Subsequently, the phosphoryl group is transferred to 
an aspartate (D) residue in the REC domain of a cognate response regulator, causing conformational 
changes that activate the output domain. Sometimes, the transfer of the phosphoryl group is not 
done in one direct step to the REC domain of the response regulator but in three steps, creating a 
phosphorelay (Ventre et al., 2004). In this case, the phosphoryl group is firstly transferred to an extra 
REC domain located in the sensor kinase, then to an Hpt domain (H phosphotransfer domain, found 
in tandem with the sensor or as a cytoplasmic protein) and finally, to the REC domain of the 
response regulator. Additionally, many classical sensor kinases are bifunctional showing 
phosphorylation activity in the active form and phosphatase activity in the absence of an input 
signal. This phosphatase activity is not so well understood as the phosphorylation reactions but it is 
thought to be important to fine-tune the activity of the response regulators output domain and to 
prevent cross-talk between different two-component systems in the same cell (Huynh & Stewart, 
2011). 
 
Given their abundance in P. aeruginosa, the biological processes regulated by two-component 
systems are diverse, ranging from nutrient metabolism and motility control to virulence and 
antibiotic resistance (Table 1.2) (Gooderham & Hancock, 2009; Mikkelsen et al., 2011; Ventre et al., 
2004). Among all the two-component systems characterized so far, one of them stands out for its 
global role on the inverse regulation of phenotypes associated with acute and chronic infections. 
This system is named the Gac system and is depicted below. Another remarkable example of the 
regulation exerted by two-component systems is related to the control of the biofilm development 
which has been shown to be mediated by the synchronized and sequential action of at least three 
two-component systems: the Bfi, Bfm and Mfi systems. 
 
 
Table 1.2 Two-component systems of known function in P. aeruginosa. 
Name Sensor 
Response 
regulator 
Associated functions References 
Sensing of nutrients 
PfeRS 
PfeS 
(PA2687) 
PfeR 
(PA2686) 
Iron assimilation Dean et al., 1996 
NarLX 
NarX 
(PA3878) 
NarL 
(PA3879) 
Nitrate assimilation 
Van Alst et al., 2007; Van Alst 
et al., 2009 
CbrAB 
CbrA 
(PA4725) 
CbrB 
(PA4726) 
Carbon and nitrogen assimilation 
Li & Lu, 2007; Nishijyo et al., 
2001 
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Name Sensor 
Response 
regulator 
Associated functions References 
PhoBR 
PhoR 
(PA5361) 
PhoB 
(PA5360) 
Phosphate assimilation, quorum 
sensing, T2SS 
Anba et al., 1990; Ball et al., 
2002; Faure et al., 2013; 
Filloux et al., 1988; Jensen et 
al., 2006 
Motility     
FleRS  
FleS 
(PA1098) 
FleR 
(PA1099) 
Flagella-driven motility 
Dasgupta et al., 2003; 
Ritchings et al., 1995 
PilRS  
PilS 
(PA4546) 
PilR 
(PA4547) 
T4P-mediated motility 
Boyd et al., 1994; Boyd & 
Lory, 1996; Boyd, 2000; Ethier 
& Boyd, 2000; Hobbs et al., 
1993; Jin et al., 1994 
Biofilm formation and Virulence 
GacAS 
GacS 
(PA0928) 
GacA 
(PA2586) 
Exopolysaccharides, T4P, T3SS, 
T6SS, quorum sensing, iron 
homeostasis, cyanide production 
Brencic & Lory, 2009; Brencic 
et al., 2009; Kay et al., 2006; 
Parkins et al., 2001; Pessi & 
Haas, 2001; Reimmann et al., 
1997; Soscia et al., 2007 
Roc/Sad 
RocS1 
(PA3946) 
RocS2 
(PA3044) 
RocR 
(PA3947) 
RocA1 
(PA3948) 
RocA2 
(PA3045) 
CupB and CupC frimbriae 
regulation, T3SS, antibiotic 
resistance, biofilm maturation 
Kuchma et al., 2005; 
Kulasekara et al., 2005; 
Sivaneson et al., 2011 
BfmRS 
BfmS 
(PA4102) 
BfmR 
(PA4101) 
Biofilm maturation Petrova & Sauer, 2009 
BfiRS 
BfiS 
(PA4197) 
BfiR 
(PA4196) 
Biofilm initiation 
Petrova & Sauer, 2009; 
Petrova & Sauer, 2010 
PprAB 
PprA 
(PA4293) 
PprB 
(PA4296) 
T4Pb/Flp pilin regulation, CupE 
fimbriae, quorum sensing, 
antibiotic resistance 
Bernard et al., 2009; de 
Bentzmann et al., 2012; Dong 
et al., 2005; Giraud et al., 
2011; Wang et al., 2003 
Fim/Alg 
FimS 
(PA5262) 
AlgR 
(PA5261) 
Alginate production, cyanide 
production, T4P-mediated 
motility, quorum sensing 
Carterson et al., 2004; 
Lizewski et al., 2002; Lizewski 
et al., 2004; Morici et al., 
2007; Whitchurch et al., 
1996; Yu et al., 1997 
Kin/Alg 
KinB 
(PA5484) 
AlgB 
(PA5483) 
Alginate production 
Chand et al., 2011; Goldberg 
& Dahnke, 1992; Ma et al., 
1997; Wozniak & Ohman, 
1991 
MfiRS 
MfiS 
(PA5512) 
MfiR 
(PA5511) 
Microcolony formation Petrova & Sauer, 2009 
PvrRS 
PvrS 
[PA14] 
PvrR [PA14] CupD regulation Mikkelsen et al., 2009a 
RcsBC 
RcsC 
[PA14] 
RcsB 
[PA14] 
CupD regulation 
Mikkelsen et al., 2009a; 
Nicastro et al., 2009 
Metal and Antibiotic resistance 
PhoPQ 
PhoQ 
(PA1180) 
PhoP 
(PA1179) 
Antibiotic resistance 
Barrow & Kwon, 2009; 
Macfarlane et al., 1999; 
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Name Sensor 
Response 
regulator 
Associated functions References 
McPhee et al., 2006 
ParRS 
ParS 
(PA1798) 
ParR 
(PA1799) 
Antibiotic resistance 
Fernandez et al., 2010; Muller 
et al., 2011 
CzcRS 
CzcS/Czr
S 
(PA2524) 
CzcR/CzrR 
(PA2523) 
Metal and antibiotic resistance 
Hassan et al., 1999; Perron et 
al., 2004 
CopRS 
CopS 
(PA2810) 
CopR 
(PA2809) 
Metal and antibiotic resistance Caille et al., 2007 
PmrAB 
PmrB 
(PA4777) 
PmrA 
(PA4776) 
Antibiotic resistance 
Barrow & Kwon, 2009; 
McPhee et al., 2003; McPhee 
et al., 2006; Moskowitz et al., 
2004 
 
 
Regulation of virulence: the Gac system 
The Gac system is particularly well understood and has been related to the switch between the 
planktonic and biofilm lifestyles in P. aeruginosa (Figure 1.6). It is found in pretty much all the 
Pseudomonas spp. genomes sequenced to date and has orthologs in other Gammaproteobacteria 
species such as Escherichia spp., Salmonella spp., Vibrio spp. or Legionella spp. (Lapouge et al., 
2008). 
 
The core GacAS two-component system 
The GacAS two-component system is composed of the sensor GacS and the response regulator 
GacA. GacS (PA0928) is an unorthodox sensor that has a transmembrane domain and an HAMP 
domain at the N-terminus – HAMP domains function as linkers and were named after the proteins 
where they are commonly found (Table 1.1) (Parkinson, 2010) – followed by an H kinase domain, a 
REC domain and an Hpt domain at the C-terminus. GacA (PA2586) is a typical response regulator, 
with an N-terminal REC domain and a C-terminal helix-turn-helix DNA binding domain. What exactly 
drives autophosphorylation of GacS is not known, but when active, the phosphoryl group travels via 
the REC and Hpt domains of GacS to the REC domain of GacA (Goodman et al., 2009; Zuber et al., 
2003). Once phosphorylated, GacA drives the expression of two small non coding RNAs (sRNAs), 
RsmY (PA0527.1) and RsmZ (PA3621.1), by directly binding to the upstream region of their 
promoters (Brencic et al., 2009).  
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Figure 1.6 The Gac regulatory cascade in P. aeruginosa inversely regulates the bacterial lifestyle 
and mode of infection. 
This complex cascade is composed of a central two-component system, GacS and GacA. Upon 
phosphorylation of the response regulator GacA by the sensor GacS, transcription of two sRNAs is 
initiated. These sRNAs, RsmY and RsmZ, bind to RsmA and antagonize its activity. RsmA is a 
translational repressor that functions by binding to GGA motifs in the ribosome binding site of target 
mRNAs. Known direct targets of RsmA are the H1-T6SS genes and the psl genes. Two additional 
sensors impact the function of GacAS - RetS has a negative impact whereas LadS has a positive 
impact. The RetS inhibition occurs by direct binding of the sensor to GacS. Another sensor, PA1611 is 
also able to bind RetS, counteracting its inhibitory effect on GacAS (Kong et al., 2013). In addition, 
PA1611 phosphorylates HptB which then translates the phosphate to HsbR. Phosphorylation of HsbR 
inhibits its phosphatase activity and therefore HsbA, a putative anti-anti-sigma factor, remains 
phosphorylated and somehow prevents the expression of RsmY (Bordi et al., 2010). The sigma factor 
required for the expression for RsmY is not known but HsbA was shown to bind to FlgM, a repressor 
of σ28 (FliA, PA1455) which is required in the flagellum biosynthesis (Bhuwan et al., 2012). This Gac 
regulatory cascade is known to inversely regulate attributes related to the switch between acute and 
chronic infections. The proteins coloured in red behave as antagonists of the central GacAS and 
deletion mutants of the genes encoding those proteins have a hyperbiofilm phenotype. All the other 
proteins are coloured in green. Dashed arrows indicate unknown regulatory mechanism. 
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The antagonist sensor RetS 
Although the chemical signal that activates GacS is not known, one other sensor, RetS (PA4856), can 
prevent and control its activity. RetS is an orphan sensor with an N-terminus transmembrane input 
domain and a C-terminus with the H kinase domain and two REC domains. The input domain is a 
7TMR-DISM domain (seven transmembrane receptors with diverse intracellular signalling modules) 
which consists of seven transmembrane segments with a periplasmic ligand-binding domain (Table 
1.1) (Anantharaman & Aravind, 2003). Structural analysis of this domain in RetS revealed that it can 
form oligomers and that the periplasmic ligand-binding domain folds like a carbohydrate binding 
module (Vincent et al., 2010). On the other hand, molecular and biochemical studies of the C-
terminus of RetS revealed that RetS does not respond by autophosphorylation and instead, it seems 
to interact via its H kinase domain either with GacS or with another protein, PA1611 (Goodman et 
al., 2009; Kong et al., 2013; Laskowski & Kazmierczak, 2006). The formation of heterodimers 
between GacS and RetS inhibits GacA phosphorylation which is also prevented by the ability of RetS 
to promote the dephosphorylation of GacS (S. Porter, personal communication). Remarkably, 
deletion of retS or overexpression of PA1611 had the same impact on phenotypes like the activity of 
T3SS and biofilm formation, indicating that PA1611 can act as an antagonist of RetS. In addition, the 
impact observed on T3SS and biofilms was dependent on the central two-component system GacAS, 
demonstrating that indeed these proteins belong to the same pathway (Goodman et al., 2004; Kong 
et al., 2013). 
 
The sensor PA1611 and HptB  
PA1611 is a hybrid sensor kinase with transmembrane regions and a HAMP domain at the N-
terminus and an H kinase and REC domain at the C-terminus. Despite the fact that the kinase activity 
of PA1611 is not required for the interaction with RetS, PA1611 alone is able to undergo 
autophosphorylation and create a phosphorelay that goes via an Hpt domain protein, HptB 
(PA3345), to the response regulator HsbR (PA3346) (Hsu et al., 2008; Lin et al., 2006). Interestingly, 
the regulon of an hptB deletion mutant was shown to correspond to a subset of the regulon of a retS 
deletion mutant (Figure 1.7) and the T3SS and biofilm phenotypes associated with the hptB mutant 
were dependent on GacAS (Bordi et al., 2010).    
 
The additional sensor LadS 
Besides RetS, there are only three other genes in P. aeruginosa PAO1 that encode for proteins with a 
predicted 7TMR-DISM input domain: LadS, PA3462 and PA4929. LadS (PA3974) is another orphan 
and hybrid sensor that has a H kinase and REC domain at the C-terminus. Strikingly, the regulon of a 
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ladS deletion mutant partially overlaps with the regulon of a retS mutant and in more than 90% of 
the cases the genes are oppositely regulated (Figure 1.7) (Ventre et al., 2006). Also, deletion of ladS 
causes a similar reduction on rsmZ expression as a deletion in gacS, supporting a model in which 
LadS acts synergistically with GacAS to activate the expression of the downstream rsmY and rsmZ 
targets (Ventre et al., 2006). Like LadS, PA3462 is an orphan and hybrid sensor whose function was 
very recently shown to reduce the phosphorylation of GacS (Francis et al., 2013) and PA4929 (Table 
1.5) instead of having an H kinase transmitter domain at the C-terminus, it has an enzymatic output 
domain with putative catalytic activity.         
 
 
Figure 1.7 Venn diagrams showing the number of genes in the regulons of RetS, LadS, GacA, HptB, 
RsmYZ and RsmA. 
(A) A total of 139 genes of the RetS and RsmA regulons overlap and are regulated in the same 
direction. (B) A total of 40 genes of the RetS and LadS regulons overlap and are antagonistically 
regulated with the exception of PA1001 which was regulated in the same orientation. (C) The 
regulon of HptB falls into the regulon of RetS. (D) The regulons of GacA and RsmYZ (RsmY and RsmZ) 
overlap almost in their entirety (227 genes) and are regulated in the same direction with the 
exception of PA2560. 
 
The sRNAs: RsmY and RsmZ 
At least three different sensors (RetS, PA1611 and LadS) feed into the GacAS two-component system 
to regulate the expression of two sRNAs, RsmY and RsmZ.  Importantly, once expressed, these sRNAs 
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are both subjected to and exerting a regulatory action. For instance, it was demonstrated that two 
transcriptional regulators, MvaT (PA4315) and MvaU (PA2667), can bind AT-rich stretches upstream 
of rsmZ and inhibit its expression (Brencic et al., 2009). Also, RsmZ seems to be regulated 
posttranscriptionally by the RNase CafA (PA4477) to allow the natural progression of the biofilm 
developmental cycle (Petrova & Sauer, 2010). On the other hand, RsmY was shown to be 
posttranscriptionally stabilized by an RNA-binding protein called Hfq (PA4944) (Sonnleitner et al., 
2006). It has also been demonstrated that HptB controls the levels of RsmY expression (Bordi et al., 
2010). In this case, the precise regulatory mechanism is not known, but a model has been proposed 
where the downstream targets of HptB, i. e. HsbR and HsbA, control the release of a sigma factor 
that impacts rsmY expression. Briefly, HptB leads to phosphorylation of the response regulator HsbR, 
therefore repressing the phosphatase activity of the HsbR output domain. Subsequently, the HsbR 
downstream target, a putative anti-anti-sigma factor named HsbA (PA3347), is not activated by 
dephosphorylation and prevents the release of the sigma factor required for rsmY expression (Bordi 
et al., 2010).  More recently, a model for HsbR was proposed in which HsbR can act as both a 
phosphatase and a S (serine) kinase of HsbA and HsbA was shown to bind to the anti-sigma factor 
FlgM which negatively regulates the σ28 sigma factor involved in the expression of flagellar genes 
(Bhuwan et al., 2012). However, the authors of this study did not explore if σ28 is the sigma factor 
involved in the expression of RsmY.  
 
The translational repressor RsmA 
In relation to the regulatory role that RsmY and RsmZ exert, it has been shown that the two sRNAs 
can bind a small protein called RsmA (Heurlier et al., 2004; Kay et al., 2006). RsmA (PA0905) is a 
RNA-binding protein that acts as a posttranscriptional repressor by binding to GGA motifs in the 
ribosome binding site (RBS) of target RNAs and preventing translation (Brencic & Lory, 2009). In a 
very exciting work, Brencic and Lory at the Harvard Medical School, identified the regulon of RsmA 
(more than 500 genes) and showed that indeed the negative regulation exerted by RsmA is 
dependent on the direct binding of RsmA to the mRNA targets. Among many others, these targets 
were mRNA of genes belonging to operons responsible for T6SS or exopolysaccharide production. 
Remarkably, approximately one third of the RsmA regulon was positively regulated rather than 
negatively. This included genes of the T3SS and T4P. For this positive regulation, direct binding of 
RsmA to mRNA targets was not observed supporting the notion that RsmA can only act as a 
posttranscriptional repressor and suggesting that the positive regulation is indirect, probably 
exerted at the level of transcription via the negative regulation of regulatory factors (Brencic & Lory, 
2009). Indeed, this seems to be the case for the control of motility in Pseudomonas fluorescens 
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where RsmA was shown to bind a sigma factor, σ22 (PA0762) and block its translation. By doing so, 
RsmA is indirectly preventing the expression of σ22 targets which include a transcriptional repressor 
of the flagellar genes (Martinez-Granero et al., 2012). It remains to be investigated if the same 
mechanism operates in P. aeruginosa.  
 
 
Figure 1.8 Regulation of the sRNAs, RsmY and RsmZ.   
At the transcriptional level, the two-component system GacAS is required for the transcription of the 
two sRNAs whereas HptB indirectly affects positively rsmY expression and the transcriptional 
regulators MvaT and MvaU negatively affect the expression of rsmZ. The control exerted by GacA is 
likely dependent on GacA dimerization upon phosphorylation and occurs by binding of GacA to a 
conserved upstream activating sequence in the promoter regions (Humair et al., 2010). HptB is an 
Hpt domain protein that phophorylates HsbR and HsbR has an output domain with phosphatase 
activity. This phosphatase activity was hypothesized to activate an anti-anti-sigma factor which binds 
an anti-sigma factor and realeases a sigma factor involved in the transcription of rsmY (Bordi et al., 
2010). MvaT and MvaU bind AT-rich stretches upstream of rsmZ and inhibit its expression (Brencic et 
al., 2009). At the posttranscriptional level, the RNA-binding protein Hfq is known to stabilize RsmY 
(Sonnleitner et al., 2006) and the RNase CafA is involved in degrading RsmZ. The production of CafA 
is transcriptionally regulated by binding of BfiR, the response regulator of the sensor BfiS, to the 
region upstream of cafA (Petrova & Sauer, 2010). Dashed arrows indicate unknown regulatory 
mechanism. 
 
In summary, the Gac system is composed of a central two-component system, GacAS whose 
response regulator GacA drives the expression of two sRNAs upon phosphorylation. The sRNAs then 
compete for binding to RsmA, sequestering it and allowing translation of its mRNA targets. This leads 
to biofilm formation and expression of T6SS. In addition, other sensors have been shown to intersect 
with this central cascade. More specifically, LadS and PA1611 act in concert with GacAS to 
counteract the RsmA repression and promote biofilm formation; and RetS acts as an antagonist of 
 44 
 
GacAS, preventing phosphorylation of GacA and promoting a motile lifestyle with the expression of 
the T3SS (Figure 1.6). 
 
Regulation of biofilm development: the Bfi, Bfm and Mif systems 
Two-component systems can regulate a broad range of phenotypes, like the Gac system, but they 
can also regulate specific traits in a very timely and ordered manner. This is the case, for instance, of 
the Bfi, Bfm and Mif systems which are activated one after the other to allow the progression of the 
biofilm developmental cycle from initial attachment to maturation.  
 
These systems were identified when studying the phosphoteome of P. aeruginosa biofilms at 
different stages of development. Petrova and Sauer found three two-component systems that were 
phosphorylated at different stages: BfiRS at the initiation of biofilm formation, BfmRS during biofilm 
maturation and MifRS at the stage of microcolony formation (Petrova & Sauer, 2009). Although the 
three sensors, BfiS (PA4197), BfmS (PA4102) and MifS (PA5512), all have C-terminal H kinase 
domains, their predicted N-terminal structure is different: BfiS has a PAS domain, BfmS has 
transmembrane domains followed by a HAMP domain, and MifS harbours transmembrane domains. 
Regarding the response regulators, BfiR (PA4196), BfmR (PA4101) and MifR (PA5511), the same 
modular organization of an N-terminal REC domain and a C-terminal DNA binding domain is 
recognizable. However, the structure of their DNA binding domain is different and belongs to 
different families of transcriptional regulators – BfiR belongs to the NarL family, BfmR to the OmpR 
family and MfiR to the NtrC family (Ventre et al., 2004).   
     
In addition to these three two-component systems, the sensor SagS (PA2824) was shown to be 
activated prior to BfiS and to be able to interact with BfiS to modulate its autophosphorylation 
(Petrova & Sauer, 2011). Interestingly, SagS is a membrane associated hybrid sensor that was 
identified in the same screen that led to the characterization of RetS (Goodman et al., 2004) and that 
is able to phosphorylate HptB (Hsu et al., 2008). Furthermore, during the biofilm mode of growth it 
was shown that a sagS deletion mutant has elevated levels of both RsmY and RsmZ (Petrova & 
Sauer, 2011). This is in agreement with the concepts presented earlier. Firstly, deletion of sagS 
prevents phosphorylation of HptB and the sigma factor required for RsmY expression is released 
(Bordi et al., 2010). Secondly, deletion of sagS prevents BfiS phosphorylation and this does not 
contribute for the degradation of RsmZ by CafA (Petrova & Sauer, 2010).          
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In summary, in the initial stages of biofilm development a synchronized action of at least four 
sensors is required. While it is not known how the communication occurs between BfiS and BfmS or 
BfmS and MifS, it has been shown that BfiS phosphorylation is SagS dependent (Petrova & Sauer, 
2011).  
 
Regulation by eukaryotic-like kinases 
In eukaryotic cells, two-component systems as seen in prokaryotic cells are not widely distributed 
and instead pathways that use STY (serine, threonine or tyrosine) phosphorylation in 
posttranslational modifications are common. Curiously, in an analysis of the STY phosphoproteome 
of the P. aeruginosa PAO1 strain, a total of 57 proteins were identified. One of them, PpkA (PA0074) 
is a known kinase involved in the posttranslational control of the H1-T6SS (Ravichandran et al., 
2009). Briefly, the membrane associated PpkA undergoes autophosphorylation in a specific S residue 
upon sensing of a signal. The phosphoryl group is then transferred to a T residue in the Fha1 
(PA0081) protein, allowing assembly of the T6SS machinery and secretion of the effector proteins. 
The kinase activity of PpkA is counteracted by its cognate phosphatase PppA (PA0075) which keeps 
Fha1 dephosphorylated and prevents secretion. The signal that drives autophosphorylation of PpkA 
is unknown but is thought to be perceived in the periplasm and be surface-contact dependent 
(Casabona et al., 2012; Mougous et al., 2007; Silverman et al., 2011; Silverman et al., 2012).    
 
1.2.3 Regulation by phosphorylation and methylation 
 
In addition to direct binding of a signal to an effector protein (one-component systems) and 
cascades of phosphorylation reactions (two-component systems), bacteria also have sophisticated 
regulatory mechanisms that use a combination of both phosphorylation and methylation processes 
and allow the sensing of the rate of change of different environmental cues. These regulatory 
cascades are referred to as chemotactic pathways and are usually involved in chemotaxis, i.e. the 
signal transduction pathway that allows flagellated bacteria to sense extracellular signals and swim 
towards favourable niches.   
 
At least six proteins are involved in a typical Escherichia coli chemotactic pathway: a receptor (MCP, 
methyl accepting chemotaxis protein), an adaptor (CheW), a kinase (CheA), two response regulators 
(CheY and CheB) and a methyltransferase (CheR). Occasionally, an additional phosphatase (CheZ) is 
present (Figure 1.5) (Scott et al., 2012). The functional organization of a chemotactic signalling 
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pathway starts with a signal being perceived by a MCP (usually membrane associated with an 
extracellular sensing domain) and then transduced through its C-terminus and by means of an 
adaptor protein, to a cytoplasmic kinase. When triggered, the kinase suffers autophosphorylation of 
an H residue and the phosphoryl group is then transferred to the two response regulators CheY and 
CheB. CheY, is an atypical response regulator as it only consists of the REC domain but CheB has a 
methylesterase output domain. Upon phosphorylation, CheY goes to the flagellar motor where it 
interacts with flagellum proteins to modulate motility and CheB demethylates the MCP affecting the 
rate at which CheA autophosphorylates. The methylesterase activity of CheB is counteracted by the 
methyltransferase activity of CheR which is constitutively active. Together, CheB and CheR work as a 
module that resets the system, guaranteeing that the bacterial behaviour is being constantly 
adapted to the surrounding environment. An additional level of control can be added by CheZ which 
acts as a phosphatase of CheY to quickly restart the system. 
      
Based on homology to the CheA kinase, there are four chemotaxis clusters in the genome of P. 
aeruginosa PAO1 and a total of 26 MCP genes are found (Table 1.3) (Porter et al., 2011; Parales et 
al., 2004). Again, this high number of chemotaxis clusters and MCPs contrasts with other bacteria – 
for instance, E. coli has only one cluster and 5 MCPs. Interestingly, not all the four clusters found in 
P. aeruginosa are involved in chemotaxis. The pil-chp cluster (PA0408-PA0417) is involved in T4P-
mediated twitching motility and the wsp cluster (PA3702-PA3708) is involved in c-di-GMP dependent 
biofilm formation.   
 
A variety of MCPs   
P. aeruginosa is known to have a chemotactic behaviour towards a variety of amino acids, sugars, 
organic acids, aromatic compounds and oligopeptides (Kato et al., 2008). So far, only half of the 
MCPs have been characterized to date and in most of the cases, the data does not provide 
biochemical insights about their function. It has been shown, however, that MCPs in other model 
organisms tend to form homodimers and then oligomerise, appearing as cluster of different MCPs at 
the cell poles. By aggregating, these clusters of MCPs allow for both sensing of multiple signals and 
amplification of an input signal.  
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Table 1.3 MCPs found in P. aeruginosa. 
MCP Function 
Transmembrane 
domains 
Other 
domains 
References 
Chemotaxis 
PA0176  
(McpB/ 
Aer2/TlpG) 
Aerotaxis -- PAS 
Hong et al., 2004; Watts 
et al., 2011 
PA0180 
(McpA/CttP) 
Low chloroethylenes   -- Kim et al., 2006 
PA1561 
(Aer/TplC) 
Aerotaxis   PAS Hong et al., 2004 
PA2561 (CtpH) Low inorganic phosphate   HAMP Wu et al., 2000 
PA2652 Malic acid   
Cache, 
HAMP 
Alvarez-Ortega & 
Harwood, 2007 
PA4307 (PctC) 
PA4309 (PctA) 
PA4310 (PctB) 
L-aminoacids and high 
chloroethylenes 
  
Cache, 
HAMP 
Shitashiro et al., 2005; 
Taguchi et al., 1997 
Kuroda et al., 1995; 
Shitashiro et al., 2005 
Shitashiro et al., 2005; 
Taguchi et al., 1997 
PA4844 (CtpL) High inorganic phosphate   HAMP Wu et al., 2000 
Other functions 
PA0411 (PilJ) Type IV pili biogenesis   HAMP DeLange et al., 2007 
PA1423 (BdlA) Biofilm dispersal -- PAS Morgan et al., 2006 
PA2573 Virulence   HAMP McLaughlin et al., 2012 
PA3708 (WspA) Biofilm formation   HAMP O'Connor et al., 2012 
Unknown function 
PA1251    HAMP -- 
PA1608    HAMP -- 
PA1646    HAMP -- 
PA1930 (McpS) Polar localisation -- PAS Bardy & Maddock, 2005 
PA2654    HAMP -- 
PA2788    HAMP -- 
PA2867    HAMP -- 
PA2920    HAMP -- 
PA4290    -- -- 
PA4520    HAMP -- 
PA4633    HAMP -- 
PA4915    HAMP -- 
PA5072    HAMP -- 
 
 
In terms of modular organization, MCPs usually have N-terminal transmembrane segments that 
place the input domain extracellularly; a cytoplasmic HAMP domain that allows transduction of the 
signal through the membrane; and a C-terminal kinase control module that harbours a methylation 
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glycine hinge and interacts with the downstream components of the cascade to modulate CheA 
autophosphorylation.    
In P. aeruginosa, a few MCPs involved in chemotactic responses to amino acids (PctA, PctB, PctC), 
organic acids (PA2652), inorganic phosphate (CtpH, CtpL), oxygen (Aer, Aer2) and ethylene 
derivatives (CttP) have been identified (Table 1.3). Sometimes, like for Aer and Aer2, MCPs have PAS 
domains and lack transmembrane domains, serving as sensors of the redox status of the cell 
(Schweinitzer & Josenhans, 2010). Also, in the case of PctA, PctB, PctC and PA2652, an N-terminal 
input domain – called Cache domain for being frequently found in animal calcium channels and 
prokaryotic chemotaxis receptors –, is bioinformatically recognizable but its function remains 
unknown (Table 1.1) (Anantharaman & Aravind, 2000).  
Interestingly, a few other MCPs have been implicated in functions other than chemotaxis. These 
include PilJ, WspA, BdlA and PA2573. Briefly, PilJ (PA0411) belongs to the Pil-Chp cluster and has 
been shown to be required for proper biogenesis of the T4P (DeLange et al., 2007). WspA (PA3708) 
belongs to the Wsp cluster and does not seem to form clusters at the cell poles or respond to 
binding of small extracellular signal molecules. Instead, it localises to the periphery of the cells and 
responds to signals associated with growth on a surface (Guvener & Harwood, 2007; O'Connor et al., 
2012). BdlA (PA1423) is an orphan MCP with two N-terminal PAS domains and is required for biofilm 
dispersal. To become activated, BdlA is subjected to a quite complex posttranslational modification. 
Upon phosphorylation of a Y residue located after the second PAS domain, the protein suffers 
protease cleavage between the two PAS domains, leading to an interaction of the two cleaved 
fragments that causes structural modifications which activate downstream targets (Morgan et al., 
2006; Petrova & Sauer, 2012a; Petrova & Sauer, 2012b). Finally, another orphan MCP, PA2573, has 
been implicated in virulence and antibiotic resistance. It has been shown that PA2573 interacts with 
the REC domain of the response regulator PA2572 (Table 1.5) and that the regulon of PA2573 and 
PA2572 deletion mutants overlaps in the negative regulation of the T3SS and the modulation of 
various genes involved in antibiotic resistance (McLaughlin et al., 2012).  
 
The che and che2 clusters 
These two clusters are related to flagella-driven swimming motility and include genes that share 
homology with the components of the chemotactic pathway found in E. coli.  
The Che system is essential for chemotaxis and has homologues to CheA (PA1458), CheB (PA1459), 
CheW (PA1464), CheY (PA1456) and CheZ (PA1457). It misses a recognizable MCP, it encodes four 
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additional proteins – two of which are the MotCD homologues of the MotAB flagellum stator 
proteins –, and it lacks the methyltransferase CheR (PA3348) which is encoded elsewhere in the 
chromosome (Kato et al., 1999; Masduki et al., 1995). Next to CheR, a protein with homology to 
CheW at the N-terminus and CheY at the C-terminus, CheV (PA3349), is found (Alexander et al., 
2010). Interestingly, CheR was shown to be able to methylate the MCP PctA in response to addition 
of amino acids (Schmidt et al., 2011).  
The Che2 system is thought to play a role in chemotaxis when the cells enter stationary growth 
(Schuster et al., 2004). This cluster encodes two MCPs (McpA and McpB) and all the other 
components of a chemotactic pathway: CheA2 (PA0178), CheB2 (PA0173), CheW2 (PA0177), CheY2 
(PA0179) and CheR2 (PA0175). In addition, it has a CheD (PA0174) homologue which, in other 
microorganisms, functions as a MCP deamidase and is involved in the adaptation of the chemotactic 
response (Scott et al., 2012). Intriguingly, both Che and Che2 protein complexes locate to the cell 
poles but do not colocalize and whereas McpB (PA0176) is required for Che2 protein complex 
formation, McpA (PA0180) seems to be recruited to the Che protein complex when cells enter 
stationary phase (Guvener et al., 2006).  
 
The pil-chp cluster 
The pil-chp cluster is related to the function and biogenesis of the T4P (Whitchurch, 2004). It 
encodes one MCP (PilJ), one methylesterase (ChpB), two adaptor proteins (PilI and ChpC), two 
response regulators (PilG and PilH), and one methyltransferase (PilK). A kinase, ChpA (PA0413), is 
also encoded but this is an unusually complex protein harbouring an extra eight potential 
phosphorylation sites (six Hpt, one T and one S) at the N-terminus, and a REC domain at the C-
terminus. In addition, two other genes are found, chpD and chpE, but their exact function is 
unknown. ChpD (PA0416) is a predicted transcriptional regulator and ChpE (PA0417) a small 
membrane protein (Whitchurch et al., 2004).  
It has been proposed that the functional organisation of the Pil-Chp system starts when PilJ, the 
MCP, senses a yet unknown signal that induces the autophosphorylation of ChpA with the help of 
one of the adaptor proteins PilI (PA0410) and/or ChpC (PA0415). The precise role of the extra 
phosphorylation sites of CheA is not well understood but the REC domain at the C-terminus has been 
shown to be essential for twitching motility (Leech & Mattick, 2006). Nonetheless, the phosphoryl 
group is thought to be transferred from CheA to the methylesterase ChpB (PA0414) and to the two 
response regulators PilG (PA0408) and PilH (PA0409) which then interact with downstream targets 
to control pilus extension and retraction, respectively (Bertrand et al., 2010).     
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Given the complexity of the kinase ChpA, it is possible that the Pil-Chp system has additional roles 
that go beyond the direct control of twitching motility. For instance, at the tip of the N-terminus, a 
domain that resembles FimL (PA1822) is recognizable. FimL is a known regulator of the levels of an 
intracellular signalling cyclic nucleotide called cyclic AMP (cAMP). This cyclic nucleotide is known to 
regulate a variety of processes including T2SS, T3SS, T4P and flagella biogenesis (Inclan et al., 2011; 
Nolan et al., 2012; Whitchurch et al., 2005). Remarkably, it has recently been described that 
mutations in chp genes have an effect on the levels of cAMP. Although the precise molecular 
mechanism of this effect is yet to be elucidated, if it turns out that there is a direct link between the 
two, a new and broader impact of the Pil-Chp pathway will be unravelled (Fulcher et al., 2010). 
                                
The wsp cluster 
The wsp cluster has been associated with biofilm formation and harbours homologues to a MCP 
(WspA), a methylesterase (WspF), two adaptor proteins (WspB and WspD) and a methyltransferase 
(WspC) (Hickman et al., 2005). Similar to the Pil-Chp cluster, the kinase WspE (PA3704) has also a 
REC domain at the C-terminus (but lacks the remaining ChpA complexity). The WspR (PA3702) 
response regulator has the typical REC domain and in addition, a C-terminal output domain with 
enzymatic activity (Figure 1.9, Table 1.5). 
The Wsp system is associated with the formation of biofilms. Upon sensing of a signal associated 
with growth on a surface and with the help of the adaptor proteins WspB (PA3707) and/or WspD 
(PA3705), the MCP WspA induces autophosphorylation of WspE (O'Connor et al., 2012). The 
function of the REC domain of WspE is not known but the phosphoryl group is then transferred to 
the methylesterase WspF (PA3703) and the response regulator WspR. Once phosphorylated, WspR 
forms oligomers which are visible as patches in the bacterial cells (Guvener & Harwood, 2007; 
Huangyutitham et al., 2013). Together, the phosphorylation and the clustering of WspR activate its 
output domain whose catalytic activity leads to the production of the intracellular signalling 
molecule cyclic di-GMP, stimulating biofilm formation. The P. aeruginosa c-di-GMP signalling 
network is described in the following pages and you can find more information about WspR in 
section 1.4.1. 
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Figure 1.9 The Wsp system and WspR.  
(A) Model of the Wsp signal transduction complex. WspA is a MCP protein that detects an unknown 
signal associated with growth on a surface. Upon reception of a stimulus, the H kinase WspE 
phosphorylates the response regulator WspR. Phosphorylated WspR produces c-di-GMP. The 
methyltransferase WspC and the methylesterase WspF likely play a role in adaptation to the surface 
signal. In a wspF deletion mutant WspR is constitutively active. The adaptor proteins WspB and 
WspD are important for function and proper localization of the Wsp complex. (B) Structure of a 
WspR dimer with bound c-di-GMP to the inhibition sites (I-sites). One molecule is shown in grey and 
the other in black. Cyan indicates the GGEEF motif which forms the A-site of the protein. The 
phosphorylation site is indicated in yellow (D70) and the green spheres are the magnesium ions 
needed for phosphorylation. The residues indicated in red are important for function. The V72 
residue is located in the REC domain and mutation to D activates the GGDEF domain. The L167 and 
L170 residues are located in the linker region and affect WspR tetramerization. R198 mutation to A 
renders the I-site unable to bind c-di-GMP. E253 mutation to A changes the GGEEF motif and 
inactivates the DGC activity. Figure retrieved from Huangyutitham et al. (2013). 
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1.3 Cyclic nucleotide signalling in P. aeruginosa 
 
Nucleotides are not only the building blocks of nucleic acids. They are also fundamental molecules in 
cellular energy transfer, via ATP (adenosine triphosphate), and serve as important signalling 
molecules in all domains of life. In eukaryotic cells, the cyclic nucleotides cAMP (cyclic adenosine 
3’,5’-monophosphate) and cGMP (cyclic guanosine 3’,5’-monophosphate) have long been recognized 
as important signalling molecules that act as second messengers to regulate a great variety of 
cellular processes. More recently, a third cyclic nucleotide, cGAMP (cyclic guanosine 
monophosphate–adenosine monophosphate) has been identified and shown to have a role in 
triggering the innate immune system upon sensing of DNA in the cytosol (Davies et al., 2012; Wu et 
al., 2013; Yoon et al., 2007).  
In prokaryotic cells, cAMP, cGMP and cGAMP can be found but with the exception of cAMP, their 
role is limited to a few regulatory pathways or not well understood. Instead, cyclic dinucleotides like 
cdAMP (cyclic dimeric adenosine monophosphate) and c-di-GMP (cyclic dimeric guanosine 
monophosphate) have emerged as bacterial second messengers that are used to regulate a wide 
variety of processes in a very specific manner.  Interestingly, c-di-GMP has been described as a 
ubiquitous but not essential molecule in the bacterial world (Galperin, 2010b; Romling, 2012; Solano 
et al., 2009). In Gram-negative bacteria, it commonly forms an intricate network that regulates a 
variety of biological functions, including those associated with the transition between a motile and a 
biofilm lifestyle (Mills et al., 2011; Parsek & Aldridge, 2010). In contrast, cdAMP seems to be an 
essential but not so widespread signalling molecule. In Gram-positive bacteria, cdAMP has been 
implicated in sensing of DNA integrity, control of ion transport across the membrane and cell wall 
homeostasis (Corrigan et al., 2011; Corrigan et al., 2013; Corrigan & Grundling, 2013; Oppenheimer-
Shaanan et al., 2011). Besides cyclic nucleotides, bacteria can also use the linear nucleotides 
(p)ppGpp (guanosine pentaphosphate or tetraphosphate) to mediate their response to stress 
conditions (a process known as stringent response) (Kalia et al., 2013).  
In P. aeruginosa, two cyclic nucleotides have known regulatory functions: cAMP and c-di-GMP 
(Coggan & Wolfgang, 2012). State of the art knowledge on the signalling mechanisms of each 
molecule in P. aeruginosa is described hereafter.  
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1.3.1 Cyclic AMP signalling 
 
Cyclic AMP was first characterized in eukaryotic cells as a signalling molecule in the adrenaline 
pathway by Earl Sutherland, who later became a Nobel Laureate for his findings on the mechanisms 
of action of hormones (Kresge et al., 2005). This cyclic nucleotide was then found in bacteria where 
it is mainly associated with the carbon catabolite control. Briefly, this is the response that bacterial 
cells undergo to avoid the unnecessary use of energy when more than one carbon source is available 
in the surrounding medium (Rojo, 2010).  
In E. coli, the carbon catabolite control is well characterized in relation to glucose, the preferred 
carbon source, and lactose, a secondary carbon source. In very simple terms, the presence of 
glucose in the medium is concomitant with a repression of the lac operon which encodes proteins 
required for lactose degradation. This repression is owed to the presence of a cAMP receptor 
protein (Crp) that has a cAMP-binding domain at the N-terminus and a DNA-binding domain at the C-
terminus. When glucose is depleted from the medium, the production of cAMP is stimulated by the 
glucose transporter system in the membrane, leading to the formation of cAMP-Crp complexes that 
act as transcription activators of the lac operon (Botsford, 1981). In P. aeruginosa, however, organic 
acids such as succinate and amino acids are the preferred carbon sources and carbon catabolite 
control does not operate in a similar fashion. Instead, the CbrAB two-component system (Table 1.2) 
is a key player in carbon catabolite control, acting through the regulation of the availability of a RNA-
binding protein, Crc, that inhibits translation of genes involved in the catabolism of nonpreferred 
nutrients (Rojo, 2010). 
Nonetheless, P. aeruginosa is able to produce cAMP and this is known to play a role in virulence. 
Typically, cAMP is produced from ATP by adenylyl cyclases (ACs), degraded by phosphodiesterases 
(PDEs) and perceived by cAMP-binding proteins. P. aeruginosa harbours three ACs (CyaA, CyaB and 
ExoY), one PDE (CpdA) and two cAMP-binding proteins (Vfr and CbpA).  
CyaA (PA5272) is a cytoplasmic AC with catalytic activity that has been implicated in glucose 
starvation induced biofilm dispersal through a yet unknown mechanism that requires cAMP 
synthesis (Huynh et al., 2012). In the case of CyaB (PA3217), the protein has a recognizable N-
terminus MASE domain and a C-terminus AC domain.  MASE domains are membrane associated 
sensory domains that were bioinformatically identified and whose function is largely unexplored 
(Nikolskaya et al., 2003). Very recently however, a MASE domain has been characterized for the first 
time. In a protein from Salmonella enterica, mutation of a KKE (lysine – lysine – glutamic acid) motif 
located in one of the cytoplasmic loops of the MASE domain rendered the protein unable to mediate 
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aspartate chemotaxis, a function that was also dependent on the redox status of the cell (Table 1.1) 
(Lacey et al., 2013).  
Like CyaA, the AC CyaB has also catalytic activity. Both under laboratory growth conditions and 
during infection of an acute murine model, CyaB seems to be the dominant AC (Smith et al., 2004; 
Wolfgang et al., 2003).   
The two CyaA and CyaB have been shown to be involved in the regulation of a total of 181 genes and 
most of them (162 genes) were shown to be also regulated by the cAMP-binding protein Vfr 
(Wolfgang et al., 2003). Vfr (PA0652) has 67% sequence identity to Crc in E. coli and upon binding of 
cAMP acts as a transcriptional activator of different virulence factors including T4P, T2SS and T3SS 
genes. In contrast, it can act as a transcriptional repressor of a subset of other targets (45 out of 206 
genes), including the transcription regulator of the genes involved in flagellar biogenesis (Dasgupta 
et al., 2002; Wolfgang et al., 2003). Curiously, Vfr also affects positively the transcription of the 
quorum sensing related LasR protein but this occurs in a cAMP independent manner (Fuchs et al., 
2010a). 
The cAMP catalytic action of CyaA and CyaB is counteracted by the action of the PDE CpdA. CpdA 
(PA4969) was shown to be able to degrade cAMP upon binding of an iron cofactor and transcription 
of cpdA is under positive control of Vfr (Fuchs et al., 2010b). Hence, CpdA is thought to act in concert 
with CyaA and CyaB to adjust the bacterial intracellular cAMP levels and fine tune the expression of 
different virulence traits. Overall, the modulation of cAMP concentration is known to be dependent 
or correlated to host cell contact, calcium concentration in the medium, activity of the Pil-Chp 
system, production of alginate and expression of fimL (Fulcher et al., 2010; Inclan et al., 2011; Jones 
et al., 2010; Wolfgang et al., 2003). 
Interestingly, the third AC of P. aeruginosa is ExoY, an effector protein that is secreted via the T3SS 
into eukaryotic host cells. Unlike CyaA or CyaB, ExoY (PA2191) does not synthesize cAMP in the 
bacterial cells. Instead, the protein acts as a toxin in the T3SS targeted cells where it becomes 
capable of producing cAMP (Yahr et al., 1998). The increased levels of cAMP generated in the host 
cells are an oedema factor but the precise mechanisms of action underlying this phenomenum are 
not well understood yet (Hritonenko et al., 2011; Ochoa et al., 2012; Prasain et al., 2009).  
In addition to Vfr, a second cAMP-binding protein, CbpA (PA4704), is found in P. aeruginosa genome. 
This protein has two cAMP-binding domains: one degenerated at the N-terminus and one conserved 
and functional at the C-terminus. Unfortunately, not much is known about CbpA, except that it is 
under positive regulation of Vfr and that it localizes to the cell poles in a cAMP dependent manner 
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(Endoh & Engel, 2009). It is noteworthy that the proteins CyaB, FimL and PilJ (the latter belonging to 
the Pil-Chp system), also appear localised at the cell poles although in this case the localisation 
seems to be bipolar whereas for CbpA it is unipolar (DeLange et al., 2007; Inclan et al., 2011).  
 
1.3.2 Cyclic di-GMP signalling  
 
Cyclic di-GMP was first identified by Moshe Benziman when studying cellulose biogenesis in an 
innocuous Gram-negative bacterium called Gluconacetobacter xylinus (Amikam et al., 2010; Ross et 
al., 1987). Coincidently, both c-di-GMP and two-component systems were described for the first 
time in the decade of 1980 but unlike two-component systems, research on c-di-GMP was hampered 
for more than 15 years. Only in the last decade the understanding of c-di-GMP signalling took a leap 
and today, c-di-GMP is known as a ubiquitous bacterial second messenger that modulates a variety 
of biological processes that shape the bacterial lifestyle. In particular, the role of c-di-GMP in the 
regulation of the transition between a planktonic/motile and a biofilm/sessile lifestyle has become 
evident. At high levels of c-di-GMP, bacteria tend to adopt a biofilm lifestyle while at low levels of c-
di-GMP bacteria are directed towards a motile lifestyle (Gjermansen et al., 2006; Hengge, 2009; 
Jenal & Malone, 2006; Simm et al., 2004). 
 
The intracellular levels of c-di-GMP are known to be controlled by the biosynthetic activity of 
diguanylate cyclases (DGCs), which are enzymes that carry a GGDEF domain; and by the hydrolytic 
activity of PDEs that have an EAL or HD-GYP domain (Figure 1.10) (Schirmer & Jenal, 2009). 
Sometimes proteins have a GGDEF domain followed by an EAL domain and this domain is referred to 
as GGDEF/EAL domain. Cyclic di-GMP is synthesized from two molecules of GTP (guanosine 
triphosphate) and is degraded into pGpG (phosphoguanylyl guanosine) and/or GMP (guanosine 
monophosphate). Once in the cell, c-di-GMP can bind an array of different c-di-GMP receptors that 
act as effector proteins, translating the signal message into a molecular readout.  
 
The GGDEF domain 
The GGDEF domain is approximately 170 amino acids long and exhibits a series of conserved motifs 
including a GGDEF (glycine – glycine – aspartic acid – glutamic acid – phenylalanine) motif that folds 
into a β-hairpin (Figure 1.11) (Galperin, 2010b). This motif, or the variant GGEEF motif, harbours the 
DGC catalytic activity and constitutes half of the active site (A-site) as production of c-di-GMP 
requires the formation of dimers. Often, another motif, the RxxD (arginine – x – x – aspartic acid; 
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where x is any amino acid) motif, acts as an inhibition site (I-site) where c-di-GMP binds and prevents 
the encounter of the two halves of the A-site, therefore exerting a negative feedback on the DGC 
catalytic activity. Interestingly, the RxxD motif is found just five residues upstream of the GGDEF 
motif but in the three-dimensional structure it adopts an antipodal localization in relation to the 
GGDEF motif (Table 1.4) (Chan et al., 2004; De et al., 2008).  
 
 
Figure 1.10 Cyclic di-GMP related proteins. 
The second messenger is synthesized from two molecules of GTP by DGCs which have a GGDEF 
domain (in a reaction that releases two diphosphate) and degraded into pGpG or GMP by PDEs 
which have an EAL or HD-GYP domain. Often, the DGCs activity is inhibited by binding of c-di-GMP to 
the I-site. The I-site is an RxxD motif of the GGDEF domain that is located upstream of the GGDEF 
motif. Proteins that bind to c-di-GMP function downstream to transmit the signal and are referred to 
as c-di-GMP receptors. High levels of c-di-GMP are associated with a sessile lifestyle whereas low 
levels of c-di-GMP correlate to a motile lifestyle.  
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The EAL domain 
The EAL domain is approximately 240 amino acids long and folds in a central β-barrel with flanking 
α-helices (Figure 1.11) (Galperin, 2010b). This domain is highly specific for c-di-GMP and its PDE 
activity requires the binding of a metal ion that is coordinated by five to ten conserved residues. In 
addition, EAL domains are able to form dimers and this seems to be structurally and biochemically 
relevant. Overall, the E residue of the EAL (glutamic acid – alanine – leucine) motif, or the variant EVL 
(glutamic acid – valine – leucine) motif, together with a few downstream residues and a conserved 
loop 6 (corresponding to β5-α5 loop), are known to be important for coordinating ion binding, 
dimerization and catalysis (Minasov et al., 2009; Rao et al., 2008; Rao et al., 2009) (Table 1.4). 
 
The HD-GYP domain 
The HD-GYP domain is approximately 150 amino acids long and folds in seven α-helices (Figure 1.11). 
It is a c-di-GMP specialized hydrolase belonging to the widespread HD superfamily. Typically, the PDE 
activity is centred on the HD (histidine – aspartic acid) motif and dependent on binding to metal 
ions. The GYP (glycine – tyrosine – proline) motif is within a conserved region of residues located 
downstream of the HD motif. In the only three-dimensional structure of an HD-GYP domain available 
to date, at the same time that the GYP motif is positioned in close proximity to the A-site, it 
constitutes a surface exposed region (Table 1.4) (Lovering et al., 2011). This suggests a role of the 
GYP motif on either assisting the specificity to c-di-GMP binding or mediating the interaction with 
other proteins.        
 
Table 1.4 Structurally characterized proteins with a GGDEF, EAL or HD-GYP domain.  
Protein  Species Domains Mode of action References 
GGDEF domain proteins 
PleD C. crescentus 2xREC, GGDEF 
Phosphorylation of the first REC 
domain promotes dimerization 
and DGC activity; binding of c-di-
GMP to RxxD inhibits DGC 
activity. 
Chan et al., 
2004; Paul et 
al., 2007 
WspR P. aeruginosa REC, GGDEF 
Phosphorylation and 
oligomerization via the REC 
domain regulates DGC activity; 
binding of c-di-GMP to RxxD motif 
inhibits DGC activity. 
De et al., 2008; 
De et al., 2009 
XCC4471 X. campestris 
TM1, HAMP, 
GGDEF 
Conserved GGDEF motif and 
degenerated RxxD motif; binding 
of 2 c-di-GMP molecules to the 
GGDEF motif inhibits its catalytic 
activity. 
Yang et al., 
2011 
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Protein  Species Domains Mode of action References 
PelD P. aeruginosa 
TM, GAF, 
GGDEF 
Degenerated GGDEF motif; c-di-
GMP binds to the RxxD motif. 
Li et al., 2012 
DgcZ E. coli CZB2, GGDEF 
Constitutively active dimer; 
binding of zinc to the CZB domain 
inhibits the DGC activity. 
Zahringer et al., 
2013 
EAL domain proteins 
YkuI B. subtilis EAL, PAS 
c-di-GMP and one metal ion bind 
the EAL domain but catalytic PDE 
activity was not demonstrated. 
Minasov et al., 
2009 
BlrP1 K. pneumoniae BLUF, EAL 
Light and dimerization modulate 
PDE activity; EAL domain binds to 
c-di-GMP and to two catalytic 
metal ions. 
Barends et al., 
2009 
RocR P.aeruginosa REC, EAL 
Phosphorylation and 
oligomerization modulate PDE 
activity; EAL domain binds to c-di-
GMP and to one catalytic metal 
ion. 
Chen et al., 
2012 
GGDEF/EAL domain proteins 
TBD1265 T. denitrificans 
PBPb, TM, 
GGDEF, EAL 
Catalytic active PDE; the EAL 
domain forms dimers and binds 
to c-di-GMP and to two metal 
ions.  
Tchigvintsev et 
al., 2010 
FimX 
P. aeruginosa 
X. axonopodis 
REC, PAS, 
GGDEF, EAL 
Degenerated GGDEF and RxxD 
motifs; c-di-GMP binds to the 
catalytic inactive EAL domain. 
Forms dimers via N-terminal 
domains and interacts with c-di-
GMP and other proteins via the 
EAL domain. 
Guzzo et al., 
2013; Navarro 
et al., 2009; Qi 
et al., 2012 
 
LapD P. fluorescens 
TM, HAMP, 
GGDEF, EAL 
Degenerated GGDEF and RxxD 
motifs; forms dimers via the N-
terminal domains; c-di-GMP binds 
to the catalytic inactive EAL 
domain and the protein adopts an 
active conformation. 
Navarro et al., 
2011 
DosP E. coli 
2xPAS, GGDEF, 
EAL 
Catalytic active PDE; EAL domain 
binds c-di-GMP and two metal 
ions; presence of O2, CO or NO 
sensed by the first PAS domain 
modulates PDE activity. 
Tarnawski et 
al., 2013 
HD-GYP domain proteins 
Bd1817 B. bacteriovorus NTD3, HD-GYP 
Catalytic PDE activity was not 
demonstrated; degenerated GYP 
motif. 
Lovering et al., 
2011 
1TM – transmembrane domain 
2CZB – chemoreceptor zinc binding domain 
3NTD – unknown N-terminal domain 
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The c-di-GMP receptors 
The mechanisms by which c-di-GMP signalling translates into a molecular readout are various and 
only now they start to be understood. Reflecting the diversity of pathways where c-di-GMP takes 
part, the c-di-GMP receptors include (i) proteins with inactive GGDEF, EAL or HD-GYP domains, (ii) 
proteins with a PilZ domain, (iii) riboswitches and proteins involved in RNA processing and (iv) 
proteins that act as transcriptional factors (Ryan et al., 2012b; Sondermann et al., 2012). 
Interestingly, (v) c-di-GMP receptors in eukaryotic cells have also been identified (Krasteva et al., 
2012).  
 
(i) Proteins with inactive GGDEF, EAL or HD-GYP domains 
Sometimes, proteins with recognizable GGDEF, EAL or HD-GYP domains carry degenerated motifs 
that lose the catalytic function but maintain the ability to bind c-di-GMP. This is the case of the 
characterized PelD (c-di-GMP binds the conserved I-site), LapD (c-di-GMP binds to the EAL domain) 
and FimX (c-di-GMP binds to the EAL domain) proteins of P. aeruginosa which are described later. 
 
(ii) Proteins with a PilZ domain 
The PilZ domain is approximately 100 amino acids long and folds as six stranded β-barrels (Figure 
1.11). Two conserved motifs have been implicated in c-di-GMP binding: the RxxxR (arginine – x – x – 
x – arginine; where x is any amino acid) motif and the DxSxxG (aspartic acid – x – serine – x – x – 
glycine; where x is any amino acid) motif (Amikam & Galperin, 2006). A well characterized PilZ 
domain protein from P. aeruginosa is Alg44 which is described later. 
 
(iii) Riboswitches and proteins involved in RNA processing 
Riboswitches are segments of RNA that work as receptors of small molecules in the 5’ untranslated 
region of mRNAs. First in Vibrio cholerae and later in Clostridium difficile, it was shown that c-di-GMP 
can bind two different classes of riboswitches (class I and II) which exhibit a complex secondary and 
tertiary structure (Kulshina et al., 2009; Lee et al., 2010a; Smith & Strobel, 2011; Sudarsan et al., 
2008). Binding of c-di-GMP to these riboswitches was shown to exert a regulatory role upon the 
targeted mRNA, affecting transcription termination, translation or intron self-splicing (Hengge, 
2010). No riboswitches capable of binding c-di-GMP have yet been found in P. aeruginosa.  
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Figure 1.11 Three dimensional structure of c-di-GMP related proteins.  
(A) Structure of a PleD homodimer. The two monomers form a two-fold dimer. The monomer 
consists of three domains: the first (residues 2–140, red) and second (residues 141–285, yellow) REC 
domains and the catalytic DGC domain (286–454, green). The first REC domain carries the 
phosphoacceptor D53. The GGEEF signature motif is located on the β-hairpin (blue) and constitutes 
part of the A-site to which a c-di-GMP molecule is bound. Two c-di-GMP molecules are found at the 
I-site and the figure represents a non-activated PleD dimer. The two chains interact via Y26 from the 
first REC domain. Figure retrieved from Chan et al. (2004). (B) Structure of a YkuI homodimer. The 
two monomers form a two-fold dimer. One chain is coloured and the other is grey. The monomer 
consists of two domains connected by a long helix (residues 246–289, blue). The N-terminal EAL 
domain is shown in yellow and the C-terminal PAS domain is shown in magenta. The interaction 
between the two EAL domains involves the loop between β5-α5 (loop 6) and the α6-helix. Figure 
retrieved from Minesov et al. (2009). (C) Superposition of the three dimensional structures of the 
HD-GYP fold with a representative of the wider HD family. Bd1817 is shown in yellow with the GYP 
motif in orange, the HD motif in stick form, and the active-site binuclear metal center in sphere 
form. The HD fold of YfbR from E. coli is shown in blue. All the α-helices of the HD-GYP fold have 
counterparts in the generalized HD fold, although α6 sits at a different angle. The GYP motif of 
Bd1817 replaces the short loop between α4 and α5 of HD proteins, with the 20 residues long loop of 
Bd1817 contrasting with the 5 residues long loop of YfbR. Figure retrieved from Lovering et al. 
(2011). (D) Structure of the PilZ domain protein PA4608. Cyclic di-GMP (in stick form) binds as an 
intercalated, symmetric dimer to one side of the β-barrel. Both termini of the protein undergo 
structural changes upon ligand binding. In particular, the C-terminal helix is displaced and the N-
terminus containing the RxxxR motif wraps around the ligand. Figure retrieved from Habazettl et al. 
(2011). 
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In addition to the riboswitches, very recently a protein from E. coli involved in the degradation of 
RNA, PNPase (polynucleotide phosphorylase), has been shown to bind c-di-GMP, widening even 
more the range of c-di-GMP receptor proteins. In this case, c-di-GMP binding leads to the activation 
of PNPase in order to mediate RNA processing. This signaling pathway in E. coli is actually quite 
interesting as it seems to respond to the presence of oxygen and involves two other c-di-GMP 
related proteins (DosC, with a C-terminus active GGDEF domain; and DosP, with C-terminus active 
EAL domain, see Table 1.4) (Tuckerman et al., 2011). An homologuous PNPase protein from 
Xanthomonas campestris has been shown to also bind c-di-GMP, indicating that this may be 
occurring in other bacterial species (Wang et al., 2012).  
 
(iv) Transcriptional factors 
Transcriptional factors are proteins that control transcription of a gene by binding to their promoter 
region in response to signals around them. They are often abundant (P. aeruginosa has more than 
500) and can act as repressors, activators or both (Galan-Vasquez et al., 2011; Stover et al., 2000). 
The function of transcriptional factors can be modulated in different ways: covalent modifications 
(like the phosphorylation of response regulators with DNA binding output domains), levels of the 
transcriptional factor (controlled by auto-regulation of their own expression or by proteolysis), 
competition for binding to other molecules (for example, titration of the transcriptional factor by 
binding to a regulatory protein) and binding to small ligands (like cAMP binding to Crp in the carbon 
catabolite control of E. coli) (Browning & Busby, 2004).  
In a number of bacterial species – namely P. aeruginosa (FleQ), V. cholerae (VpsT), B. cenocepacia 
(Bcam1349), X. campestris (Clp) and Klebsiella pneumonia (MrkH) –, c-di-GMP has been shown to 
bind to transcriptional factors and modulate their activity. In P. aeruginosa, the mechanism of action 
of such transcriptional factor, FleQ, is described later.    
 
(v) Eukaryotic c-di-GMP receptors 
Despite the fact that eukaryotic cells are not recognized as being able to produce c-di-GMP, recently, 
two c-di-GMP receptors were identified in mammalian cells. One of them is DDX41, a cytosolic 
protein with two domains: a DEAD (aspartic acid – glutamic acid – alanine – aspartic acid) domain 
that binds DNA and cyclic nucleotides; and a helicase domain that hydrolysis ATP (Parvatiyar et al., 
2012). The other c-di-GMP receptor is STING, a membrane protein that locates to the endoplasmic 
reticulum and senses both DNA and cyclic nucleotides in the cytosol (Burdette et al., 2011). DDX41 
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has a greater affinity for c-di-GMP than STING and is thought to act upstream of STING, sensing the 
presence of foreign molecules and, together with STING, eliciting the innate immune system with a 
type I interferon response (Bowie, 2012).  
Because c-di-GMP stimulates the immune system, its use as a therapeutic molecule and vaccine 
adjuvant has been explored and is proving very promising. Several early studies have recognized the 
potential of c-di-GMP as an anticancer drug, as an immunomodulator of the burden caused by 
bacterial infections and as a vaccine adjuvant (Brouillette et al., 2005; Chen et al., 2010; Karaolis et 
al., 2005; Karaolis et al., 2007).  
 
1.4 Proteins involved in cyclic di-GMP signalling in P. aeruginosa 
 
Cyclic di-GMP signalling is widespread in bacteria and many species encode a large number of c-di-
GMP related proteins – a few proteins with PilZ domains or HD-GYP domains, and many proteins 
with a GGDEF or EAL domain (2010; Galperin, 2010b). Usually, the domains involved in c-di-GMP 
metabolism (i.e., GGDEF, EAL and HD-GYP domains) are located at the C-terminus of the proteins 
and N-terminal transmembrane regions or input domains are present. All together, these proteins 
create an intricate c-di-GMP signaling network that specifically regulates many biological processes 
crucial for bacterial adaptation and virulence. Not surprisingly, P. aeruginosa encodes a vast array of 
c-di-GMP related proteins, summing up a total of 51 proteins: eighteen with a GGDEF domain, six 
with an EAL domain, sixteen with a GGDEF/EAL domain, three with an HD-GYP domain and eight 
with a PilZ domain (Kulasakara et al., 2006; Merighi & Lory, 2010). A list of all these proteins is 
available in Table 1.5 and a description of the ones that have been characterized follows. Curiously, 
and as a mirror of the speed at which research in this field has progressed in the last years, when this 
work was initiated in 2009 only 9 out of the 51 proteins had been characterized. Today, publications 
on at least 20 of these proteins can be found.   
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Table 1.5 Proteins with a GGDEF, EAL, HD-GYP or PilZ domain in P. aeruginosa.  
ORF 
(name) 
Domain 
organization1 
Additional 
Domains 
Activity References  
GGDEF domain    
PA0169 
(siaD)  -- DGC
2 
Irie et al., 2012; 
Klebensberger et al., 
2009 
 
PA0290  PAS -- --  
PA0338  PAS -- --  
PA0847  
CHASE4, 
HAMP, PAS 
DGC Kulasakara et al., 2006  
PA1107 
(roeA)  
TM2 DGC Merritt et al., 2010  
PA1120 
(yfiN)  
HAMP DGC 
Malone et al., 2010; 
Malone et al., 2012; Pu 
& Wood, 2010; Ueda & 
Wood, 2009; Ueda & 
Wood, 2010 
 
PA1851  TM -- --  
PA2771  GAF -- --  
PA2870  TM DGC Kulasakara et al., 2006  
PA3061 
(pelD)  
TM, GAF 
c-di-GMP 
receptor 
Lee et al., 2007; Li et 
al., 2012; Whitney et 
al., 2012 
 
PA3177  -- DGC 
J. Overhage, personal 
communication 
 
PA3343  TM DGC Kulasakara et al., 2006  
PA3702 
(wspR)  
REC DGC 
De et al., 2008; De et 
al., 2009; Guvener & 
Harwood, 2007; 
Hickman et al., 2005; 
Huangyutitham et al., 
2013; Malone et al., 
2007 
 
PA4332 
(sadC)  
TM DGC 
Irie et al., 2012; 
Kuchma et al., 2010; 
Kuchma et al., 2012; 
Merritt et al., 2007; 
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ORF 
(name) 
Domain 
organization1 
Additional 
Domains 
Activity References  
Merritt et al., 2010 
PA4396  REC -- --  
PA4843 
(adcA)  
REC DGC 
C. J. Jones, personal 
communication 
 
PA4929  7TMR_DISM -- --  
PA5487  -- DGC Kulasakara et al., 2006  
GGEDF/EAL domain 
PA0285 
 TM, PAS -- --  
PA0575  PBPb, PAS -- --  
PA0861 
(rbdA)  
TM, PAS PDE An et al., 2010  
PA1181  MASE, PAS -- --  
PA1433 
(lapD)  
HAMP 
c-di-GMP 
receptor4 
Hinsa & O'Toole, 2006; 
Navarro et al., 2011; 
Newell et al., 2009; 
Newell et al., 2011 
 
PA1727 
(mucR)  
MHYT DGC, PDE 
Hay et al., 2009; Li et 
al., 2013 
 
PA2072  Chase4, PAS PDE This study  
PA2567  GAF PDE Rao et al., 2009  
PA3258  CBS -- --  
PA3311 
(nbdA)  
MHYT PDE Li et al., 2013  
PA4367 
(bifA)  
TM PDE Kuchma et al., 2007  
PA4601 
(morA)  
TM, PAS -- Choy et al., 2004  
PA4959 
(fimX)  
PAS 
c-di-GMP 
binding 
Huang et al., 2003; Jain 
et al., 2012; 
Kazmierczak et al., 
2006; Navarro et al., 
2009; Qi et al., 2012 
 
PA5017  PAS, GAF DGC Roy et al., 2012  
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ORF 
(name) 
Domain 
organization1 
Additional 
Domains 
Activity References  
(dipA) 
PA5295  -- -- --  
PA5442  TM, PAS -- --  
EAL domain 
PA0707 
(toxR)  -- -- 
Walker et al., 1994; 
Wozniak et al., 1987 
 
PA2133  -- PDE Kulasakara et al., 2006  
PA2200  TM PDE Kulasakara et al., 2006  
PA2818 
(arr)  
TM PDE 
Gotoh et al., 2008; 
Hoffman et al., 2005 
 
PA3825  -- PDE Kulasakara et al., 2006  
PA3947 
(rocR)  
REC PDE 
Chen et al., 2012; 
Kotaka et al., 2009; 
Rao et al., 2008; Rao et 
al., 2009 
 
HD-GYP domain 
PA2572 
 REC -- Ryan et al., 2009  
PA4108  -- PDE Ryan et al., 2009  
PA4781  REC PDE Ryan et al., 2009  
PilZ domain 
PA0012 
 -- 
c-di-GMP 
receptor 
Merighi et al., 2007  
PA2799  -- 
c-di-GMP 
receptor 
Merighi et al., 2007  
PA2960 
(pilZ)  
-- -- Merighi et al., 2007  
PA2989  -- 
c-di-GMP 
receptor 
Merighi et al., 2007  
PA3353  -- 
c-di-GMP 
receptor 
Merighi et al., 2007  
PA3542 
(alg44)  
TM 
c-di-GMP 
receptor 
Merighi et al., 2007; 
Oglesby et al., 2008 
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ORF 
(name) 
Domain 
organization1 
Additional 
Domains 
Activity References  
PA4324  -- 
c-di-GMP 
receptor 
Merighi et al., 2007  
PA4608  -- 
c-di-GMP 
receptor 
Habazettl et al., 2011; 
Shin et al., 2011 
 
1 Blue boxes represent the GGDEF domain, pink boxes represent the EAL or HD-GYP domain, and 
purple boxes represent the PilZ domain. Grey shapes represent the additional domains as presented 
in the next column.  
2 Activity not confirmed biochemically. 
3 TM – transmembrane domain 
4 Based on the homologous protein found in P. fluorescens. 
 
 
1.4.1 Proteins with DGC activity 
 
WspR, a role in biofilm formation 
WspR (PA3702) is a cytoplasmic protein with a REC domain at the N-terminus and a GGDEF domain  
with conserved I- and A-sites at the C-terminus. It is the response regulator of the chemotactic-like 
Wsp system and plays a role in biofilm formation. 
Among all the DGC studied so far, the structure and function of WspR is one of the most well 
understood. Although the first reference to WspR in P. aeruginosa comes from D’Argenio et al. 
(2002) and links this protein to a CupA fimbriae dependent aggregative phenotype, subsequent 
studies come mainly from the groups of Caroline Harwood and Holger Sondermann and link WspR to 
biofilm formation and the production of Pel and Psl exopolysaccharide (Hickman et al., 2005). 
Several structural and microscopy studies of WspR have shown that the regulation of the DGC 
activity occurs by three different means: phosphorylation, feedback inhibition and cluster formation 
(Figure 1.9). Firstly, WspR forms homodimers via the interaction of the REC domain and DGC activity 
is stimulated by the formation of tetramers and phosphorylation of the REC domains (De et al., 
2008; De et al., 2009; Malone et al., 2007). Secondly, feedback inhibition of the DGC activity was 
shown to occur by binding of c-di-GMP to the I-sites of the tetramers, locking the complex in a 
conformation that prevents the encounter of the A-sites (De et al., 2008; De et al., 2009). Finally, the 
DGC activity is amplified by the formation of phosphorylated WspR subcellular clusters that are 
dynamic and locate to the periphery of the cells (Guvener & Harwood, 2007; Huangyutitham et al., 
2013).   
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Although there is a good insight on the structure and mode of action of WspR and this represents a 
great contribution to the field, the knowledge about the molecular pathway that operates 
downstream of WspR and leads to biofilm formation is very limited. 
 
SadC, a role in swarming motility 
SadC (PA4332) is a membrane associated DGC with a cytoplasmic GGDEF domain at the C-terminus 
that exhibits conserved I- and A-sites. Similar to WspR, SadC also forms subcellular clusters and this 
is indicative of the importance of oligomerization for its DGC catalytic activity (Merritt et al., 2010). 
In a screen of transposon mutants with a hypobiofilm phenotype, sadC was hit and shown to be 
arrested at the irreversible attachment stage (Merritt et al., 2007). Further analyses showed that this 
phenotype was concomitant to a hyperswarming phenotype, verifying the overall concept about c-
di-GMP regulation: high levels of c-di-GMP promote biofilm formation and low levels promote 
motility. Two other proteins are known to be in the same pathway as SadC. One of them is SadB 
(PA5346) which is required downstream of SadC in the induction of biofilm formation and repression 
of swarming motility. The other protein is BifA (PA4367) which is a PDE and antagonizes SadC (see 
section 1.4.2). 
In addition to this, several components of the T4P (namely, PilY1, PilX and PilW) have been shown to 
repress swarming motility in a SadC dependent manner, and the same is true for biofilm induction 
through the production of Psl (Irie et al., 2012; Kuchma et al., 2010; Kuchma et al., 2012).  
 
RoeA, a role in exopolysaccharide production 
RoeA (PA1107) has been shown to harbour DGC activity via its GGDEF domain (conserved I- and A-
sites) and is predicted to have N-terminal transmembrane domains (Kulasakara et al., 2006).  
The characterization of RoeA came from a comparative study of the effects caused by deletion of 
roeA and deletion of sadC (Merritt et al., 2010). Deletion of both proteins individually results in a 
hypobiofilm phenotype and simultaneous deletion has an additive effect. The same is true in relation 
to c-di-GMP: individual deletions cause an approximate 50% reduction in the levels of c-di-GMP 
when compared to the wild-type strain (PA14) but simultaneous deletion of both genes causes a 
greater reduction. However, the two mutants exhibit different phenotypes in relation to two 
features: swarming motility and Pel exopolysaccharide. A sadC mutant had a more pronounced 
effect on swarming motility whereas a roeA mutant was more affected for exopolysaccharide 
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production. The exact mechanism by which RoeA impacts Pel production is not known, although an 
attempt at elucidating this indicated that it is not at the transcriptional level.  
Overall, this work from George O’Toole’s laboratory is supportive of a signalling model where 
localized pools of c-di-GMP are formed to coordinate and execute their regulatory roles.    
 
SiaD, a role in detergent stress aggregation 
SiaD (PA0169) is encoded in the sia operon (PA0169-72) and consists of just a GGDEF domain. This 
protein was identified after a transposon screen for mutants that lost the ability to auto-aggregate in 
the presence of SDS stress. Two operons were hit, the sia operon (hit one time in SiaD, PA0172) and 
the cupA frimbriae operon (hit five times in the gene encoding the fimbrial unit CupA1, PA2128, or 
the usher protein CupA3, PA2130). This study suggested that production of CupA fimbriae is 
required for the SDS aggregative phenotype and that the products of the sia operon are involved in 
its regulation – in fact, it is shown that the SDS-induced up-regulation of cupA is dependent on 
functional SiaD and SiaA (PA0172) proteins (Klebensberger et al., 2009). In accordance to this, a 
previous study that looked at transposon insertions leading to a CupA fimbriae dependent 
aggregative phenotype mapped to siaB (PA0171) and suggested that SiaB may act as an antagonist 
of SiaA (D'Argenio et al., 2002).   
Unfortunately, direct evidence of the ability of SiaD to produce c-di-GMP remains to be provided. 
However, a close look at its GGDEF domain shows that the protein harbours conserved I- and A-sites. 
Moreover, in the PA14 transposon collection screened by Kulasekara et al., an insertion in siaD 
exhibited a hypobiofilm phenotype indicating a putative role in c-di-GMP synthesis (Kulasakara et al., 
2006). In addition to the work carried out by the group of Bodo Philipp, siaD was found to be up-
regulated in the hyperbiofilm wspF deletion mutant, together with the up-regulation of the pel and 
psl exopolysaccharide operons (Hickman et al., 2005). Interestingly, the SDS aggregative phenotype 
had previously been identified as dependent on Psl production and Psl, in turn, has been reported to 
act as a signal to SiaD to mediate c-di-GMP production (Irie et al., 2012; Klebensberger et al., 2007).  
 
YfiN or TpbB, a role in small colony variant formation 
YfiN (PA1120) is a membrane protein with a periplasmic PAS domain and C-terminal cytoplasmic 
HAMP and GGDEF (conserved I- and A-sites) domains. Its catalytic function is thought to be 
dependent on the dimerization of the cytoplasmic portion of the protein via the HAMP domain. 
Interestingly, yfiN belongs to the yfiBNR operon and is regulated by its neighbours: a small 
 69 
 
periplasmic protein named YfiR (PA1121); and an outer membrane lipoprotein YfiB (PA1119) 
(Malone et al., 2010).  
The YfiR periplasmic protein is a constitutive repressor of YfiN that interacts with the YfiN PAS 
domain and inhibits c-di-GMP production, resulting in the prevention of the appearance of small 
colony variants. On the other hand, YfiB is an antagonist of YfiR that probably acts as both a sensor 
and sequester of YfiR to the outer membrane, releasing YfiN from its inhibition and inducing small 
colony variants (Malone et al., 2012). The signal at which the Yfi system responds is not known but 
the system plays a role in the response to high salt concentrations and SDS stress. Transcriptional 
analysis of putative downstream targets of YfiN revealed that the pel exopolysaccharide operon is 
strongly up-regulated in a ∆yfiR mutant with the psl exopolysaccharide and cupB fimbriae genes (but 
not cupA or cupC) being only mildly affected (Malone et al., 2010). Interestingly, both gain- and loss-
of function mutations in the Yfi system were identified in small colony variants isolated from cystic 
fibrosis patients, highlighting the dynamic environment in the lung and the involvement of c-di-GMP 
signalling in disease progression. 
As suggested by the double nomenclature, YfiN was characterized by two different research groups 
at the same time: Urs Jenal’s group was working in the PAO1 background strain and named it YfiN; 
and Thomas Wood’s group was working with PA14 and named it TpbB. Nevertheless, the signalling 
pathway identified by the latter was different to the one described above. In this case, YfiN (TpbB) 
was found to be under the negative control of a different periplasmic protein called TpbA (PA3885). 
This protein was then shown to be under the regulation of quorum sensing and to act as a 
phosphatase (Ueda & Wood, 2009). Intriguingly, the phosphatase activity of TpbA is towards the 
unusual STY phosphorylation which was observed in YfiN (Pu & Wood, 2010). Therefore, a 
mechanism whereby two different periplasmic proteins act to negatively control the DGC activity of 
YfiN (via TpbA dephosphorylation of YfiN or direct binding of YfiR to YfiN) seems to operate and 
culminates in the regulation of biological functions that prevention the formation of small colony 
variant. Whether these two pathways operate simultaneously, act synergistically or are active at 
different stages or upon different stimulation is not currently known.   
Finally, YfiN was also identified, together with MorA (see section 1.4.5), in an identical study about 
small colony variants. This time, the phenotype was highly dependent on the expression of cupA 
fimbriae and deletion of yfiN or morA was accountable for the loss of phenotype (Meissner et al., 
2007). Nonetheless, the molecular details of this regulation need further validation and 
investigation. The same is true for a more recent study that establishes an inverse link between 
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extracellular DNA and c-di-GMP. In this study, the TpbA repressed YfiN was suggested to contribute 
to the pool of extracellular DNA in a biofilm via the induction of cell lysis (Ueda & Wood, 2010). 
 
1.4.2 Proteins with PDE activity 
 
RocR or SadR, a role in Cup fimbriae  
RocR (PA3947) has an N-terminal REC domain and a C-terminal EAL domain which exhibits PDE 
activity (Rao et al., 2008). It is encoded next to RocS1 (PA3946), an unorthodox sensor with a REC 
and Hpt domain after the H kinase domain, and RocA1 (PA3948), a response regulator with a C-
terminus DNA binding domain.  
The RocR response regulator was identified simultaneously by the groups of George O’Toole and 
Stephen Lory and therefore it can also be found referred to as SadR. Structural insights of the 
protein mode of action revealed that it forms a tetramer where only two A-sites seem to be 
available for c-di-GMP hydrolysis and that phosphorylation of the REC domain modulates PDE 
activity (Chen et al., 2012).  In terms of function, detailed molecular mechanisms are largely not 
understood, but it has been reported that RocR counteracts RocA1 positive effect on cupC fimbriae 
transcription (Kulasekara et al., 2005). In a different study, RocR was shown to have a role in the 
repression of T3SS under a biofilm mode of growth (Kuchma et al., 2005).    
Interestingly, the involvement of PDEs in Cup fimbriae regulation seems to be broad. First of all, at 
the same time that RocS1 leads to transcriptional activation of cupC fimbriae via RocA1, it also leads 
to the up-regulation of cupB fimbriae expression via a yet unidentified protein, and to the repression 
of efflux pump genes involved in antibiotic resistance via the response regulator RocA2 (PA3045) 
(Sivaneson et al., 2011). Secondly, although cupA expression is not altered by the Roc system, the 
catalytic active PA2133 protein with an EAL domain is encoded in the cupA operon. Thirdly, the CupD 
fimbriae produced by P. aeruginosa PA14 strain are under the regulation of two two-component 
systems (Rcs and Pvr, Table 1.2) and comprise a response regulator, PvrR, that has a C-terminal EAL 
domain with PDE activity and is associated with the conversion between antibiotic 
resistant/susceptible phenotypic variants (Drenkard & Ausubel, 2002; Mikkelsen et al., 2011; 
Mikkelsen et al., 2013). 
 
  
 71 
 
BifA, a PDE that works with SadC and RoeA 
BifA (PA4367) is a membrane protein with a C-terminal GGDEF (no conserved I- or A-sites) and EAL 
domain. It has been shown to have PDE activity and this is dependent on both domains (probably 
because the GGDEF domain is required for GTP binding and consequent stimulation of PDE activity, 
as it has been described for similar PDEs) (An et al., 2010; Christen et al., 2005; Kuchma et al., 2007). 
In contrast to a sadC or a roeA mutant which have hypobiofilm and hyperswarming phenotypes, a 
transposon insertion in bifA was identified for its ability to form hyperbiofilms and be a 
hyposwarmer (Kuchma et al., 2007; Merritt et al., 2007; Merritt et al., 2010). Interestingly, when a 
sadC deletion is created in a bifA mutant, there is a reduction in the c-di-GMP levels compared to the 
wild-type and the hyperswarming phenotype is restored. When, in turn, a roeA deletion is inserted 
in ∆bifA, the same level of reduction in c-di-GMP is observed but it is the Pel exopolysaccharide 
phenotype that is restored and not the swarming phenotyoe. Finally, if the three genes are deleted 
at the same time, the strain has c-di-GMP levels close to the wild-type and shows a 
hypobiofilm/hyperswarming phenotype, indicating that BifA may function to specifically counteract 
the effect of SadC and RoeA.  
Suppressors of a bifA mutant phenotype have been identified in sadB and pilY1. As mentioned 
before, SadB seems to be a downstream target of SadC, thus reinforcing the notion that BifA and 
SadC are in the same regulatory pathway. The latter, PilY1 (PA4554) is a protein related to T4P and is 
now linked to the inverse regulation of swarming and biofilm phenotypes via the SadC/RoeA/BifA 
pathway. Overexpression of PilY1 inhibits swarming motility in a way that is dependent on the SadC 
DGC activity, and the same seems to be true for the T4P minor pilins PilX and PilW (Kuchma et al., 
2010; Kuchma et al., 2012). Together, PilY1, PilX and PilW seem to inversely coordinate T4P-
mediated twitching motility and flagella-driven swarming motility. At the same time that they are 
required for normal twitching motility, they seem to act as a communication pathway that integrates 
signals associated with growth on surfaces and drives the repression of swarming motility, leading to 
irreversible attachment and allowing the progression of the biofilm developmental cycle.  
 
  
 72 
 
NbdA, RbdA and DipA, a role in biofilm dispersal 
 
NbdA (nitric oxide induced biofilm dispersal) 
NbdA (PA3311) is a membrane protein with an N-terminal MHYT domain and C-terminal GGDEF 
(conserved I-site) and EAL domains.  
In a very recent study, NbdA was shown to be specifically required for nitric oxide induced biofilm 
dispersal, a phenotypic behaviour that requires a decrease in c-di-GMP levels (Li et al., 2013). 
Biochemical analysis showed that the protein carried PDE activity but had no detectable DGC 
activity. Furthermore, the presence of the GGDEF domain was required to stimulate the PDE activity 
of the protein by binding to GTP (Li et al., 2013). Successful attempts in understanding how nitric 
oxide acts as a signal, i.e., transcriptionally, posttranscriptionally or posttranslationally, showed that 
addition of nitric oxide increases nbdA mRNA levels. It remains to be established however, if the 
MHYT domain plays a role in sensing nitric oxide to activate the PDE activity.  
 
RbdA (regulator of biofilm dispersal) 
RbdA (PA0861) is thought to be a membrane protein and has an N-terminal PAS domain and C-
terminal GGDEF (conserved I- and A-sites) and EAL domains. 
Similar to other PDEs that have a GGDEF domain, this domain is required to stimulate the PDE 
activity of RbdA by binding to GTP. In addition, critical residues within the PAS domain, thought to be 
involved in sensing oxygen, were also shown to be required for the function of RbdA (An et al., 
2010). A rdbA deletion mutant was shown to be unable to disperse like the wild-type strain, 
suggesting that this is a PDE that lowers the levels of c-di-GMP in biofilms so that biofilm dispersal is 
initiated.  
RbdA is predicted to be encoded in an operon together with PA0860 and PA0862. However, this is 
missing experimental validation and there is currently no data supporting a relationship of RbdA 
with its neighbours. 
 
DipA (dispersal induced phosphodiesterase) 
DipA (PA5017) is a membrane associated PDE and has GAF and PAS domains at the N-terminus and 
GGDEF (no conserved I- or A-sites) and EAL domains at the C-terminus. GAF domains were named 
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after some of the proteins where it is found and have been shown to serve as an interface for 
protein interaction or binding to ligands (Aravind & Ponting, 1997; Cann, 2007; Heikaus et al., 2009). 
A first study on DipA suggested that this protein is required for flagella-driven motility and normal 
biofilm development (Li et al., 2007). In agreement with this, DipA has recently been shown to be 
required for biofilm dispersal upon induction with nutrients, nitric oxide or inorganic compounds like 
ammonium chloride (Roy et al., 2012). Overall, the expression of DipA was maximum in dispersed 
cells and its PDE activity was shown to contribute for the regulation of the c-di-GMP pool in 
planktonic cells rather than in biofilms. In addition, the PDE activity of the protein was found to be 
modulated by the GAF domain in such a way that it exerts an inhibitory effect that is released in the 
presence of cAMP (Roy et al., 2012). This finding is very important because it suggests that DipA 
might serve as a component of a regulatory cascade where the cAMP and c-di-GMP signalling 
networks intersect, allowing the cell to inversely coordinate the levels of the two cyclic nucleotides. 
 
Arr, a role in drug induced biofilm formation 
Arr (PA2818) is a membrane associated PDE with a cytoplasmic C-terminal EAL domain. Curiously, 
while GTP is known to stimulate PDE activity when a GGDEF domain is present, in PDEs like Arr that 
lack a GGDEF domain, GTP seems to have an inhibitory role (Hoffman et al., 2005; Ross et al., 1990).  
In two independent studies, Arr was shown to be involved in the biofilm formation response 
triggered by the presence of subinhibitory concentrations of different drugs. In one case, the drug 
used was an aminoglycoside antibiotic of clinical relevance in the treatment of cystic fibrosis 
patients, tobramycin, which works by inhibiting translation (Hoffman et al., 2005). In the other case, 
two drugs that inhibit DNA replication, the antibiotic nalidixic acid and hydroxyrurea, were used 
(Gotoh et al., 2008). In both cases, it was shown that induction of biofilm formation was dependent 
on the PDE activity of Arr. Since low levels of c-di-GMP are commonly known to induce a motile 
lifestyle and not the formation of biofilms, the role of Arr is an exception to the commonly accepted 
concept of c-di-GMP regulation. However, one should consider the following issues. Firstly, upon the 
addition of drugs, even if at very low concentrations, the bacterial cells are subjected to high 
selective pressure. Secondly, induction of the PDE activity of Arr results in the reduction of the 
already low levels of c-di-GMP of a classic wild-type strain (the levels of free c-di-GMP in P. 
aeruginosa does not reach 1 picomole per mg of cells (Simm et al., 2009)), bringing it to a new low 
where the function of c-di-GMP signalling might be insignificant. Since the c-di-GMP network is not 
an essential bacterial trait, it is possible that under the conditions tested, Arr PDE activity suppresses 
the c-di-GMP signalling which then leads to an improved fitness.  
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PA4108 and PA4781, two HD-GYP that are catalytic active 
PA4108 has only a recognizable HD-GYP domain and PA4781 has an N-terminal REC domain and a C-
terminal HD-GYP domain.  
Although deletion of each of these genes caused a similar increase in the c-di-GMP intracellular 
levels and a similar repression of twitching and swarming motility, they had different effects on 
other phenotypes (Ryan et al., 2009). For instance, whereas a PA4108 mutant reduced pyocyanin 
production, a PA4781 mutant increased pyoverdine production. Also, the three dimensional 
structure of the biofilms was different and while a PA4108 mutant affected T3SS, a mutant in 
PA4781 had no effect.  
Curiously, PA4781 and its neighbouring gene, PA4782, were identified in a microarray study to be 
positively regulated by magnesium via the two-component system PmrAB (Table 1.2) (McPhee et al., 
2006).  
 
1.4.3 Protein with DGC and PDE activity 
 
MucR, a role in alginate biogenesis and biofilm dispersal 
MucR (PA1727) has a modular organization similar to NbdA, harbouring an N-terminal MHYT domain 
and C-terminal GGDEF (conserved I- and A-sites) and EAL domains. Curiously, MucR and NbdA are 
the only proteins found in P. aeruginosa that harbour a MHYT domain. 
Initially described as an exclusive DGC, this protein has recently been shown to actually carry both 
DGC and PDE activities (Hay et al., 2009; Kulasakara et al., 2006; Li et al., 2013). These two activities 
are thought to be activated in vivo at different stages so that in planktonic cells MucR works as a 
DGC and in biofilms, as a PDE. In accordance to this, MucR has been described as a positive regulator 
of exopolysaccharide alginate biogenesis in mucoid strains (correlating to DGC activity), and as a 
positive regulator of biofilm dispersal induced by nitric oxide or glutamate (correlating to PDE 
activity). Interestingly, in in vitro conditions, the presence of the EAL domain accelerated 
substantially the rate at which the GGDEF domain was able to convert GTP to c-di-GMP but the 
physiological relevance of this or the mechanisms of positive feedback is unknown (Li et al., 2013).   
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1.4.4 Proteins that bind c-di-GMP 
 
PelD, a role in Pel exopolysaccharide production 
PelD (PA3061) is a membrane protein with a cytoplasmic GAF domain followed by a GGDEF domain 
(conserved I-site). It does not have DGC catalytic activity but it has been shown to be able to bind c-
di-GMP via the I-site (Lee et al., 2007; Li et al., 2012; Whitney et al., 2012). 
The fact that the pel operon encodes a protein that is able to bind c-di-GMP and is required for the 
production of the Pel exopolysaccharide means that this biological trait is regulated by c-di-GMP at 
least at two different levels: transcriptional and posttranslational. Transcriptionally, it has been 
demonstrated that the Wsp system, for instance, increases the mRNA levels of the pel genes. 
Posttranslationally, it is known that the PelD protein binds c-di-GMP. Unfortunately, mechanistic 
details about both levels of regulation are missing. 
 
FimX, a role inT4P-mediated twitching motility 
FimX (PA4959) is a cytoplasmic protein with N-terminal REC and PAS domains and C-terminal GGDEF 
(no conserved I- or A-sites) and EAL domains. Notably, the REC domain lacks important conserved 
residues and is likely not able to accept phosphoryl groups. 
Although FimX exhibits low PDE activity in vitro, in vivo this protein seems to work as a c-di-GMP 
binding protein that is required for surface assembly of T4P and hence, for twitching motility (Huang 
et al., 2003; Kazmierczak et al., 2006; Navarro et al., 2009; Rao et al., 2008; Robert-Paganin et al., 
2012). The exact signals at which FimX responds are not known but a fimX mutant was shown to not 
respond to two out of three twitiching motility inducers, namely tryptone and mucin (Huang et al., 
2003).  
The c-di-GMP binding ability of FimX resides in the EAL domain but both GGDEF and EAL domains are 
required for the twitching phenotype. On the other hand, the REC domain seems to be required for 
protein dimerization and unipolar localization – FimX is seen to localize to the cell pole where pili are 
assembled (Kazmierczak et al., 2006; Navarro et al., 2009; Qi et al., 2011). Interestingly, fimX 
expression is known to be positively controlled by the transcriptional regulator Vfr but the 
requirement of FimX in T4P assembly is bypassed at high levels of intracellular c-di-GMP (Wolfgang 
et al., 2003). This last observation was made after a screen for fimX suppressors that restored T4P 
assembly (Jain et al., 2012). The hits located to three genes belonging to operons that lead to c-di-
GMP production, the sia, yfi and wsp operons. All together, this indicates that FimX is required for 
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T4P-mediated twitching motility at the early stages of biofilm formation and that as the c-di-GMP 
concentration in the cells increase, although T4P can still be assembled, other features intrinsic to 
biofilms mask the twitching phenotype. 
Curiously, an homologous protein to FimX from Xanthomonas axonopodis has been shown to 
interact with a PilZ domain protein involved in T4P biogenesis (Chin et al., 2012; Guzzo et al., 2009; 
Guzzo et al., 2013). In P. aeruginosa, although homologues of both proteins are present, this 
interaction is not conserved, thus the molecular mechanism by which FimX regulates twitching 
motility may vary from species to species (Qi et al., 2012).  
 
Alg44, a role in alginate production 
Alg44 (PA3542) is a membrane protein with a cytoplasmic PilZ domain at the N-terminus and an 
uncharacterized periplasmic C-terminus domain (Merighi et al., 2007; Oglesby et al., 2008). It is able 
to bind c-di-GMP and this is required for the polymerization and transport of alginate. It is possible 
that Alg44 responds to the c-di-GMP produced via MucR but experimental data supporting this is 
missing (Hay et al., 2009).   
With the exception of one protein, all proteins involved in alginate biogenesis are encoded in the alg 
operon. Although transcription of this operon is complex and involves many proteins, the alternative 
σ22 sigma factor, also known as AlgT or AlgU (PA0762), is required for alg transcription. The 
availability of σ22 is known to be controlled by a membrane associated anti-sigma factor, MucA 
(PA0763), which is subjected to proteolysis to allow the release of σ22 (Damron & Goldberg, 2012; 
Ramsey & Wozniak, 2005).    
 
FleQ, a c-di-GMP responsive transcriptional factor 
Unlike the other proteins described so far, FleQ (PA1097) does not have an identifiable GGDEF, EAL, 
HD-GYP or PilZ domain. Instead, it has an N-terminal FleQ domain which is associated to 
transcriptional activators of σ54-dependent flagellar genes; a central ATPase domain; and a C-
terminus DNA-binding domain. Curiously, FleQ has been shown to be able to bind c-di-GMP, possibly 
via its central ATPase domain. 
The fleQ gene is known to be constitutively expressed and to be subjected to negative regulation by 
the alginate related σ22 sigma factor and the cAMP-binding transcriptional regulator Vfr (Dasgupta et 
al., 2002; Tart et al., 2005). Once produced and at low levels of c-di-GMP, FleQ acts as an activator 
and a repressor of different genes: an activator of genes involved in flagella-driven swimming 
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motility (including the two-component system FleRS, Table 1.2); and a repressor of the pel, psl and 
cdr genes involved in exopolysaccharide and adhesin production (Arora et al., 1997; Hickman & 
Harwood, 2008). To act as a repressor, FleQ binds to another protein, FleN (PA1454), and to the 
promoter region of the target genes (Dasgupta & Ramphal, 2001). Remarkably, at high levels of c-di-
GMP, FleQ is able to bind c-di-GMP and switch from a repressor to an activator of transcription 
(Baraquet et al., 2012). Possibly, FleQ responds to the c-di-GMP produced by WspR, as activation of 
this DGC has been shown to up-regulate the pel, psl and cdr operons. The impact of elevated levels 
of c-di-GMP on the ability of FleQ to activate the expression of flagellar genes is still unclear. 
 
LapD, a role in attachment in P. fluorescens 
LapD (PA1433) is a membrane protein with cytoplasmic HAMP, GGDEF (no conserved I- or A-sites) 
and EAL domains that does not have catalytic activity but binds c-di-GMP via the EAL domain (Newell 
et al., 2009). Although this protein remains largely uncharacterized in P. aeruginosa, its mode of 
action and signaling pathway in P. fluorescens has been studied in detail by the group of George 
O’Toole and will be described here (Figure 1.12). 
In P. fluorescens, LapD is known to be able to bind c-di-GMP and control the release of an adhesin, 
LapA, from the cell surface. The secretion of this adhesin is dependent on a T1SS encoded by the 
lapBCE operon located next to the large lapA gene. In P. aeruginosa, a similar operon is found, 
PA1875-PA1877, but the adjacent large PA1874 gene has not been recognized as being homologous 
to lapA (Hinsa et al., 2003). In addition, while in P. fluorescens the c-di-GMP binding protein lapD is 
encoded in the same genetic locus as the adhesin and the ABC transporter, the same is not true in P. 
aeruginosa. 
In terms of the signaling pathway, the secretion of the adhesin LapA is required for the irreversible 
attachment and is inhibited at low levels of phosphate. Under these conditions, a two-component 
system called PhoBR, is activated and leads to the up-regulation of a protein with PDE activity, RapA 
(which has 76% sequence identity to PA3258) (Monds et al., 2007). By lowering the c-di-GMP levels 
in the cell, RapA prevents LapA secretion and further inhibits biofilm formation. At these low levels 
of c-di-GMP, the c-di-GMP binding protein LapD is inactive and a periplasmic calcium dependent 
protease, LapG, is free to cleave LapA from the cell surface, preventing attachment (Boyd et al., 
2012; Hinsa & O'Toole, 2006; Navarro et al., 2011; Newell et al., 2011). Conversely, at higher levels 
of phosphate in the medium, c-di-GMP is not degraded by RapA and is therefore available to bind 
LapD. Once c-di-GMP is bound to the EAL domain of LapD, a signal is translated via the HAMP 
domain to the periplasmic region of the protein. A conformational change in the periplasmic region 
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of LapD caused by the intracellular binding of c-di-GMP then increases the affinity of the protease 
LapG to LapD. Binding of LapG to LapD prevents the cleavage of LapA and consequently, allows the 
progression of biofilm development.  
 
 
Figure 1.12 LapD inside-out signalling in P. fluorescens. 
(A) Structural model of full-length LapD in the autoinhibited state and the c-di-GMP-activated state. 
LapD dimerizes via its EAL domain (green). Only the c-di-GMP-bound LapD is capable of binding LapG 
in the periplasm. The model is based on crystal structures obtained for the LapD periplasmic (purple) 
and cytoplasmic fragments (green and orange). The HAMP domain was modelled (blue). (B) Model 
for LapD-mediated control of biofilm formation. At low levels of phosphate, the PhoBR system is 
activated and the PDE RapA degrades c-di-GMP. In the absence of c-di-GMP, LapD is inactive and the 
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periplasmic protease LapG cleaves the LapA adhesin from the cell surface, preventing biofilm 
formation. At high levels of phosphate, the levels of c-di-GMP increase and LapD is activated. Binding 
of c-di-GMP to the cytoplasmic EAL domain increases the affinity of the periplasmic domain to LapG. 
The interaction between LapG and LapD prevents the cleavage of the adhesin and therefore biofilm 
formation is induced. Figure retrieved from Navarro et al. (2011). 
 
In conclusion, in this signaling pathway LapD works as a modulator of cell surface exposure of the 
LapA adhesin. This control occurs by a c-di-GMP dependent inside-out signalling mechanism where 
intracellular high levels of c-di-GMP serve as a signal for the inhibition of LapA release, leading to 
biofilm formation.  
Curiously, in P. aeruginosa the gene encoded next to the RapA homologue, Prc (PA3257), is a 
predicted protease that has been correlated to the mucoid phenotype and the modulation of the σ22 
sigma factor that is involved in the transcription of the alg operon (Sautter et al., 2012). 
 
1.4.5 Other c-di-GMP related proteins  
 
MorA, a role in biofilm development 
MorA (PA4601) is a membrane protein with four PAS domains in tandem at the N-terminus and a 
GGDEF domain (conserved A-site) followed by an EAL domain at the C-terminus. Since this protein 
has both the GGDEF and EAL domains, it is unclear which catalytic activity it harbours, if any. The 
studies on MorA so far have implicated the protein in the regulation of CupA fimbriae and the early 
stages of biofilm development in P. aeruginosa (Choy et al., 2004; Meissner et al., 2007). In P. 
putida, deletion of morA not only impaired biofilm formation, but also led to an increase in flagella-
driven swimming motility (Choy et al., 2004). Overall, these results suggest a possible DGC function 
but this and the mechanism of action of the protein are still obscure.  
 
ToxR or RegA, a role in exotoxin A production 
ToxR (PA0707) has an EAL domain but it is not known if it has PDE activity. This protein was 
characterized before there was an established understanding of the c-di-GMP signalling so its 
enzymatic activity was not explored. An alignment of ToxR with other EAL domain proteins reveals 
that the EAL motif is not conserved, suggesting that it may be catalytic inactive. 
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This protein, also known as RegA, was identified for its role in the regulation of the production of 
exotoxin A, a virulence factor secreted by the T2SS (Wozniak et al., 1987). The precise mechanism of 
this regulation is not known, but other proteins like the iron regulated sigma factor PvdS (PA2426) 
and the cAMP binding transcriptional regulator Vfr have been shown to also impact exotoxin A 
production (Davinic et al., 2009; Gaines et al., 2007).    
 
PA2572, a degenerated HD-GYP domain protein 
PA2572 has an N-terminal REC domain and a C-terminal HD-GYP domain followed by an 
uncharacterized extension. 
The HD motif of PA2572 is degenerated and the protein has been shown not to be catalytically 
active (Ryan et al., 2009). However, phenotypes related with pyoverdine, rhamnolipid and biofilm 
formation are observed when the protein is not produced. Furthermore, a truncated version of 
PA2572 where the C-terminal extension is missing revealed an ability of the protein to repress 
swarming motility. Overall, despite the fact that PA2572 lacks PDE activity, its function as a 
regulatory protein seems obvious. Recently, the neighbouring putative MCP PA2573 was shown to 
bind PA2572 and the regulon of both deletion mutants overlaps in the regulation of at least 49 genes 
(McLaughlin et al., 2012).  
 
PilZ, a PilZ domain protein that does not bind c-di-GMP 
PilZ (PA2960) has only a PilZ domain and is required for normal pilus assembly (Alm et al., 1996). 
Tragically, although the c-di-GMP binding PilZ domains were named after this protein, PilZ does not 
bind c-di-GMP because it lacks certain key residues (Merighi et al., 2007). It also does not interact 
with the c-di-GMP binding protein FimX which was shown to interact with PilZ in other species (Chin 
et al., 2012; Qi et al., 2012). Therefore, the precise role of PilZ in T4P biogenesis and its possible link 
to c-di-GMP remain unclear. 
 
Uncharacterized proteins 
Although significant amounts of knowledge have been produced in relation to the proteins that are 
involved in c-di-GMP signalling, in many cases very incomplete information is available and there is 
still a lot to do. Besides the proteins that were detailed here, a significant number of other c-di-GMP 
related proteins remain uncharacterized despite an early effort by Kulasekara et al. in performing a 
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comprehensive analysis of a collection of PA14 transposon mutantos in genes encoding GGDEF and 
EAL domain proteins (Kulasakara et al., 2006). 
Proteins with a C-terminal GGDEF domain that remain uncharacterized are: PA0290, PA0338, 
PA0847, PA1851, PA2771, PA2870, PA3177, PA3343, PA4396, PA4843, PA4929 and PA5487. Among 
these, PA0847, PA2870, PA3343 and PA5487 are known to have DGC activity (Kulasakara et al., 
2006). 
Proteins with both GGDEF and EAL domains that have not been characterized are: PA0285, PA0575, 
PA1181, PA2072, PA2567, PA3258, PA5295 and PA5442. Of these, the EAL domain of PA2567 is 
known to have PDE activity (Rao et al., 2009). Noteworthy, PA0575 has an N-terminal PBPb domain 
followed by four PAS domains in tandem; and PA3258 has an N-terminal EAL domain and a C-
terminal GGDEF domain separated by a CBS domain. PBPb domains (also referred to as SBP_bac_3 
domains) are periplasmic solute-binding protein domains found in bacteria (Table 1.1) (Bermejo et 
al., 2010; Tam & Saier, 1993). CBS domains are found in cystathionine beta-synthase and other 
proteins in all domains of life. They are small modules that can sense intracellular metabolites, like 
ATP, or mediate protein interactions (Table 1.1) (Bateman, 1997).  
Proteins with a C-terminal EAL domain that are not yet characterized are: PA2133, PA2200, PA3825. 
However, all of them are known to have PDE activity and PA2133 is used as a model. 
Finally, proteins with a PilZ domain that are uncharacterized are: PA0012, PA2799, PA2989, PA3353, 
PA4608 and PA4324. All of them have been shown to bind c-di-GMP and a three dimensional 
structure of PA4608 is available (Habazettl et al., 2011; Merighi et al., 2007; Shin et al., 2011).   
 
1.4 Cyclic di-GMP signalling pathways in other bacteria 
 
The ubiquity of c-di-GMP in bacteria means that this signalling molecule has been in the forefront of 
research in different species during the past years. In a few cases, the signalling pathways that 
involve c-di-GMP are well established and represent milestones in the understanding of its signalling 
mechanisms. Generally, a c-di-GMP dependent signalling cascade involves the perception of a signal 
by a sensor that responds by modulating the activity of DGCs or PDEs to control a pool of c-di-GMP. 
Then, the availability of c-di-GMP determines the binding of c-di-GMP to receptors proteins, creating 
a molecular output that ultimately translates into a change in bacterial behaviour. Below, famous 
regulatory cascades involving c-di-GMP in species other than P. aeruginosa are described. 
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The control of virulence and T4P motility in X. campestris 
In this phytopathogen, a cluster of 8 genes, the rpf(A-H) genes, is known to be involved in the 
regulation of pathogenicity factors and the production of a cell-to-cell signalling molecule. This 
signalling molecule is referred to as DSF, for diffusible signalling factor, and is a cis-unsaturated fatty 
acid that can be extracted with organic solvents from the supernatant of X. campestris cultures.  
DSF is produced by two genes of the rpf cluster, RpfB and RpfF, and sensed by a two-component 
system also encoded in the cluster, RpfC and RpfG (Barber et al., 1997; Slater et al., 2000). Upon 
sensing of DSF, the sensor RpfC acts via its response regulator RpfG to positively control the 
production of virulent extracellular enzymes and T4P-mediated motility (Figure 1.13).  
The response regulator RpfG harbours a C-terminal HD-GYP domain whose PDE activity is dependent 
on a functional HD motif. By degrading c-di-GMP, RpfG positively impacts the production of 
extracellular enzymes by modulation of Clp activity (Chin et al., 2010; He et al., 2007; Tao et al., 
2010). Clp is transcriptional regulator with homology to Crp from E. coli or Vfr from P. aeruginosa, 
but in X. campestris rather than binding to cAMP, it binds c-di-GMP via an E residue at the N-
terminus (Beatson et al., 2002; Gorshkova et al., 1995). Binding of c-di-GMP to Clp inhibits the 
transcription of virulence factors meaning that the PDE activity of RpfG is required for their 
production. 
In addition to this, RpfG can interact with GGDEF domain proteins via its GYP motif to modulate 
motility (Ryan & Dow, 2010; Ryan et al., 2010). The interaction between RpfG and two GGDEF 
domain proteins (with additional N-terminal domains) is dependent on a DxD (aspartic acid – x – 
aspartic acid) motif located upstream of the GGDEF motif, but independent of DGC activity. 
Formation of this HD-GYP/GGDEF protein complex was then shown to be able to bind to a PilZ 
domain protein and interact with PilT, an ATPase protein of the T4P machinery required for pili 
retraction. Despite the fact that the PilZ domain protein was able to bind c-di-GMP, the formation of 
the multiprotein complex was independent of this ability (Ryan et al., 2012a). 
In summary, this signalling pathway shows how c-di-GMP related proteins can coordinate the 
regulation of more than one bacterial phenotype upon sensing of one particular signal. It also shows 
how the same protein can lead, at the same time, to the regulation of gene expression at different 
levels (transcriptional level via Clp and allosteric level via the formation of the multiprotein 
complex).  
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Figure 1.13 Model for the control of virulence and T4P motility in X. campestris. 
The DSF signal is perceived by the two-component system RpfCG. Upon sensing of DSF, the sensor 
RpfC autophosphorylates and transfers the phosphoryl group to the response regulator RpfG. The 
output domain of RpfG is a HD-GYP domain with PDE activity. The activation of RpfG catalytic activity 
by phosphorylation decreases the levels of c-di-GMP in the cell and leads to the production of 
extracellular enzymes like endoglucanase and protease via Clp. Clp is a transcriptional activator that 
is inhibited by binding to c-di-GMP. In parallel, the phosphorylation of RpfG also promotes the 
interaction of RpfG with two GGDEF domain proteins, XC_0249 and XC_0420, to regulate T4P-
mediated motility. The interaction between RpfG and the proteins containing the GGDEF domain 
requires the GYP motif of the HD-GYP domain and a DxD motif in the GGDEF domain but is 
independent of the DGC activity of the proteins. This complex goes on to recruit a PilZ domain 
protein, XC_2249, which interacts with the PilT ATPase involved in the depolymerisation of the pilus. 
The recruitment of the protein containing the PilZ domain is independent of c-di-GMP binding and 
the RpfG influence in pilus function is exerted at the posttranslational level. The RpfCG system also 
regulates negatively biofilm formation but the mechanism is unknown. OM, outer membrane; IM, 
inner membrane. Figure retrieved from Ryan, R. (2013). 
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The Csr regulatory cascade and exopolysaccharide production in E. coli 
In E. coli, the pga(A-D) operon is responsible for the production and secretion of the 
exopolysaccharide PGA (poly-β-1,6-N-acetylglucosamine), one of the major components of its 
biofilm extracellular matrix (Romeo & Babitzke, 2010). While PgaC and PgaD are involved in PGA 
synthesis, PgaA and PgaB are required for its secretion. Both the expression of the pga operon and 
the production of PGA are regulated by c-di-GMP and depend on the RsmA E. coli homologue, CsrA 
(Fig 1.14). 
CsrA is a downstream target of the Gac system (in E. coli referred to as BarA/UvrY system, where 
BarA is the sensor and UvrY is the response regulator) and acts as a translational repressor of pga 
expression (Lapouge et al., 2008). Like in P. aeruginosa, the CsrA repressing activity is counteracted 
by two sRNAs, CsrB and CsrC. In this case, the transcription of these sRNAs is not only controlled by 
BarA/UvrY, but it also requires CsrA which, via a yet unknown mechanism, positively regulates BarA 
activity. 
Once transcribed, the levels of the sRNAs CsrB and CsrC are regulated posttranscriptionally by a 
membrane protein called CsrD with a cytoplasmic HAMP domain followed by a GGDEF and EAL 
domain (Jonas et al., 2008). Interestingly, both of these domains have no catalytic activity and 
instead, the protein works as a RNA-binding protein to mediate the degradation of CsrB and CsrC. 
Along with other ribonucleases, the c-di-GMP binding PNPase described earlier is involved in this 
RNA processing (Tuckerman et al., 2011). 
When CsrA is sequestered by the two sRNAs, translation of its mRNA targets can occur. These are 
the pga operon and many other genes, including those encoding two GGDEF domain proteins, YdeH 
and YcdT. Whereas YcdT is a membrane protein with DGC activity whose specific function is not 
clear, YdeH was shown to be specifically involved in the production of PGA (Boehm et al., 2009). 
YdeH is a cytoplasmic DGC whose gene expression is transcriptionally regulated by a two-component 
system and posttranscriptionally regulated by CsrA. Once produced, its DGC activity is thought to 
control a pool of c-di-GMP that is required for the allosteric activation of PGA synthesis. The two 
proteins involved in the PGA catalytic process are the membrane proteins PgaC and PgaD. In the 
absence of the YdeH DGC activity, PgaD is unstable and unable to interact with PgaC. However, 
when YdeH is present, the produced c-di-GMP binds both PgaC and PgaD and stabilizes their 
interaction therefore promoting the synthesis of PGA (Steiner et al., 2013).  
In conclusion, PGA biogenesis is CsrA-dependent but is subjected to c-di-GMP control at various 
levels: indirectly at the posttranscriptional level through c-di-GMP regulation of the sRNAs CsrB and 
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CsrC metabolism; and directly at the posttranslational level by the participation of c-di-GMP in the 
formation of a protein complex that is required for PGA synthesis.  
 
 
Figure 1.14 Cyclic di-GMP and the Gac system in E. coli.  
The activity of the RsmA homologue, CsrA is controlled by the sRNAs CsrB and CsrC. The expression 
of the sRNAs is controlled by the GacAS homologue system where the sensor is referred to as BarA 
and the response regulator as UvrY, and by CsrA. Posttranscriptionally, the production of the sRNAs 
is controlled by the RNA-binding protein CsrD which in turn is also under the control of CsrA. CsrA 
modulates the switch between motility and sessility by controlling directly the production of flagella, 
c-di-GMP and exopolysaccharides. CsrA has a positive impact on the mRNA levels of flagella genes 
(flhDC) and a negative impact on PGA exopolysaccharide genes (pgaABDC) and genes encoding 
proteins with a GGDEF domain (ycdT and ydeH). In this network, extracellular signals can be 
integrated via BarA/UvrY, CsrD and YcdT. In addition, the transcription of ydeH is also known to be 
controlled by the CpxAR two-component system which responds to cell envelope stress and external 
copper. Although CsrD does not bind c-di-GMP or have a c-di-GMP associated catalytic function, the 
negative impact upon the sRNAs is dependent on the ribonucleases RNase E and PNPase and the 
latter has been shown to bind c-di-GMP. In relation to PGA biogenesis, c-di-GMP also acts at the 
allosteric level. Figure retrieved from Jonas et al. (2008). 
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The production of cellulose in S. enterica 
In S. enterica, the csg(A-G) genetic locus encodes genes required for the production of curli fimbriae 
and is involved in the regulation of the rdar morphotype (Romling et al., 2010). This morphotype is 
frequent in clinical isolates of S. enterica and correlates with both the expression of curli frimbriae 
and the production of the exopolysaccharide cellulose. One of the genes of the csg cluster, csgD, is a 
transcriptional regulator and is central for the occurrence of the rdar morphotype.  
In this signalling pathway, CsgD production is positively regulated, posttranscriptionally or 
posttranslationally, by two membrane associated DGCs, STM2123 and STM3388. Although these 
proteins individually do not contribute greatly to the global pool of intracellular c-di-GMP and have 
in tandem GGDEF and EAL domains at the C-terminus, their ability to function as DGCs and 
synergistically influence csgD expression was demonstrated. In addition, the specific PDE activity of 
two other proteins, STM4264 and STM1703, was shown to counteract the effect of the mentioned 
DGCs (Romling et al., 2010). 
Once produced, the transcriptional regulator CsgD acts an activator of AdrA, a membrane protein 
with a cytoplasmic GGDEF domain. AdrA was shown to be a potent DGC and production of c-di-GMP 
activates cellulose biogenesis. This occurs posttranslationally, by binding of c-di-GMP to the C-
terminal PilZ domain of the cellulose synthase BcsA protein (Romling et al., 2010). 
So, in cellulose biogenesis in S. enterica, c-di-GMP regulation seems to be spatially and temporarily 
separated: firstly, a specific pool of c-di-GMP modulates CsgD; secondly, the c-di-GMP produced by a 
target of CsgD, activates the synthesis of cellulose. 
 
The control of the cell cycle in Caulobacter crescentus 
In the aquatic bacterium C. crescentus, cell division yields two different cells: a motile cell with polar 
flagellum and pili, and a sessile cell that is attached to the surface by a stalk and a holdfast. While 
the motile cell cannot undergo cell division and needs to swarm away from the sessile cell to later 
attach to a surface, cell division always occurs in the attached cells. In these, the stalk and holdfast 
develop at the same pole of the flagellum and pili, and it is the opposite pole that drives cell division. 
The coordination of this process is accomplished by a dynamic network that involves 
phosphorylation, proteolysis and c-di-GMP signalling (Abel & Jenal, 2010). 
Very briefly, at least five c-di-GMP related proteins are required for progression of this C. crescentus 
cell cycle and the temporal activation and spatial localization of these proteins is crucial for the 
process (Abel & Jenal, 2010). Generally, the inability of the motile cell to divide is due to the 
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presence of the phosphorylated response regulator CtrA which blocks the initiation of DNA 
replication. When a motile cell attaches to a surface to start differentiating into a sessile cell, the 
levels of c-di-GMP increase at the swarmer-to-stalked cell pole by three means: (i) DGC activity of 
phosphorylated PleD, (ii) DGC activity of DgcB, and (iii) proteolysis of the PDE PdeA. This increased 
level of c-di-GMP is required for the formation of the holdfast and the ejection of the flagellum. At 
the same time, c-di-GMP binds a catalytic inactive GGDEF domain protein, PopA, which recruits CtrA 
to the same pole. Here, CtrA suffers proteolysis, allowing the initiation of replication. Interestingly, 
when PopA is not recruited to the swarmer-to-stalked cell pole by binding to c-di-GMP, it interacts 
with another protein and localizes to the opposite cell pole.  At this cell pole, where the new 
swarmer cell is then formed, an EAL domain protein, TipF, is present and its PDE activity is known to 
be required for the assembly of the flagellum in the swarmer cell (Abel & Jenal, 2010).  
 
The swimming motility velocity in E. coli 
A role of c-di-GMP in the control of the speed of flagella-driven swimming motility has elegantly 
been elucidated recently. Briefly, during exponential growth, E. coli cells are motile and c-di-GMP 
levels are kept low due to the action of a PDE, YjhH. Upon depletion of nutrients, the activity of YjhH 
is repressed whereas DGCs are active and therefore, the levels of c-di-GMP increase. This leads to 
the binding of c-di-GMP to a protein, YcgR, which has a C-terminal PilZ domain. Binding of c-di-GMP 
to the PilZ domain of YcgR enables the protein to interact with components of the flagella motor, 
acting as a brake and reducing swimming motility. There is no consensus yet on what protein or 
proteins of the flagella motor interact with YcgR, but interactions with the stator protein MotA and 
two rotor proteins (FliG and FliM) have been demonstrated (Boehm et al., 2010; Fang & Gomelsky, 
2010; Paul et al., 2010). In conclusion, this is a signaling pathway where c-di-GMP modulates the 
swimming phenotype of the bacterial cells by promoting protein-protein interactions. At high levels 
of c-di-GMP, motility is reduced via a c-di-GMP-dependent braking system and at the same time, 
biofilm formation is induced. 
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1.6 Aims of this study 
 
In order to adapt to an ever-changing environment, bacteria need to integrate signals into molecular 
readouts that modulate their biological behaviour. Many of the biological functions that define the 
mode of infection of P. aeruginosa depend on regulatory cascades that involve the second 
messenger c-di-GMP. To explore the molecular mechanisms employed by these cascades, the aims 
of the present study were: 
1. To understand the level of specificity at which the c-di-GMP network operates.  P. aeruginosa 
encodes many putative DGCs and PDEs but they are thought to specifically regulate a wide variety of 
functions. In Chapter 3, I look at different GGDEF and EAL domain proteins and to their role in 
biofilm formation and dispersal; 
2. To investigate how c-di-GMP relates to other signalling cascades. Like c-di-GMP, the Gac system is 
also known to regulate the transition between the motile and sessile bacterial lifestyles. In addition, 
the Gac system modulates the switch between two different secretion machineries and therefore, 
the impact of c-di-GMP in this switch is explored in Chapter 4; 
3. To elucidate the molecular basis of the link between the Gac signalling cascade and the c-di-GMP 
network. In other words, to find out which c-di-GMP related proteins are under regulation of the Gac 
signalling cascade (Chapter 5). 
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Chapter 2 – Materials and Methods 
 
2.1 Strains, Plasmids and Growth conditions 
 
The bacterial strains and plasmids used in this study are listed in Table 2.1.  
Bacteria were routinely cultured at 37oC with shaking in LB medium or at 37oC on LB agar plates.  
When appropriate, culture media were supplemented with antibiotics at the following 
concentrations. For E. coli: 50 μg/mL ampicilin (Ap), 50 μg/mL kanamycin (Km), 50 μg/mL 
streptomycin (Sm), 50 μg/mL gentamycin (Gm), 15 μg/mL tetracyclin (Tc). For P. aeruginosa: 500 
µg/mL carbenicillin (Cb) for selection and 300 µg/mL Cb for maintenance; 150 μg/mL Gm for 
selection and 100 μg/mL Gm for maintenance; 2000 μg/mL Sm for selection; 200 μg/mL Tc for 
selection and 100 μg/mL for maintenance.  
When indicated, calcium chelation was used to induce the T3SS by adding 5 mM EGTA (ethylene 
glycol tetra-acetic acid, Sigma) followed by 20 mM MgCl2 to the growth medium. 
The M9 minimal medium was prepared according to Sambrook & Russell (2001) and supplemented 
with 01% or 0.4% glucose, 2 mM MgSO4 and 0.1 mM CaCl2. 
 
Table 2.1 Strains and plasmids used in this study. 
Strain or Plasmid Genotype/Description Source 
Escherichia coli   
   TOP10 
Strain used for transformation of pCR2.1 and 
pCR-Blunt plasmids; F- mcrA Δ(mrr-hsdRMS-
mcrBC) φ80lacZΔM15 ΔlacΧ74 recA1 araD139 
Δ(ara-leu) 7697 galU galK rpsL (StrR) endA1 nupG 
λ- 
Invitrogen 
   OmniMAX 
F´ {proAB+ lacIq lacZΔM15 Tn10(TetR) Δ(ccdAB)} 
mcrA Δ(mrr-hsdRMS-mcrBC) Φ80lacZΔM15 
Δ(lacZYA-argF) U169 endA1 recA1 supE44 thi-1 
gyrA96 relA1 tonA panD 
Invitrogen 
   CC118λpir 
Host strain for pKNG101; D (ara-leu) araD 
DlacX74 galE galK-phoA20 
thi-1 rpsE rpoB argE (Am) recA1 Rfr (lpir) 
Herrero et al., 
1990 
   Sm10λpir 
Host strain for miniCTX1; F- thi-1 thr-1 leuB6 recA 
tonA21 lacY1 supE44 (MuC+) l- [RP4-2(Tc::Mu)] 
Kmr Tra+ 
de Lorenzo & 
Timmis, 1994 
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Strain or Plasmid Genotype/Description Source 
   XL1-Blue 
Strain used for transformation of plasmids 
subjected to the site-directed mutagenesis 
protocol; recA1 endA1 gyrA96 thi-1 hsdR17 
supE44 relA1 lac [F´ proAB lacIqlacZ∆M15 Tn10 
(Tetr)] 
Stratagene 
   DHM1 
Strain used for transformation of the bacterial 
two-hybrid plasmids; F-, cya-854, recA1, endA1, 
gyrA96 (Nal r), thi1, hsdR17, spoT1, rfbD1, 
glnV44(AS) 
Karimova et 
al., 1998 
   BL21(DE3) 
F- ompT gal dcm lon hsdSB(rB
- mB
-) λ(DE3 [lacI 
lacUV5-T7 gene 1 ind1 sam7 nin5]) 
Stratagene 
   BL21(DE3) C41 
Spontaneous BL21 (DE3) mutant that has a 
mutated promoter that slows down transcription 
of the T7 RNA polymerase; F– ompT gal dcm 
hsdSB(rB
- mB
-)(DE3) 
Lucigen 
Pseudomonas aeruginosa   
   PAO1 Wild-type 
Stover et al., 
2000 
   PAO1∆PA0847 Deletion of PA0847 in PAO1 This study 
   PA14 Wild-type 
Liberati et al., 
2006 
   PA14∆wspR Deletion of wspR in PA14 This study 
   PAK Wild-type 
Goodman et 
al., 2004 
   PAK∆retS Deletion of retS in PAK 
Goodman et 
al., 2004 
   PAK∆pelG Deletion of pelG in PAK 
Vasseur et al., 
2005 
   PAK∆retS∆pelF Deletion of retS and pelF in PAK 
Sadovskaya et 
al., 2010 
   PAK∆rsmY∆rsmZ Deletions of rsmY and rsmZ in PAK 
Bordi et al., 
2010 
   PAK∆ladS Deletions of ladS in PAK 
Ventre et al., 
2006 
   PAK∆gacS Deletion of gacS in PAK 
Bordi et al., 
2010 
   PAK∆gacA Deletions of gacA in PAK 
Bordi et al., 
2010 
   PAK∆retS∆rsmY∆rsmZ Deletions of retS, rsmY and rsmZ in PAK 
Bordi et al., 
2010 
   PAK∆retS∆rsmY Deletion of retS and rsmY in PAK 
Bordi et al., 
2010 
   PAK∆retS∆rsmZ Deletion of retS and rsmZ in PAK 
Bordi et al., 
2010 
   PAK∆retS∆PA0338 Deletion of retS andPA0338 in PAK This study 
   PAK∆retS∆sadC Deletion of retS and sadC in PAK This study 
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Strain or Plasmid Genotype/Description Source 
   PAK∆hptB Deletion of hptB in PAK 
Bordi et al., 
2010 
   PAK∆hptB∆sadC Deletions of hptB and sadC in PAK This study 
   PAK∆sadC Deletion of sadC in PAK This study 
   PAK∆rsmA Deletion of rsmA in PAK 
Ventre et al., 
2006 
   PAK∆rsmA∆sadC Deletion of rsmA and sadC in PAK This study 
   PAK∆retS∆sadB Deletion of retS and sadB in PAK This study 
   PAK∆hptB∆sadB Deletion of hptB and sadB in PAK This study 
Plasmids*   
   pRK2013 
Tra+ Mob+ helper plasmid for mobilization of non-
self-transmissible plasmids, KmR 
Figurski & 
Helinski, 1979 
   pCR2.1 Cloning plasmid, ApR, KmR Invitrogen 
   pCR-Blunt Cloning plasmid, KmR Invitrogen 
   pBBR1-MCS4 Broad host range vector, ApR 
Kovach et al., 
1995 
   pJN105 
Plasmid allowing protein expression under the 
arabinose inducible PBAD promoter, Gm
R 
Newman & 
Fuqua, 1999 
   pKNG101 Suicide vector carrying sacB, SmR 
Kaniga et al., 
1991 
   miniCTX1 
Plasmid for the integration of genes into the att 
site of the P. aeruginosa chromosome, TcR 
Hoang et al., 
2000 
   pKT25 
Plasmid allowing construction of in-frame fusions 
at the C-terminus of the T25 polypeptide, KmR 
Karimova et 
al., 1998 
   pKNT25 
Plasmid allowing construction of in-frame fusions 
at the N-terminus of the T25 polypeptide, KmR 
Euromedex 
   pUT18C 
Plasmid allowing construction of in-frame fusions 
at the C-terminus of the T18 polypeptide, ApR 
Euromedex 
   pUT18 
Plasmid allowing construction of in-frame fusions 
at the N-terminus of the T18 polypeptide, ApR 
Karimova et 
al., 1998 
   pKT25-zip 
Fusion of zip encoding leucine zipper from GCN4 
to cyaA gene T25 fragment in pKT25, KmR 
Karimova et 
al., 1998 
   pUT18C-zip 
Fusion of zip encoding leucine zipper from GCN4 
to cyaA gene T18 fragment in pUT18C, ApR 
Karimova et 
al., 1998 
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Strain or Plasmid Genotype/Description Source 
   pKNG101-∆PA0847 
Mutator fragment for deletion of PA0847 (from 
amino acid 61 to 733), SmR 
This study 
   pKNG101-∆wspR 
Mutator fragment for deletion of wspR (from 
amino acid 4 to 347), SmR 
This study 
   pKNG101-∆PA0338 
Mutator fragment for deletion of PA0338 (from 
amino acid 2 to 367), SmR 
This study 
   pKNG101-∆sadC 
Mutator fragment for deletion of sadC (from 
amino acid 87 to 414), SmR 
This study 
   pKNG101-∆sadB 
Mutator fragment for deletion of sadB (from 
amino acid 4 to 467), SmR 
This study 
   pJN105-wspR wspR cloned into pJN105 (SacI/XbaI), GmR This study 
   pJN105-wspR** 
wspR** encoding mutations of the I-site and the 
phosphorylation residue, cloned into pJN105 
(SacI/XbaI), GmR 
This study 
   pJN105-PA2133 PA2133 cloned into pJN105 (SacI/XbaI), GmR This study 
   pBBR1-MCS4-wspR wspR cloned into pBBR1-MCS4 (SacI/XbaI), ApR This study 
   pBBR1-MCS4-wspRR242A 
wspR(R252A) cloned into pBBR1-MCS4 
(SacI/XbaI), ApR 
This study 
   pBBR1-MCS4-PA2133 PA2133 cloned into pBBR1-MCS4 (SacI/XbaI), ApR This study 
   pBBR1-MCS4-PA2072 
PA2072 cloned into pBBR1-MCS4 (BamHI/XbaI), 
ApR 
This study (E. 
Musial) 
   pBBR1-MCS4-PA2072GGAAF    
PA2072(GGAAF) cloned into pBBR1-MCS4 
(BamHI/XbaI), ApR 
This study (E. 
Musial) 
   pBBR1-MCS4-PA2072AAL 
PA2072(AAL) cloned into pBBR1-MCS4 
(BamHI/XbaI), ApR 
This study (E. 
Musial) 
   pBBR1-MCS4-yfiN 
yfiN (PA1120) cloned into pBBR1-MCS4 
(SacI/XbaI), ApR 
This study 
   pBBR1-MCS4-ladS Plasmid expressing ladS (PA3974), ApR 
Ventre et al., 
2006 
   pBBR1-MCS4-hsbR Plasmid expressing hsbR (PA3346), ApR 
Bordi et al., 
2010 
   pVL847 (MBP) 
Plasmid expressing MBP (maltose-binding 
protein), CbR 
Roelofs et al., 
2011 
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Strain or Plasmid Genotype/Description Source 
   pVL882 (MBP-Alg44PilZ) Plasmid expressing MBP-Alg44PilZ, CbR 
Roelofs et al., 
2011 
   pJB3 Broad host range vector, ApR, CbR 
Blatny et al., 
1997 
   pJB3-PA5487 PA5487 cloned into pJB3, ApR, CbR Isabel Cortés 
   pET28a 
Plasmid allowing protein expression under the T7 
promoter, KmR 
Novagen 
   pET28a-FLAG-retS FLAG-retS cloned into pET28a (NdeI/HindIII), KmR This study 
   pET28a-FLAG-ladS FLAG-ladS cloned into pET28a (NdeI/HindIII), KmR This study 
   pET28a-FLAG-gacS FLAG-gacS cloned into pET28a (NdeI/HindIII), KmR This study 
   pET28a-FLAG-gacA 
FLAG-gacA cloned into pET28a (NdeI/HindIII), 
KmR 
This study 
   pET28a-FLAG-rsmA 
FLAG-rsmA cloned into pET28a (EcoRI/HindIII), 
KmR 
This study 
   pET42b-HIS-dgrA Plasmid expressing HIS-dgrA, KmR 
Christen et al., 
2007; Nesper 
et al., 2012 
   pET42b-HIS-yfiN Plasmid expressing HIS-yfiN, KmR T. Jaeger  
   pKNT25-sadCfl sadCfl cloned into pKNT25, KmR This study 
   pKT25-sadCct sadCct cloned into pKT25, KmR This study 
   pKT25-sadB sadB cloned into pKT25, KmR This study 
   pKT25-PA4379 PA4379 cloned into pKT25, KmR This study 
   pUT18-sadCfl sadCfl cloned into pUT18, ApR This study 
   pUT18C-sadCct sadCct cloned into pUT18C, ApR This study 
   pUT18C-sadB sadB cloned into pUT18C, ApR This study 
   pUT18C-PA4379 PA4379 cloned into pUT18C, ApR This study 
   miniCTX1-PBAD araC-PBAD cloned into miniCTX1 (SacI/SpeI) This study 
   miniCTX1-PBAD-sadC
R392A 
SadC(R392A) cloned into miniCTX1-PBAD 
(SmaI/KpnI) 
This study (Q. 
Pan) 
   PcdrA-gfp 
Plasmid expressing gfp from the promoter of 
cdrA, ApR, GmR 
Rybtke et al., 
2012 
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Strain or Plasmid Genotype/Description Source 
PAO1 transposon mutants – all come from Jacobs et al. (2003) 
   PW1288 PA0169 (siaD), TcR  
   PW1531 PA0290, TcR  
   PW1627 PA0338, TcR  
   PW2543 PA0847, TcR  
   PW2999 PA1107 (roeA), TcR  
   PW3023 PA1120 (yfiN), TcR  
   PW4248 PA1851, TcR  
   PW5641 PA2771, TcR  
   PW5818 PA2870, TcR  
   PW6315 PA3177, TcR  
   PW6631 PA3343, TcR  
   PW7263 PA3702 (wspR), TcR  
   PW8315 PA4332 (sadC), TcR  
   PW8423 PA4396, TcR  
   PW9146 PA4843, TcR  
   PW9303 PA4929, TcR  
   PW10280 PA5487, TcR  
   PW1520 PA0285, TcR  
   PW2060 PA0575, TcR  
   PW2569 PA0861 (rbdA), TcR  
   PW3133 PA1181, TcR  
   PW3602 PA1433, TcR  
   PW4043 PA1727 (mucR), TcR  
   PW4568 PA2072, TcR  
   PW5308 PA2567, TcR  
   PW6465 PA3258, TcR  
   PW6567 PA3311, TcR  
   PW8371 PA4367 (bifA), TcR  
   PW8754 PA4601 (morA), TcR  
   PW9347 PA4959 (fimX), TcR  
   PW9424 PA5017 (dipA), TcR  
   PW9918 PA5295, TcR  
   PW10193 PA5442, TcR  
   PW2282 PA0707 (toxR), TcR  
   PW4665 PA2133, TcR  
   PW4747 PA2200, TcR  
   PW5718 PA2818 (arr), TcR  
   PW7455 PA3825, TcR   
   PW7674 PA3947 (rocR), TcR  
   PW5317 PA2572, TcR  
   PW7948 PA4108, TcR  
   PW9032 PA4781, TcR  
PA14 transposon mutants – all come from Liberati et al. (2006) 
   55715 PA14_02110 (PA0169), GmR  
   41840  PA14_03790 (PA0290), GmR  
   55979  PA14_04420 PA0338), GmR  
   53886  PA14_53310 (PA0847), GmR  
   35398  PA14_50060 (PA1107), GmR  
   37761  PA14_49890 (PA1120), GmR  
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Strain or Plasmid Genotype/Description Source 
   41347  PA14_40570 (PA1851), GmR  
   29609  PA14_23130 (PA3177), GmR  
   48657  PA14_20820 (PA3343), GmR  
   28622  PA14_16500 (PA3702), GmR  
   26451  PA14_56280 (PA4332), GmR  
   30693  PA14_57140 (PA4396), GmR  
   44678  PA14_64050 (PA4843), GmR  
   48450  PA14_65090 (PA4929), GmR  
   33256  PA14_72420 (PA5487), GmR  
   30208 PA14_03720 (PA0285), Gm
R
   
   54913   PA14_07500 (PA0575), Gm
R
  
   43246 PA14_53140 (PA0861), Gm
R
   
   41487 PA14_49160 (PA1181), Gm
R
   
   55781   PA14_45930 (PA1433), Gm
R
  
   42074 PA14_42220 (PA1727), Gm
R
   
   56016   PA14_37690 (PA2072), Gm
R
  
   27009 PA14_12430 (PA2567), Gm
R
  
   23726 PA14_21870 (PA3258), Gm
R
   
   32733 PA14_21190 (PA3311), Gm
R
   
   52637 PA14_56790 (PA4367), Gm
R
   
   26307 PA14_60870 (PA4601), Gm
R
   
   27822 PA14_65540 (PA4959), Gm
R
   
   45771 PA14_66320 (PA5017), Gm
R
   
   23485 PA14_69900 (PA5295), Gm
R
   
   30226 PA14_71850 (PA5442), Gm
R
   
   26651 PA14_36990 (PA2133), Gm
R
  
   23393 PA14_36260 (PA2200), Gm
R
   
   32363 PA14_14530 (PA3825), Gm
R
  
   46879 PA14_12810 (PA3947), Gm
R
   
   37812 PA14_59790 (pvrR), Gm
R
   
   53749 PA14_30830 (PA2572), Gm
R
   
   56340 PA14_10820 (PA4108), Gm
R
   
   55086 PA14_63210 (PA4781), Gm
R
   
   56214 PA14_27930 (PA2799), GmR   
   44270 PA14_25770 (PA2960), GmR   
   48398 PA14_25420 (PA2989), GmR   
   54293 PA14_20700 (PA3353), GmR   
   23859 PA14_18550 (PA3542), GmR   
   27409 PA14_56180 (PA4324), GmR   
   44974 PA14_60970 (PA4608), GmR   
* All constructs were confirmed to be error-free by sequencing at GATC Biotech (Germany). 
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2.2 Molecular Biology Techniques 
 
Standard methods were performed, if not otherwise indicated, according to the Sambrook & Russel 
books (Sambrook & Russell, 2001a; Sambrook & Russell, 2001b; Sambrook & Russell, 2001c). 
 
2.2.1 Primers 
The primers used in this study are listed in Table 2.2.  
 
Table 2.2 Oligonucleotides used in this study. 
Name Sequence Comments 
Primers for clean deletion mutants 
1PA0847F GGTCGATCAGGAACGAAGCAC Mutator for PA0847 
2PA0847R TCAGGCTGGGTGCGAATTGAAATTCGACATTTC Mutator for PA0847 
3PA0847F AATTCGCACCCAGCCTGAAATGCGCGG Mutator for PA0847 
4PA0847R GGCAGGAAGTAGGCGAGCTTGC Mutator for PA0847 
5PA0847F CACCATCTCGTCCACCTCAC Mutator for PA0847 
6PA0847R ATCATCCAGATGCCGAAGAG Mutator for PA0847 
1wspRF GCAGCATGTCGACGAGGTAT Mutator for wspR 
2wspRR TCAGGCCCAGTTGTGCATGTTTCTCTCCGG Mutator for wspR 
3WspRF ATGCACAACTGGGCCTGATGGAACAGCCG Mutator for wspR 
4WspRR GATGTCCAGGTAGGCGTTGT Mutator for wspR 
5wspRF GAGGATCGGAATCGTCAATG Mutator for wspR 
6wspRR CTGCATTTCCAGCTCGTACA Mutator for wspR 
1PA0338F GACTTCCTTTCGGTCGGTTC Mutator for PA0338 
2PA0338R ATCGCGACGCACGACGAAGCGTCC Mutator for PA0338 
3PA0338F TTCGTCGTGCGTCGCGATTGCGTG Mutator for PA0338 
4PA0338R CCATCAGCTCTGGCACTACA Mutator for PA0338 
5PA0338F ATCCTGCTGCCGATGATCT Mutator for PA0338 
6PA0338R ACTATTCCGGCTTCAACCTG Mutator for PA0338 
1sadCF TATCGTCGACGCTCATGGTA Mutator for sadC 
2sadCR TTCCAGCTGAGCGGACCGCGGATTTATC Mutator for sadC 
3sadCF CGGTCCGCTCAGCTGGAAAGCTGTTGCGA Mutator for sadC 
4sadCR TCAGGATCGAAAGGCTGCAA Mutator for sadC 
5sadCF ATGGTCGGTACGGTTTTCAG Mutator for sadC 
6sadCR CTCCACAGCAGCAGGTGCT Mutator for sadC 
1SadBF ACTGCGTGCTGCTCTACCAC Mutator for sadB 
2SadBR TCACCCCGGTTCTGTCATGACGAGACCATG Mutator for sadB 
3SadBF ATGACAGAACCGGGGTGACCGGGTAG Mutator for sadB 
4SadBR GGCAAGGACCTGGTGTTCCAGTT Mutator for sadB 
5SadBF CAACGCCAGCCTGATGAT Mutator for sadB 
6SadBR CGTCTTCTCCTGTGGATGCT Mutator for sadB 
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Name Sequence Comments 
Primers for expression vectors 
WspRF CGTGGAACAGCATTCAATTT wspR 
WspRR AAAGATACCCCCGAATGGTC wspR 
PA2133F TTCACACAGGAAACTACAGTGAACGGTTCCCCAC PA2133 
PA2133R GGAAGGCTGATTGCTCTGTT PA2134 
PA2072F GCCCCCTGGATGCTTAACTA PA2072 
PA2072R AAGACGGGAAGGGAATCAGT PA2072 
PA1120F TTCACACAGGAAACCGTGATGAACCGTCGTC yfiN 
PA1120R AACAGCACCTTGCTCGACAT yfiN 
sadCF TTCACACAGGAAAAGGAGATGAACTGCAGGGC sadC 
sadCR GATCGAAAGGCTGCAACAC sadC 
FaraC-PBAD AACATATGCGTCAATTGTCTGATTCGTTACCAAT NdeI, araC-PBAD 
RaraC-PBAD AATCGCTAGCCCAAAAAAACGG NheI, araC-PBAD 
pETretSFow 
GATAACATATGGACTACAAAGACCATGACGGTGATTATAA
AGATCATGATATCGACTACAAAGATGACGACGATAAAGTA
CGGCTTCGGATCGCCATAGG 
NdeI, 3xFLAG-RetS 
pETretSRev CTATTAAGCTTTCAGGAGGGCAGGGCGT HindIII, 3xFLAG-RetS 
pETladSFow 
GATAACATATGGACTACAAAGACCATGACGGTGATTATAA
AGATCATGATATCGACTACAAAGATGACGACGATAAACGG
CACTGGCTGATTCTCTTTC 
NdeI, 3xFLAG-LadS 
pETladSRev CTATTAAGCTTTCAGGCGGACTTGGTGA HindIII, 3xFLAG-LadS 
pETgacSFow 
GATAACATATGGACTACAAAGACCATGACGGTGATTATAA
AGATCATGATATCGACTACAAAGATGACGACGATAAATTC
AAGGATCTCGGCATCAAGGGG 
NdeI, 3xFLAG-GacA 
pETgacSRev CTATTAAGCTTTCAGAGTTCGCTGGAGTCGA HindIII, 3xFLAG-GacA 
pETgacAFow 
GATAACATATGGACTACAAAGACCATGACGGTGATTATAA
AGATCATGATATCGACTACAAAGATGACGACGATAAAATT
AAGGTGCTGGTGGTCGACGA 
NdeI, 3xFLAG-GacS 
pETgacARev CTATTAAGCTTCTAGCTGGCGGCATCGA HindIII, 3xFLAG-GacS 
pETrsmAFow 
CATATGGACTACAAAGACCATGACGGTGATTATAAAGATC
ATGATATCGACTACAAAGATGACGACGATAAACTGATTCT
GACTCGTCGGGTCG 
NdeI, 3xFLAG-RsmA 
pETrsmARev CTATTAAGCTTTTAATGGTTTGGCTCTTGATC HindIII, 3xFLAG-RsmA 
THflPA4332Fxba GCTCTAGAGATGAACTGCAGGGCATC XbaI, sadCfl 
THctPA4332Fxba GCTCTAGAGCAGGGGGCAGGGTACATT XbaI, sadCct 
THPA4332Reco GGTGAATTCGAGGCACTGGTGACCTCCC EcoRI, sadC 
THsadBFxba GCTCTAGAGATGACAGAAGCCGCCCTG XbaI, sadB 
THsadBRkpn AAGGTACCTCACCCCGGCAAGCG KpnI, sadB 
THPA4379Fxba GCTCTAGAGATGAACAATCCGCCTGT XbaI, PA4379 
THPA4379Rkpn AAGGTACCTTATTCCTTTCGCAAGATATAGAC KpnI, PA4379 
Primers for site-directed mutagenesis 
WspRmutD70EF GTGATCCTCCAGGAACTGGTGATGCCCGG Phosphorylation site 
WspRmutD70ER CCGGGCATCACCAGTTCCTGGAGGATCAC Phosphorylation site 
WspRmutR242AF CGAGGGCTGCAGTGCCTCCTCGGACCTG I-site, R242A 
WspRmutR242AR CAGGTCCGAGGAGGCACTGCAGCCCTCG I-site, R242A 
PA2072EF TCGCCTCGGCGGCAGCGTTGATCCG EAL, E631A 
PA2072ER CGGATCAACGCTGCCGCCGAGGCGA EAL, E631A 
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Name Sequence Comments 
PA2072GF GGCTCGGCGGCGCCGCGTTCGTGGTGGT 
GGDEF, D505A and 
E506A 
PA2072GR ACCACCACGAACGCGGCGCCGCCGAGCC 
GGDEF, D505A and 
E506A 
sadCmutRxxDF GCGTTCCTGTCTGGCCGATGGCGACGTC I-site, R392A 
sadCmutRxxDR GACGTCGCCATCGGCCAGACAGGAACGC I-site, R392A 
Primers for RT-PCR 
IG1PA3348-47F CGAATACGACACCCTGGCGATG PA3348/PA3347 
IG1PA3348-47R CCTGGATCTGGATGGTCAAC PA3348/PA3348 
IG2PA3347-46F GATCCTCGCCATCTCCAACTTCG PA3347/PA3346 
IG2PA3347-46R CCTGGCGGCTGACGATGGTCGA PA3347/PA3346 
IG3PA3346-45F GTCTGCTGGTGCGGGTCGAGGA PA3346/hptB 
IG3PA3346-45R AGCACGAAGGTATCCAGCAGG PA3346/hptB 
IG4PA3345-44F AACAGGAACGTCAGCGCTAT hptB/recQ 
IG4PA3345-44R CCTGGAAACACAGGGACTTG hptB/recQ 
IG5PA3344-43F AGGAACTCCTCGGCGAAAT recQ/PA3343 
IG5PA3344-43R ATTGGTCGGCATAGAGGTTG recQ/PA3343 
IG6PA3343-42F CAACGACCTGAAGCGTCTCT PA3343/PA3342 
IG6PA3343-42R GATCAGGCCGAAGTACTGGA PA3343/PA3342 
IG7PA3342-41F GCGAGCAACTTCAAGCAGAT PA3342/PA3341 
IG7PA3342-41R AGCAAGGTGCCGAAATAGTG PA3342/PA3341 
IG8PA3341-40F GTTCGCAACGACGTACTGAC PA3341/PA3340 
IG8PA3341-40R AGTTCGATATCCGCATCCAG PA3341/PA3340 
Primers for qRT-PCR 
qGyrAF  AACGACTGGAACAAGCCCTACA gyrA 
qGyrAR GCGCACGATGGTGTCGTA gyrA 
qPcrVF AGTGGGATCTGCGCGAGTT pcrV 
qPcrVR TGGGTCTGCAGGACATCCTT pcrV 
qHsiA1F ATCGCCTGCTCGAGTATTACG hsiA1 
qHsiA1R GGGATGAGATTCCTCACGATTT hsiA1 
qSiaDF GCTGGCAATGCTCGATGTG PA0169 
qSiaDR TGTCGTGGCCCCAGGTAT PA0169 
qPA0290F GGATACCGTTGGCGTTCCT PA0290 
qPA0290R AGCGGTCGTTGATCTTCTTGA PA0290 
qPA0338F GAGCGTGGAGACCTGGAAGA PA0338 
qPA0338R GCAGTATTCCGGGCTTTCG PA0338 
qPAKPA0847F TCGGCGGTATCTGGCTCTT PA0847 
qPAKPA0847R CTGGTCCTCTCGGTCGAAAC PA0847 
qPA1107F AACGCAAGCTGGAGTTGCA PA1107 
qPA1107R CAGGTACTCCAACTGGCGATTC PA1107 
qPA1120F CGCCTGGCGGAACTCA PA1120 
qPA1120R GGGTAGCACTGTCTATCTCCTTTTCT PA1120 
qPA1851F GGCTGGTCTGCCGGATAAT PA1851 
qPA1851R ACCGCAACCAACGAAAGC PA1851 
qPA2771F GCACCAGCATGAACTGGAGTT PA2771 
qPA2771R TTGAAATGGTCGATATCGCTGTA PA2771 
qPAKPA2870F CCAGGCGGAGCTCATGCT PA2870 
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Name Sequence Comments 
qPAKPA2870R GATGTTCTTGAAGTGGTCGATGTC PA2870 
qPelDF ACCGATGGGCGGATCCT PA3061 
qPelDR CAGGCTGAAGGTACGTTCGTT PA3061 
qPA3177F CGTGGCGGAAACCATCA PA3177 
qPA3177R CGAAGCGGAACACCATGTC PA3177 
qPA3343F TGCTACCTGCTGGAGTTCAAGTC PA3343 
qPA3343R GCCATCACCCGCAACAG PA3343 
qWspRF GCGGTCATGGTACTGCTTGTC PA3702 
qWspRR CGGAACAGAAATGGAAGTCGAT PA3702 
qPAKSadCF GCAGCAGCGTCTCGAGCTA sadC 
qPAKSadCR CCAGACCATTACGATGAACATCA sadC 
qPA4396F ATGGACGGCCTGGAACTG PA4396 
qPA4396R GGTGTAGTGGTTGATGCTTTCG PA4396 
qPA4843F CGAGCCACTGTCGGTGATG PA4843 
qPA4843R AGGCATTCGGGCATGTACAT PA4843 
qPA4929F TTCAAGCCGATCAACGATACC PA4929 
qPA4929R CCACGTTCTGCAGGACGAA PA4929 
qPA5487F GACCACTTCAAGCGGATCAAC PA5487 
qPA5487R AACCGTTTGCGCAATTCG PA5487 
qPA0285F CGCCTGAGCCTGGCTTATC PA0285 
qPA0285R TGTAACAAATGATCGCTCAGGAA PA0285 
qPA0575F CAAGACCGGCGAGCTGTAC PA0575 
qPA0575R GGTGGAGATATCGGCGAAGA PA0575 
qPA0861F GCCGGTGGATTACCTGAAGA PA0861 
qPA0861R GATGGGATCCTCGAGCATGT PA0861 
qPA1181F CCGGCCTGAGTTCCTTCA PA1181 
qPAKPA1181R AGCTACCGTCGATCTTGATC PA1181 
qPA1433F CCGTTGATCGCGGAACA lapD 
qPA1433R AAACCCATTTCCCGCAGTACT lapD 
qPA1727F CGGAACGGCTACTGCTTCTT mucR 
qPA1727R GCAGGTCATGCAGTAGTTGCA mucR 
qPA2072F TCCTGAAACGCAGCAACCA PA2072 
qPA2072R CGAAATGCCCGTCGACTT PA2072 
qPA2567F CGTATCGGCATCGGACATG PA2567 
qPA2567R GCGAGTCTGACGGCCTCTT PA2567 
qPA3258F AACTGGAACTACTCTGCCGACAA PA3258 
qPAKPA3258R GGGAGACGTTGAGGAACAGCAT PA3258 
qPA3311F AGGGCCTGGCGGTGAT PA3311 
qPA3311R GCCGAGGGAATCGTTGATC PA3311 
qPA4367F CATCTTCATCTCCGGCATTCTC bifA 
qPA4367R TTGGTCAGCATCCAGTGGTAGA bifA 
qPA4601F GAAGGCCGTGAATTCTTCGT morA 
qPA4601R TGGAAGTTGTTCTTGCCCATCT morA 
qPA4959F CCTTCGTCCAGGACCTCAAC fimX 
qPA4959R GCTTCTGCTGTTCGTGCAGTT fimX 
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Name Sequence Comments 
qPA5017F CAGCCGCCGCAAGAAC dipA 
qPA5017R ATGTCTTCGTAGATGCCGATGTAG dipA 
qPA5295F CCGGTTTCTCGTCCTTCGT PA5295 
qPA5295R CTGCGGTCGATCTTCAACAG PA5295 
qPA5442F CGATCCCTATCCCCAATGG PA5442 
qPA5442R GGGCACTGAGATCGGTGAA PA5442 
Sequencing/screening primers 
M13F TGTAAAACGACGGCCAGT GATC Biotech 
M13R CAGGAAACAGCTATGACC GATC Biotech 
pUT18CUp CGGATGTACTGGAAACGGTG (Houot et al., 2012) 
pUT18Dn TGCGGAACGGGCGCCGGCGCGAGCG (Houot et al., 2012) 
 
 
 
2.2.2 DNA purification, extraction and quantification 
Genomic DNA was isolated using the PureLink Miniprep kit (Invitrogen). Plasmid DNA was isolated 
using the QIAprep Spin Miniprep and Midiprep Kits (Qiagen). PCR fragments were purified using 
QIAquick PCR Purification Kit (Qiagen). Digested DNA fragments were extracted from agarose gels 
using QIAquick Gel Extraction Kit (Qiagen). DNA concentrations were determined by using the ND-
1000 Spectrophotometer (NanoDrop). 
 
2.2.3 Polymerase chain reaction (PCR) 
PCR was performed using primers purchased from Eurogentec.  
For cloning purposes, fragments were amplified from PAO1 gDNA (genomic DNA). For up to 2kb, the 
Expand High FidelityPLUS DNA polymerase from Roche was used. For bigger fragments, the KOD Hot 
Start DNA Polymerase (Merck) was used. For site-directed mutagenesis, the PfuUltraII Fusion HS 
DNA Polymerase from Agilent Technologies was used as indicated in the QuickChange Site-directed 
Mutagnesis Kit (Stratagene). In each case, the PCR reactions and thermal cycling conditions used 
were according to the manufacturer’s instructions. In all cases, 1.2 M betaine (Sigma) was added to 
the PCR reaction because of the high GC content of the P. aeruginosa genome. 
Colony PCR was used for screening purposes using the Taq polymerase from New England BioLabs, 
Inc. Single E. coli and P. aeruginosa colonies were resuspended in 100 µL of molecular biology water 
and lysed by one or two cycles, respectively, of freeze (-80oC, 10 min) and thaw (95oC, 10 min). Cell 
debris were pelleted and 5 µL of the supernatant were used in each PCR reaction (30 µL of final 
volume). DMSO was added to a final concentration of 3.3%. The fragments were amplified in 30 
cycles (95oC for 30 sec, 55oC for 30 sec, 72oC for 1 min/kb) after an initiation step of 5 min at 95oC. 
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RT-PCR (reverse transcription PCR) was performed using SuperScript III Rnase H-Reverse 
Transcriptase (Invitrogen) and according to instructions. cDNA (complementary DNA) was 
synthesized from 200 ng of RNA template (extracted as described below) adding 20 Units of 
Protector RNase Inhibitor from Roche, 10 pmol of Pd(N)6 random hexamer oligonucleotides from 
Amersham and 10 pmol dNTPs from Bioline to the reaction mix.  
 
2.2.4 Sequencing 
Sequencing was performed at GATC Biotech, Germany. 
 
2.2.5 Restriction endonuclease digestion and DNA ligation 
Restriction enzymes from Roche and T4 DNA Ligase (Roche) were used as recommended by the 
manufacturer. PCR fragments were ligated into pCR2.1 or pCR-Blunt using the TA Cloning and Zero 
Blunt Cloning kits (Life Technologies). 
 
2.2.6 Bacterial transformation 
E. coli TOP10 and OmniMAX chemically competent cells were used for standard genetic 
manipulations. TOP10 cells were purchased from Invitrogen and used according to the 
specifications. OmniMAX, CC118λpir, Sm10λpir, XL1-Blue, DHM1, BL21 (DE3) and BL21 (DE3) C41 
competent cells were home-made and prepared using a solution of 50 mM CaCl2 with 15% glycerol. 
When appropriate, IPTG (iso-propanyl-β-D-thiogalactopyranoside, Sigma) and X-gal (5-bromo-4-
chloro-3-indolyl-D-galactoside, Invitrogen) were added to the medium and blue-white screening was 
performed.  
P. aeruginosa electrocompetent cells were used for incorporation of non-conjugative plasmids. Cells 
were prepared at room temperature with 300 mM sucrose and the electric pulse was applied at 
constant 2.5 kV.  
 
2.2.7 Agarose gel electrophoresis 
DNA was visualized in a blue light transilluminator (Peqlab) after electrophoresis on an agarose gel 
supplemented with SYBR Safe (Invitrogen). 1% gels were used to separate DNA fragments between 
500bp and 3kb. Fragments bigger than 3kb were separated in 0.8% gels whereas fragments smaller 
than 500bp were separated in 1.2% gels. 
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2.2.8 RNA extraction 
Overnight PAK and PAK∆retS cultures were subcultured in LB medium with a starting OD600nm of 0.1 
and incubated at 37oC with shaking for 6 h. Cells were then harvested into RNAlater (Ambion) and 
RNA was extracted using the RNeasy extraction kit (Qiagen). To remove DNA the Turbo DNA-free kit 
(Applied Biosystems) was used and the RNA was re-purified using the RNeasy kit, following the 
supplier’s indications. 
 
2.2.9 qRT-PCR (real time reverse transcription PCR) 
qRT-PCR was performed on the ABI 7300 Real Time PCR System using the ABI SYBR Green PCR 
Master Mix. cDNA was synthesized by RT-PCR as described above.  
 
2.2.10 SDS-PAGE and Western blot 
For immunoblot analysis, overnight cultures were subcultured in LB medium with a starting OD600nm 
of 0.1 and incubated at 37oC with shaking for 6 h unless otherwise specified. To standardize samples, 
the volume of culture harvested was equal to 1.5/OD600 and cells were resuspended in loading buffer 
containing 4% glycerol, 5% β-mercaptoethanol, 0.06 M Tris pH 6.8, 2% SDS and 0.002% 
bromophenol blue. Whole cell lysates were separated by SDS‐PAGE using a 12% or 8% resolving gel. 
Proteins were electrophoretically transferred to nitrocellulose membranes (Whatman) and blocked 
overnight in 1x TBST (0.5 M Tris pH 8.0, 1.5 M NaCl, 0.1% Tween-20) containing 5% skim milk 
powder. Primary antibodies, -Hcp1 (Hachani et al., 2011), -LasB (Bleves et al., 1999) and -VgrG1 
(Hachani et al., 2011) were used at dilutions of 1:1000, and -PcrV (Lee et al., 2010b), -FLAG 
(Sigma) and -HIS (Sigma) were used at 1:10000. Secondary antibodies horseradish 
peroxidise‐conjugated goat anti‐rabbit IgG (Sigma) or anti-mouse IgG (Sigma) were used at a 1:5000 
dilution. Visualization was achieved using the SuperSignal West Pico Chemiluminescent Substrate Kit 
(Pierce) and a LAS3000 Imaging System (Fuji). 
 
2.3 Three-partner conjugation 
 
Transfer of plasmids into P. aeruginosa strains was carried out by triparental mating using the 
mobilizing plasmid pRK2013. Prior to the addition of the receiver strain to a co-culture of the donor 
and helper strains, the receiver strain was incubated for 2 h at 43oC to inactive its restriction 
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modification system and prevent the degradation of the foreign plasmid. Conjugation was then 
allowed for at least 4 h at 37oC by co-culturing the three strains on an agar plate. Transconjugants 
were isolated on Pseudomonas Isolation Agar (PIA, Difco) plates supplemented with appropriate 
antibiotics. 
 
2.4 Construction of P. aeruginosa chromosomal mutants 
 
Clean deletion mutants were engineered by using the suicide vector pKNG101 which contains the 
sacB gene conferring sensitivity to sucrose (Kaniga et al., 1991). Mutator fragments were 
constructed by PCR amplification of upstream and downstream fragments of approximately 500bp 
flanking the chromosomal region to be mutated. The two fragments were then joined together using 
overlap extension PCR (Warrens et al., 1997) and the product was cloned into pCR2.1 to check 
sequence before being sub-cloned into pKNG101. The first crossover event occurred upon 
conjugation and was selected for using Sm. The second crossover event occurred upon growth on LB 
agar plates supplemented with 5% sucrose after 3 days incubation at room temperature. Deletions 
were confirmed using external primers designed to anneal to the flanking region of the mutator 
fragment. 
 
2.5 Swimming motility 
 
Swimming motility was assessed in freshly poured 0.3% LB agar plates incubated at 30oC. Plates 
were prepared by diluting the commercial 1.2% LB agar with warm LB. Plates were inoculated by 
injecting 0.5 µL of overnight liquid cultures below the surface of the agar. 
 
2.6 Biofilm assays 
 
The formation and dispersal of biofilms was evaluated using microtiter plates and microfermentors. 
For a robust and quick visualization of biofilms, glass test tubes were used. 
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2.6.1 Microfermentors 
M9 medium with 0.1% glucose was used to grow biofilms in microfermentors (Pasteur Institute). 
This method is described in more detail in Appendix 3 (“Methods for studying biofilm dispersal in 
Pseudomonas aeruginosa” in Methods in Pseudomonas, in press). The amount of cells of overnight 
cultures equivalent to an OD600 of 2 was used as the inoculum. After an initial attachment period of 1 
h, strains were incubated for a minimum of 20h at 37oC under a continuous flow of medium 
(peristaltic pump: 4 rpm) and air (air pressure: 0.4 bar). Biofilm dispersal was induced by changing 
from growth medium to medium supplemented with 10 mM NaNO2 or prepared without glucose. 
The optical density of the effluent was monitored every 10 min during the dispersal treatment. 
 
2.6.1 Microtiter plates (for screening and time-course) 
Quantification of biofilm formation was performed in 24-well polystyrene microtiter plates. M9 
medium (1 mL/well) with 0.4% glucose and antibiotics when appropriate was inoculated to a final 
OD600nm of 0.01. The plates were incubated for different time periods at 37C under shaking 
conditions. Biofilms were stained with 100 µL of crystal violet (CV) and washed twice with water 
before being solubilized in 96% ethanol. CV staining was measured by reading the optical density at 
600 nm. 
For screening purposes, strains were inoculated in 48-well polystyrene microtiter plates (600 
µL/well, starting OD600 of 0.01) for 6 h at 37
oC under shaking conditions. Biofilm dispersal was 
induced by the addition of freshly made 10 mM NaNO2. After 30 min the supernatant was collected 
in a disposable cuvette and the optical density of the planktonic biomass was measured. Biofilms 
were stained with 0.1% CV for 10 min and washed and dissolved as above. The optical density of the 
CV staining biofilm biomass was measured at 600 nm. Three replicates were used per condition 
(treated versus untreated) and for each strain at least three independent experiments were carried 
out. The calculation of the biofilm remaining after dispersal induction corresponds to the ratio 
between the biofilm present in treated wells and the biofilm present in untreated wells at the end of 
the experiment. 
In both cases, microtiter plates were wrapped in cling film and aluminium foil to avoid spatial 
variations on biofilm formation. 
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2.6.2 Glass test tubes (for visualization) 
Visualization of biofilms was carried out in 14 mL borosilicate tubes. 3 mL of LB supplemented with 
antibiotics when appropriate were inoculated with 1 µL of overnight cultures and incubated at 37°C 
for different time periods, under static or shaking conditions, as specified. Biofilms were stained with 
300 µL of CV and tubes were washed with water twice to remove unbound dye before being 
photographed.  
 
2.7 Congo Red binding 
 
To assess exopolysaccharide production, Congo Red binding assays were performed at 30oC using 
plates with 1% agar and 1% tryptone. The dyes Congo Red and Coomassie Brilliant Blue were used at 
the following concentrations: 40 μg/mL and 20 μg/mL, respectively. Plates were inoculated by 
spotting 5-10 µL of overnight liquid cultures. After the first day of incubation at 37oC, plates were left 
at room temperature for at least 5 days.  
 
2.8 c-di-GMP detection 
 
The detection of c-di-GMP was performed using two methods: nucleotide extraction followed by LC-
MS/MS, and measurement of fluorescence produced by a c-di-GMP reporter. 
 
2.9.1 Extraction and measurement by LC-MS/MS 
Nucleotide extraction was performed as previously described (Simm et al., 2009), with some 
modifications. Bacteria from 100 mL of overnight liquid cultures grown in M9 medium supplemented 
with nutrients and appropriate antibiotics were resuspended in ice-cold 0.19 % formaldehyde to a 
final concentration of 300 mg wet weight per mL. This suspension was divided into 4 tubes and 
incubated on ice for 10 min before centrifugation (5000x g for 15min). The pellet was then 
resuspended in 300 μL of water and when required, c-di-GMP (BioLog) was spiked at a concentration 
of 1.7 μM. After the ethanol extraction of nucleotides, samples were dried under vacuum and sent 
to the University of Nottingham at -20oC. The pellets were reconstituted in 50 μL of water by 
vigorous vortexing and sonication for 5 min, centrifuged for 15 min at 10,000× g and the 
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supernatants were analyzed using an Agilent 1200 HPLC system with aC18 ACE 3 AQ 150×2.1 mm 
column with a matching guard maintained at 55oC. Themobile phase consisted of 0.1% formic acid 
run in an H2O-acetonitrile gradient at a flow rate of 300 μl/min, reaching 50% acetonitrile in 14 min. 
Mass spectrometry analysis was then performed by negative ion electrospray from the Agilent HPLC 
system into a Bruker HCT Plus ion trap in multiple reaction mode. Using SmartFrag (HyStar 
software), the trap was set to isolate from full scan and then fragment ions at m/z 688.9, with a 
monitored mass range of 450-700 m/z. DataAnalysis v3.3 was used to interrogate the acquisitions, 
and extracted ion chromatograms of m/z 538 were produced from the negative ion MS/MS of m/z 
688.9. Retention times and peak spectra were matched to the standard injected at intervals 
throughout the run. Peak areas and relative c-di-GMP levels were normalized to the levels obtained 
with the reference strains.  
 
2.9.2 c-di-GMP reporter 
The reporter PcdrA-gfp plasmid received from Matthew Parsek (Rybtke et al., 2012) was introduced in 
the P. aeruginosa strains of interest by electroporation and overnight cultures were subcultured in 
LB medium supplemented with the appropriate antibiotic to a starting OD600nm of 0.1. After shaking 
incubation at 37oC for 6 h or other specified time, 1mL of culture was harvested in a microcentrifuge 
at maximum speed and cells were resuspended in 1xPBS (phosphate buffered saline) before the 
optical density (600nm) and fluorescence (excitation 485nm, emission 520nm) was measured in a 
black 96-well plate with see-through bottom (Falcon) using a FLUOstarOptima plate reader (BMG 
Labtech). Quantifications were performed in triplicate and data are presented as relative fluorescent 
units (RFU) which are arbitrary fluorescent units corrected for cell density. 
 
2.9 c-di-GMP binding assays 
 
The ability of proteins of interest to bind c-di-GMP was assessed from whole cell lysates using two 
methods: the c-di-GMP capture compound and the DRaCALA assay. 
 
2.9.1 c-di-GMP capture compound 
This assay was carried out at the Biozentrum (University of Basel) applying the methods developed 
by Jutta Nesper (Nesper et al., 2012). Overnight liquid cultures grown in LB with appropriate 
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antibiotics were diluted 1:100 and grown to an OD600 of 0.5 before a 3 h induction with 0.5mM IPTG 
at 37oC. Cells were pelleted by centrifugation (5000x g for 20min) and resuspended in lysis buffer 
[6.7 mM MES (2-(N-morpholino)ethanesulfonic acid), 6.7 mM HEPES (4-(2-hydroxyethyl)-1-
piperazine ethanesulfonic acid), 200 mM NaCl, 6.7 mM KAc, 10 mM β-mercaptoethanol] 
supplemented with DNaseI (Roche) and protease inhibitor (Roche). Cells were lysed using a French 
press at 20 000 psi. After ultracentrifugation (10 000x g for 60min) the protein concentration in the 
supernatant was quantified using a ND-1000 Spectrophotometer (NanoDrop).  The incubation with 
the capture compound was performed in 12-tube PCR strips for 1 h at 4oC on a rotatory wheel. The 
final volume was 100 μL and 100 μg of the extract plus 20 μL of 5x capture buffer (100 mM HEPES, 
250 mM KAc, 50 mM MgAc, 50% glycerol) were used. The c-di-GMP capture compound (Caprotec 
Bioanalytics GmbH) was added at a concentration of 10 μM. Cross-linking was induced with UV light 
for 4 min in a caproBox (Caprotec Bioanalytics GmbH) and subsequently, 30 μL of magnetic 
streptavidin beads (Dynabeads MyOne Streptavidin C1, Invitrogen) together with 25 μL of 5x 
washing buffer (250 mM Tris pH 7.5, 5 M NaCl, 0.1% n-ocyl-β-glucopyranoside) were added. After 
incubation for 30 min at 4oC on a rotatory wheel the beads were collected with a caproMag 
(Caprotec Bioanalytics GmbH) and washed six times with 1x washing buffer. For immunoblot 
analysis, the beads were resuspended in 30 μL of SDS-PAGE loading buffer and the experiment 
proceeded as described in section 2.2.10. For membrane proteins, the following modifications 
applied: the IPTG induction was performed at 30oC and the collected cells were resuspended in 1x 
PBS with protease inhibitor and then lysed. After ultracentrifugation (10 000x g for 60 min), the 
pellet was resuspended in lysis buffer supplemented with n-dodecyl-β-D-maltopyranoside (DDM, 
Anatrace) and the proteins were solubilized for 3 h at 4oC on a rotatory wheel. In addition, the 
incubation with the capture compound was performed overnight using 200 μg of extract and the n-
ocyl-β-glucopyranoside in the washing buffer was replaced by 0.1% DDM.  
 
2.9.2 DRaCALA 
DRaCALA assays were performed as previously described (Roelofs et al., 2011). Briefly, radioactive 
labeled c-di-GMP was synthesized using purified WspRD70E and α-32P-GTP (PerkinElmer) and isolated 
using a Nanosep column (Pall). Overnight liquid cultures grown in LB with appropriate antibiotics 
were diluted 1:50 and grown for 6 h or to an OD600 of 0.5 before a 3 h induction with 0.5mM IPTG. 
OmniMAX cells were used to express pBBR1-MCS4 derivatives, BL21 (DE3) cells were used for 
soluble proteins expressed from pET28a, and BL21 (DE3) C41 cells were used for membrane proteins 
expressed from pET28a. Whole-cell lysates were prepared in 1x c-di-GMP binding buffer prepared 
with 100 mM KCl, 5 mM MgCl2, 100 mM Tris (pH 8.0), 100 μM PMSF, 500 µg/mL lysozyme and 20 
 109 
 
µg/mL of DNaseI. 10 µL of lysate were mixed with 4 nM radioactive labelled c-di-GMP and incubated 
for 10 min at room temperature. The mixtures were then spotted (~2.5 μL) in triplicate on dry 
untreated nitrocellulose membranes (GE Healthcare) and allowed to dry. An FLA7100 Fujifilm Life 
Science PhosphorImager was used to detect luminescence following a 5 min exposure of blotted 
nitrocellulose to phosphorimager film. Data were quantified using Fujifilm Multi Gauge software 
v3.0. 
 
2.10 Bacterial two-hybrid assay 
 
Protein interactions were assessed by using a bacterial two-hybrid approach following the BACTH 
System Kit’s methodology (Euromedex). 
 
2.10.1 Interactions between target proteins 
DNA fragments encoding the protein of interest were cloned into pKT25 or pUT18C vectors for N-
terminal fusions to the T25 or T18 fragments, respectively, of the CyaA protein of Bordetella 
pertussis. For C-terminal fusions, the plasmids pKNT25 and pUT18 were used. The AC deficient E. coli 
strain DHM1 was used to screen for positive interactions and the interaction between the leucine 
zipper domains expressed from the pKT25-zip and pUT18C-zip plasmids was used as control. DHM1 
competent cells were transformed simultaneously with the pKT25/pKNT25 and pUT18C/pUT18 
derivatives and co-transformants were selected on LB agar plates supplemented with Ap and Km. 
Interactions were identified by spotting 5 µL of overnight cultures onto MacConkey (Difco) agar 
plates supplemented with antibiotics (100 μg/mL Ap and 50 μg/mL Km) and with 1% of maltose and 
1 mM of IPTG. Positive interactions resulted in the appearance of red colonies due to the 
acidification of the medium by the cAMP-dependent degradation of maltose. The colour was 
checked after incubation for 48 h at 30oC. 
 
2.10.2 Screen of the two hybrid genome fragment PAO1 library  
This assay was carried out at the CNRS in Marseille with the guidance of Christopher Bordi. The 
library prepared by Houot et al. (2012) was tested four times by transforming 10 µL of the library 
into 100 mL of chemically competent DMH1 cells carrying the pKT25-SadCfl bait plasmid. The 
transformations were plated on MacConkey agar plates supplemented as above and the colour was 
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monitored during incubation for 48h at 30oC followed by 5 days at room temperature. Red colonies 
were picked up and re-streaked to confirm interaction prior to plasmid isolation and sequencing. 
 
2.11 Infection of Galleria mellonella with P. aeruginosa 
 
Infections were performed as previously described (Miyata et al., 2003), with some modifications. 
Overnight liquid cultures grown in LB were diluted 1:100 and grown to an OD600 of 0.3 to 0.4. Cells 
were harvested in a microcentrifuge and resuspended in 10 mM MgSO4 to an OD600 of 0.1. Six serial 
10-fold dilutions were made in 10 mM MgSO4 and 5 µL of each were injected into G. mellonella 
larvae (www.livefoods.co.uk) with a Hamilton 802N syringe (Sigma), in the right proleg of the first 
pair of prolegs. Ten larvae were injected per dilution and then incubated at 37°C in standard Petri 
dishes covered with Whatman paper. The syringe was cleaned with 96% ethanol for 10 min and 
rinsed three times with water when changing strains. The number of dead larvae, i.e. larvae that did 
not respond to touch, was counted 1 to 2 days after infection. Mock inoculations were performed to 
monitor killing due to physical injury or infection by other pathogens. 
 
2.12 Confocal microscopy 
 
The LSM510 Confocal microscope (Zeiss) was used to visualize strains expressing the PcdrA-gfp 
reporter. Bacteria were grown as described above for the c-di-GMP reporter and washed once with 
1xPBS before spotting 5 µL on a glass slide. Samples were dried for 1 h at 37oC prior to visualization. 
The image is 20x amplified.     
 
2.13 Bioinformatic tools 
 
PAO1 and PA14 sequences were retrieved from the Pseudomonas database 
(www.pseudomonas.com) (Winsor et al., 2009). The PAK sequence is unpublished and was obtained 
from Marvin Whiteley and manipulated using the Artemis genome browser (Rutherford et al., 2000). 
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Primers were designed with the help of Primer3 (Untergasser et al., 2012), OligoEvaluator (Sigma) 
and QuikChange Primer Design Program from Agilent Technologies. Sequence alignments were 
performed using NCBI-BLAST (Altschul et al., 1990). Sequencing results were analysed using Chromas 
Lite (Technelysium Pty Ltd). 
Mfold web server (Zuker, 2003) was used to predict RNA secondary structures and Phyre2 (Kelley & 
Sternberg, 2009) to predict protein three dimensional structures and performe the BackPhyre 
analysis. PyMOL (Schrödinger, LLC) was used to visualize three dimensional structures.     
 
2.14 Statistical analysis 
 
The Students t-test and ANOVA with Tukey’s posthoc test were used throughout and unless 
otherwise indicated. The software used was Microsoft Excel 2010 and SPSS (Statistical Package for 
Social Sciences, IBM), respectively. 
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Chapter 3 – Cyclic di-GMP modulation of biofilm formation and dispersal 
 
In the past decade, c-di-GMP has emerged as a signalling molecule that modulates the switch 
between motile and sessile lifestyles in bacteria (Hengge, 2009). In P. aeruginosa, which has been 
used as a model organism to study c-di-GMP regulation, a link between c-di-GMP and biofilm 
formation or dispersal is now well established, but the environmental cues or signalling cascades 
controlling these phenomena are still poorly understood.  
In P. aeruginosa, the c-di-GMP network is composed of many components including proteins with a 
GGDEF, EAL or HD-GYP domain. In order to understand the complexity and specificity of this c-di-
GMP signalling network, I started by setting up a microtiter plate (MTP) assay suitable for the study 
of both biofilm formation and dispersal. Subsequently, I used this assay to screen a collection of 42 
transposon mutants for altered biofilm formation or dispersal phenotypes. 
 
3.1 c-di-GMP influences P. aeruginosa lifestyle 
 
The paradigm of c-di-GMP regulation is that high levels of c-di-GMP repress motility and promote 
biofilm formation whereas low levels of c-di-GMP do the opposite (Jenal & Malone, 2006). To 
confirm this assumption, two genes involved in the production or degradation of c-di-GMP were 
cloned into the plasmids pJN105 or pBBR1-MCS-4.  The two cloned genes were wspR, encoding a 
known DGC that synthesizes c-di-GMP (Figure 1.9, Table 1.5) (De et al., 2009; Hickman et al., 2005); 
and PA2133, encoding a known PDE that hydrolyzes c-di-GMP (Table 1.5) (Kulasakara et al., 2006). 
The pJN105 plasmid contains an arabinose inducible promoter that allows for tight regulation of the 
expression of the cloned genes by the addition of the repressor D-glucose or the inducer L-arabinose 
(Newman & Fuqua, 1999). The pBBR1-MCS4 plasmid allows for constitutive expression of the cloned 
gene from the promoter of the lac operon (Kovach et al., 1995). To investigate the impact of c-di-
GMP in biofilms, the constructed plasmids were conjugated into the P. aeruginosa strains PAO1 and 
PAK. Biofilms were visualized and quantified by measuring crystal violet (CV) staining of the attached 
biomass. CV is one of the dyes used in the Gram technique and is able to bind to cell surface 
molecules and extracellular matrix components. 
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As shown in Figure 3.1A, the production of WspR (induced by the addition of increasing 
concentrations of L-arabinose) resulted in enhanced biofilm formation when compared to the strain 
carrying the pJN105 empty vector. In contrast, overexpression of PA2133 displayed a hypobiofilm 
phenotype. This hypobiofilm phenotype was independent of the addition of D-glucose or L-
arabinose suggesting that the expression of PA2133 is leaky. Nonetheless, these results are 
according to the established paradigm that low levels of c-di-GMP prevent biofilm formation 
whereas high levels of c-di-GMP promote the sessile lifestyle. 
To further investigate the impact of c-di-GMP in the lifestyle switch, the gene encoding for WspR 
was subjected to site-directed mutagenesis. Firstly, the I-site of WspR was mutated in order to 
release the catalytic activity of WspR from c-di-GMP inhibition. This corresponded to an A mutation 
of the R residue located in the RxxD motif, yielding WspRR242A. Secondly, and in addition to the I-site 
mutation, the phosphorylation site of WspR was also mutated in order to render the protein 
constitutively active. This corresponded to an E mutation of the D residue in the N-terminal REC 
domain, yielding WspR**. 
As expected, when the plasmid encoding for the wild-type WspR was conjugated into PAK, the 
resulting strain displayed a hyperbiofilm phenotype and this phenotype was more pronounced in the 
strain overproducing WspRR242A, suggesting that the higher the levels of c-di-GMP are, the stronger 
the biofilm phenotype is (Figure 3.1B). In agreement to this induction of the sessile lifestyle, the 
strains also displayed increased Congo Red binding which is indicative of exopolysaccharide 
production; and reduced swimming motility which is indicative of reduced flagella rotation (Figure 
3.1C). 
In relation to the constitutively active WspR** which has the phosphorylation and I- sites mutated, 
conjugation of pwspR** was only possible using the pJN105 derivative when the repressor D-glucose 
was added to the medium. No bacterial growth was observed when the production of WspR** was 
induced by arabinose, suggesting that there is a threshold when c-di-GMP becomes deleterious to 
the cells and it is possible that this is due to depletion of the precursor GTP from the cell (Figure 
3.1D). 
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Figure 3.1 Production of the DGC WspR promotes biofilm formation whereas production of the 
PDE PA2133 inhibits the sessile lifestyle.  
(A) Expression of wspR or PA2133 has antagonist effects on biofilm formation. PAO1 was conjugated 
with the control plasmid pJN105 and its derivatives encoding for WspR and PA2133. Biofilm 
formation was quantified by CV staining after growth in LB for 8 h under shaking conditions in a 
MTP. Expression was controlled by adding D-glucose (Gluc) or increasing concentrations of L-
arabinose (Ara) at the time of inoculation. Results are the average of 6 technical replicates and error 
bars represent standard deviation. Two independent experiments were performed. (B) Disruption of 
the I-site (R242A) enhances biofilm formation. PAK was conjugated with the vector control pBBR1-
MCS4 (pVC) and its derivatives pwspR and pwspRR242A encoding for WspR and WspRR242A, 
respectively. In the top, biofilms formed in glass tubes at the air-liquid interface under static 
conditions are visualized by crystal violet staining. In the chart, biofilms formed in a MTP under 
shaking conditions were quantified by crystal violet staining. An ANOVA analysis was performed with 
a p value of 0.05. Asterisks indicate statistically significant changes. At least three independent 
experiments were performed. (C) Enhanced biofilm formation is concomitant with enhanced Congo 
Red binding (top images) and reduced swimming motility (bottom images). (D) Expression of the 
constitutively active WspR** inhibits bacterial growth. WspR** produced from pJN105-wspR** 
harbours the I-site mutation (R242A) and a D70E mutation that mimics the phosphorylated stated of 
the D residue in the REC domain. In this case, optical density was measured from overnight liquid 
cultures grown at 37oC. The experiment was repeated three times with one technical replicate in 
each case. 
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3.2 Nitric oxide and glucose starvation induce biofilm dispersal 
 
In the biofilm developmental cycle, biofilms disperse so that motile cells are released from the 
biofilm to colonize new areas. In the same way that high levels of c-di-GMP are required for motile 
cells to form biofilms, it is thought that low levels of c-di-GMP are required for biofilm cells to 
disperse. However, compared to biofilm formation, the molecular mechanisms underlying biofilm 
dispersal are not well understood. 
Several studies have identified specific growth conditions and environmental cues that can induce 
biofilm dispersal including (i) up- or down-shifts in carbon sources (Sauer et al., 2004; Schleheck et 
al., 2009), (ii) addition of the chelating agent EDTA (Banin et al., 2006), (iii) oxygen limitation (An et 
al., 2010), (iv) addition of the P. aeruginosa fatty acid cis-2-decenoic acid (Davies & Marques, 2009), 
(v) addition of nitric oxide donors (Barraud et al., 2006; Barraud et al., 2009), (vi) availability of iron 
(Glick et al., 2010; Musk et al., 2005), (vii) production of the rhamnolipid surfactant (Boles et al., 
2005; Schooling et al., 2004), (viii) addition of a reverse amide oroidin analogue (Richards et al., 
2008) and (ix) addition of D-aminoacids (Kolodkin-Gal et al., 2010).  
Herein, two treatments were initially considered for the study of biofilm dispersal: glucose 
starvation, induced by changing the growth medium to medium without any carbon source; and 
exposure to nitric oxide, achieved by addition of nontoxic concentrations of sodium nitrite which 
spontaneously generate nitric oxide in solution. Both of these treatments are thought to mimic 
conditionsthat are not favourable to the bacteria, i.e. nutrient and oxygen depletion respectively. 
Before setting up the MTP assay, the dispersal response to the two treatments was studied in 
microfermentors (MFs) (Figure 3.2A). 
MFs were developed by the group of Jean-Marc Ghigo and consist of glass vessels where biofilms 
grow on a spatula under a continuous flow of medium and air (see Appendix 3) (Barraud et al., 2013; 
Garcia-Sanchez et al., 2004; Ghigo, 2001). For P. aeruginosa PAO1 strain, macroscopic growth of 
biofilms in the MFs was visible on the spatula after 1 day of incubation while for PA14, biofilms were 
visible only after 3 days but covered the spatula and the walls of the glass vessel. To induce biofilm 
dispersal, the glucose supplemented M9 minimal medium was changed to medium without glucose 
(no carbon source) or medium containing sodium nitrite (nitric oxide donor). To monitor biofilm 
dispersal, i.e. the release of cells from the biofilm, the effluent was collected in Falcon tubes every 
10 min and readings of the optical density were taken. 
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Figure 3.2 Biofilms disperse upon glucose starvation or exposure to nitric oxide in MFs.  
(A) Schematic illustration of the MF set up and visualization of a spatula before and after a dispersal 
treatment. Biofilms grow on the spatula (red) which is placed inside the glass vessel. This system is 
under a continuous flow of air and medium provided by an air compressor (symbolized by an orange 
arrow) and peristaltic pump, respectively. The effluent is collected in a waste bottle until the 
dispersal treatment is initiated. (B) Biofilm dispersal occurs upon glucose starvation or addition of 10 
mM sodium nitrite (arrows). PAO1 biofilms were grown for 24 h and dispersal was seen as an 
increase of the optical density of the biofilm effluent. (C) Biofilm dispersal upon addition of sodium 
nitrite (arrow) in PA14 biofilms grown for 3 days. (D) Constitutive production of WspR makes 
biofilms less responsive to biofilm dispersal upon addition of sodium nitrite (arrow). The pBBR1-
MCS4 vector control (pVC) and its derivative pwspR were introduced in PAK by conjugation and 
biofilms were grown for 24 h in minimal medium supplemented with the appropriate antibiotic. The 
levels of biofilm formed by the two strains at the time of the dispersal treatment were considered 
equivalent after 24 h based on a visual inspection of the spatula.  
 
For both dispersal treatments in PAO1, the dispersal response was almost immediate and the optical 
density of the effluent increased rapidly until a maximum that was reached after approximately 30 
min of the treatment initiation (Figure 3.2B). Curiously, for glucose starvation the amplitude of the 
dispersal response was higher than the sodium nitrite addition (~8-fold increase compared to ~3-
fold), but for the latter, the dispersal peak appeared wider (30 min versus 10 min). In the case of 
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PA14 which forms prominent biofilms after 3 days, the amplitude of the dispersal response upon 
addition of sodium nitrite corresponded to a 34-fold increase of bacterial cells released in the 
effluent (Figure 3.2C) and resulted in a dramatic clearance of the biofilms from the spatula and glass 
vessel.  
To confirm that the biofilm dispersal response is related to c-di-GMP, the impact of sodium nitrite 
addition to a PAK strain with constitutive high levels of c-di-GMP (achieved by means of wspR 
overexpression) was compared to dispersal of a PAK strain carrying the pBBR1-MCS4 vector control. 
After growth for 24 h in the MFs, the resulting strains formed visible biofilms on the spatula and 
dispersal was induced. As shown in Figure 3.2D, the strain overproducing WspR was less able to 
disperse than the empty vector control, supporting the notions that the observed nitric oxide 
dispersal involves c-di-GMP signalling and reduced levels of c-di-GMP are required for biofilm 
dispersal to occur.    
 
3.3 Setting up a MTP assay to monitor biofilm formation and dispersal 
 
Traditionally, the biofilm developmental cycle has been studied using flow cells and microscopy 
(Weiss Nielsen et al., 2011). However, this set up is labour-intensive and inappropriate for screening 
purposes. Therefore, in order to characterise biofilm formation in a range of mutants, assays that 
combine the use of MTPs with CV staining have been preferred (Christensen et al., 1985; Peeters et 
al., 2008).  
For the purposes of this study, a MTP assay that allows a quick evaluation of not only biofilm 
formation but also biofilm dispersal was developed. To set it up, PAO1 was used because it can form 
biofilms faster and dispersal was induced by nitric oxide treatment because it is less invasive 
(performed by simple addition of sodium nitrite without requiring the removal of the supernatant). 
Briefly, in this MTP assay the strains of interest are inoculated in duplicate (for treated versus 
untreated conditions) and incubated for a defined period of time to allow biofilm formation. After, 
the dispersal treatment is applied and biofilm dispersal is assessed through the quantification of the 
optical density of the supernatant (planktonic biomass) and CV staining (biofilm biomass). Upon 
treatment, dispersal can be observed as a reduction of the biofilm biomass and an increase in the 
planktonic biomass by comparing the values for the treated and untreated conditions (Fig 3.3A).  
For PAO1, the kinetic profiles of planktonic growth and biofilm formation in a MTP showed that the 
biofilm biomass after 6 h of incubation under shaking conditions corresponded to a CV staining of 
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approximately 2.5 OD units (Figure 3.3B). This time point was chosen to study the dispersal response 
and as shown in Figure 3.3C, addition of sodium nitrite (NaNO2) resulted in a decrease in the biofilm 
biomass and an increase in the planktonic biomass. In fact, although concentrations were kept low 
to avoid the toxic effects of nitric oxide, the response to sodium nitrite was dose-dependent and 
statistically significant changes in planktonic and biofilm biomasses occurred at a concentration of 10 
mM. Based on the dispersal response obtained in the MFs, in the MTP assay the incubation with the 
dispersal agent was performed for 30 min. To ensure that the effect of sodium nitrite addition was 
mainly due to the production of nitric oxide and not due to the addition of sodium cations, sodium 
nitrate (NaNO3) and sodium chloride (NaCl) were also tested. Unlike NO2
- which is readily converted 
to nitric oxide in the periplasm, NO3
- needs to be incorporated into the cells to be reduced to NO2
- 
(Ye et al., 1994). Only addition of NaNO2 caused a significant biofilm dispersal response (Figure 3.3D) 
confirming that the observed dispersal phenotypes are due to nitric oxide production. 
Based on these data, the developed MTP assay was considered suitable for the assessment of both 
biofilm formation and dispersal and was used for screening purposes.   
 
Figure 3.3 Assessment of biofilm formation and dispersal in the MTP assay.  
(A) Biofilm dispersal is monitored by a reduction in the biofilm biomass and an increase in the 
planktonic biomass. A photograph of two CV stained MTP wells, one treated with the PBS control (-
NaNO2) and the other treated with sodium nitrite (+NaNO2), is shown. Biofilms were stained with CV. 
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(B) Planktonic and biofilm growth curves of PAO1 grown at 37oC under shaking conditions in a MTP.  
The 6 h time-point was chosen for subsequent assays. (C) PAO1 biofilms disperse upon addition of 
10 mM of sodium nitrite in the MTP assay for 30 min. The data indicates measurements of OD600 x 
10 for the supernatant (planktonic) and OD600 of the CV staining (biofilm), and are the average of 3 
techincal replicates ± standard deviation. An ANOVA analysis was performed with a p value of 0.05. 
Asterisks indicate statistically significant changes. Two independent experiments were performed. 
(D) Statistically significant biofilm dispersal in MTPs occurs upon addition of 10 mM NaNO2 (+NO2) 
but not 1x PBS (-NO2), 10 mM NaCl or 10 mM NaNO3 (+NO3). An ANOVA analysis was performed 
with a p value of 0.05. Asterisks indicate statistically significant changes. Two independent 
experiments were performed. 
 
3.4 Biofilm formation phenotypes of transposon mutants of genes encoding 
proteins with a GGDEF, EAL or HD-GYP domain  
 
A collection of 42 P. aeruginosa PAO1 transposon mutants was screened using the developed MTP 
assay (Jacobs et al., 2003). This collection included all the known genes that encode for proteins with 
a GGDEF, EAL or HD-GYP domain, with the exception of the transposon mutant in the gene encoding 
for PelD which contains a catalytic inactive GGDEF domain (Table 2.1). In each MTP, four strains 
were assessed and the performance of mutant strains was compared to the performance of the 
wild-type strain. 
In relation to biofilm formation, six hypobiofilm formers with at least 1.5-fold reduction in the 
biofilm biomass and three hyperbiofilm formers with at least 1.5-fold increase in the biofilm 
biomass, were identified (Figure 3.4A).  
The hypobiofilm mutants corresponded to insertions in the genes siaD, PA0338 and PA4843, 
encoding proteins with a GGDEF domain; and in the genes PA1181, PA2072 and fimX, encoding 
proteins with a GGDEF/EAL domain.  The hyperbiofilm mutants corresponded to insertions in rbdA, 
bifA and dipA which encode proteins with a GGDEF/EAL domain. Mutants in genes encoding proteins 
with an EAL or a HD-GYP domain showed a biofilm formation phenotype similar to wild-type. 
 
3.5 PA2072 seems to have PDE activity 
 
Among the hypobiofilm phenotypes, the PA2072 transposon mutant had the most severe phenotype 
(~7-fold reduction) and has never been described before. The PA2072 gene is predicted to encode a 
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protein with N-terminal CHASE4 and PAS domains followed by GGDEF (conserved I- and A-sites) and 
EAL domains (Figure 3.5A).  
 
Figure 3.4 Screen of the P. aeruginosa PAO1 transposon collection of genes encoding GGDEF, EAL 
or HD-GYP domain proteins. (Figure legend continues on the next page.)  
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The mutant collection was obtained from the University of Washington Genome Center (Jacobs et 
al., 2003). Data are the average of a total of 6 technical replicates from two independent 
experiments ± standard deviation, normalized by setting the CV staining of P. aeruginosa PAO1 
strain (wt) as 1. (A) Relative biofilm formation. Strains with at least 1.5-fold impairment on biofilm 
formation are represented by grey bars while black bars represent strains with at least 1.5-fold 
enhancement on biofilm formation. (B) Relative biofilm biomass remaining on the well surfaces after 
dispersal upon addition of sodium nitrite. Grey bars represent hyperdispersive strains, i. e. strains 
with at least 2-fold decrease in the biofilm biomass. The amount of biofilm remaing after dispersal 
was calculated as the ratio between the biofilm present in treated wells and the biofilm present in 
untreated wells.  
 
 
Figure 3.5 Further characterization of two mutant strains reveals that the PA2072 transposon 
mutant has a growth defect, and a PA0847 clean deletion mutant is not hyperdispersive.  
(A) Predicted domain organization of PA2072 and PA0847. The Pfam database (Punta et al., 2012) 
was used to identify the domains and the diagram was produced in MyDomains 
(www.expasy.ch/tools/mydomains). (B) Planktonic growth curves of P. aeruginosa PAO1 and the 
PA2072 transposon mutant grown in M9 medium with 0.4% glucose at 37oC under shaking 
conditions. Data are the average of 3 technical replicates ± standard deviation. (C) Time-course 
assessment of biofilm formation in a MTP. Photograph of the bottom of the microtiter plate is 
shown. Biofilms grown in M9 medium with 0.4% glucose were stained with 0.1% CV and the wells 
were washed twice with water. (D) Biofilm dispersal of PAO1 and PAO1∆PA0847 in the MFs. Biofilms 
were grown for 24 h until the dispersal agent sodium nitrite was added to the medium (arrow). 
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To investigate the hypobiofilm phenotype of the PA2072 transposon mutant, the kinetics of the 
planktonic growth and biofilm formation were investigated. Strikingly, the mutant showed a growth 
defect (Figure 3.5B) and biofilms were visible after 24 h of incubation (Figure 3.5C). Therefore, it was 
concluded that the observed hypobiofilm phenotype is likely due to the slow growth rate of the 
mutant rather than an innate inability of the mutant to produce biofilms. 
Nevertheless, the catalytic activity of PA2072 was investigated. For that purpose, the gene was 
cloned into pBBR1-MCS4 and the resulting plasmid was conjugated into PAK. Overexpression of 
PA2072 in PAK led to a reduced biofilm formation when compared to the strain carrying the vector 
control (Figure 3.6A). This impairment in biofilm formation was also visible when PA2072 was 
overexpressed in the hyperbiofilm strain PAK∆retS, suggesting that PA2072 may work as a PDE under 
the conditions tested (Figure 3.6A). 
To further confirm this hypothesis, site-directed mutagenesis was used to disrupt the putative DGC 
and PDE catalytic sites. To test the DGC activity, the GGDEF motif was mutated to GGAAF and to test 
the PDE activity, the EAL motif was mutated to AAL. Interestingly, overexpression of both PA2072 
versions, PA2072GGAAF or PA2072AAL, was unable to cause a reduction in biofilm formation to the 
same extent of the wild type PA2072 (Figure 3.6B). Therefore, these results support the idea that 
both the EAL and GGDEF motifs are required for a fully functional PA2072. Like for other GGDEF/EAL 
domain proteins, it is possible that the GGDEF motif works by binding to GTP and stimulating the 
PDE activity of the EAL domain.   
To elucidate the relation of PA2072 with c-di-GMP, whole cell lysates of strains overexpressing the 
wild-type PA2072 or its mutated derivatives, were tested for c-di-GMP binding (Figure 3.6C). This 
work was done in collaboration with the group of Vincent Lee who developed an assay, the DRaCALA 
assay (differential radial capillary action of ligand assay) (Table 4.1), that allows for quick 
assessments of the ability of proteins to bind c-di-GMP (Roelofs et al., 2011). Basically, this assay 
measures the ability of dry nitrocellulose membranes to separate unbound radioactive labelled c-di-
GMP (c-di-GMP*) from protein bound c-di-GMP* complexes. Consistent with the hypothesis of 
PA2072 being a PDE whose activity is stimulated by the GGDEF domain, the wild-type PA2072 was 
able to bind c-di-GMP* and mutation of the GGDEF motif positively affected this binding. In contrast, 
PA2072AAL abolished c-di-GMP* binding, underpinning the role of the EAL domain in binding c-di-
GMP to drive its degradation.  
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Figure 3.6 Overexpression of PA2072 prevents biofilm formation.  
(A) PAK and PAK∆retS were conjugated with the vector control pBBR1-MCS4 (pVC) and its derivative 
pPA2072 encoding wild-type PA2072. Biofilms formed at the air-liquid interface under shaking 
conditions are visualized by CV staining. (B) Biofilms formed in a MTP under shaking conditions for 6 
h in M9 medium with 0.4% glucose were quantified by CV staining. The levels of CV staining in PAK 
conjugated with pVC were normalized to 1. An ANOVA analysis was performed with a p value of 
0.05. Asterisks indicate statistically significant changes. At least three independent experiments were 
performed. (C) Specific c-di-GMP binding assessed by DRaCALA. Graph of 32P-c-di-GMP binding by E. 
coli whole-cell lysates overproducing the indicated proteins. The average is indicated by a horizontal 
bar. The lysate of a strain overproducing MBP-Alg44PilZ was used as positive control and the lysates 
of strains harbouring the empty vectors were used as negative control. Figure provided by Vincent 
Lee (unpublished). 
 
3.6 Biofilm dispersal phenotypes of transposon mutants of genes encoding 
proteins with a GGDEF, EAL or HD-GYP domain 
 
In relation to biofilm dispersal, the MTP assay identified one hyperdispersive transposon mutant, the 
PA0847 mutant strain. As illustrated in Figure 3.4B, besides the transposon mutant in PA0847, all the 
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mutant strains displayed a dispersive phenotype similar to wild-type. For the PA0847 mutant, the 
biofilm biomass remaining after dispersal was approximately 2-fold lower than the wild-type. No 
non- or hypodispersive phenotypes were observed.  
 
3.7 The phenotypes of the PA0847 mutant 
 
In relation to the hyperdispersive phenotype of the PA0847 transposon mutant (~2-fold increase), 
the phenotype had never been reported before and thus was considered for further studies.  
The PA0847 gene is predicted to be located within an operon with PA0846 which encodes a protein 
with similarity to a sulfate uptake protein (Winsor et al., 2009). Like PA2072, PA0847 has an N-
terminal CHASE4 domain but in PA0847 this is followed by an HAMP, a PAS and a GGDEF domain 
(conserved I- and A-sites) (Figure 3.5A). In order to confirm the hyperdispersive phenotype, a clean 
deletion mutant of PA0847 was engineered in PAO1 and tested in the MTP and MF assays. 
Surprisingly, the hyperdispersive phenotype was not observed for the clean deletion mutant (Figure 
3.5D) and therefore research on PA0847 was not carried further.  
 
3.8 Discussion 
 
Since its discovery in 1987 for its role in the regulation of cellulose synthesis in G. xylinus, c-di-GMP 
has emerged as a bacterial second messenger that regulates a variety of cellular processes in a very 
specific way. However, for many years the proteins involved in the turnover of c-di-GMP remained 
poorly understood and later it was unclear how the c-di-GMP network was operating to specifically 
regulate different cellular processes. This uncertainty was primarily due to two main observations. 
On the one hand, the occurrence of a large number of genes encoding putative DGCs and PDEs in a 
single bacterium; on the other hand, the presence of additional N-terminal domains in these 
proteins. Today, although the modus operandi of many of the putative DGCs and PDEs is still 
unknown, the debate about the specificity of the c-di-GMP network seems to be settled. In a recent 
report from the laboratory of Christopher Waters, it was demonstrated for V. cholerae that there is 
no correlation between the total level of c-di-GMP in a cell and the induction of biofilm formation 
(Massie et al., 2012). Instead, only a fraction of all the DGCs found in V.cholerae was active for 
biofilm formation under the conditions tested (18 out of 40 proteins with a GGDEF domain) and 
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induction of biofilm formation was correlated to the expression of individual DGCs rather than the 
intracellular concentration of c-di-GMP.   
In light of this, the 43 GGDEF, EAL and HD-GYP domain proteins found in P. aeruginosa (Table 1.5) 
are thought not to be functionally redundant and they have been associated with the regulation of 
different biological attributes related to the motile/sessile lifestyle switch. In order to investigate 
which c-di-GMP related proteins could be specifically involved in the modulation of either biofilm 
formation or dispersal, a screen using a MTP assay was performed.   
From the 42 PAO1 transposon mutants tested, a total of six hypobiofilm formers, three hyperbiofilm 
formers and one hyperdispersive mutant were identified (Figure 3.4).  
In relation to biofilm formation, 33 out of the 42 mutants tested did not display an altered 
phenotype. This high rate of wild type phenotypes is not surprising and denotes the high specificity 
of the c-di-GMP network. For these mutants, it is possible that (i) the genes were not expressed or 
the proteins inactive under the conditions tested and therefore the phenotype was not visible, (ii) 
the encoded proteins are involved in the regulation of attributes that do not affect biofilm 
formation, or (iii) the biofilm phenotype is dominant and the impact of single gene mutants is 
masked by the expression of other genes. 
In fact, the GGDEF domain protein WspR is known to have DGC activity and to affect biofilm 
formation but the wspR transposon mutant in this study or the clean deletion mutant in the study by 
Hickman et al. (2005) (Hickman et al., 2005) show an insignificant impact of the mutation in biofilm 
formation. The observation that WspR is involved in biofilm formation comes from studies where 
WspR is overexpressed or constitutively active due to deletion of wspF (Figure 1.9). It is known that 
the activation of the Wsp system is somehow surface contact dependent, so under the conditions 
tested it is possible that the system was not active (Guvener & Harwood, 2007).  
Also, the transposon mutant in the gene encoding the PA5487 protein with a GGDEF domain did not 
show an altered biofilm formation phenotype in this study in which the biofilm assay is performed 
under shaking conditions. However, in a collaborative work with Isabel Cortés from the group of 
Cayo Ramos Rodríguez at the University of Málaga, a PA5487 clean deletion mutant showed a 
hypobiofilm phenotype under static conditions (Figure 3.7). Like for WspR, this observation reflects 
how c-di-GMP forms an intricate intracellular signalling network that responds to specific stimuli. 
Interestingly, the PA5487 mutant was also shown to be attenuated in an acute lung injury mice 
model and overexpression of PA5487 led to enhanced biofilm formation suggesting that the protein 
has DGC activity (manuscript under preparation).  
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Figure 3.7 Deletion of PA5487 causes a hypobiofilm phenotype under static growth conditions.  
This experiment was performed together with Isabel Cortés. The empty plasmid pJB3 and its 
derivative pJB3-PA5487 were conjugated into P. aeruginosa PAK strain and biofilms were grown for 
24 h at 37oC. 
 
In E. coli, 21 out of the 28 GGDEF and EAL domain proteins have been shown to be expressed at 
some point during the exponential or stationary phases of growth in batch cultures and a subset of 
genes were differentially regulated at 28oC and 37oC (Sommerfeldt et al., 2009). In P. aeruginosa, 
and based on a microarray study performed by Helga Mikkelsen in the laboratory of Martin Welch 
(Mikkelsen et al., 2009b), approximately 1/3 of the genes encoding proteins with a GGDEF, EAL or 
HD-GYP domain were not expressed in any of the conditions tested, i.e. planktonic exponential or 
stationary phase, colonies grown on a agar plate and assayed at 15h or 40h post-incubation, and 
biofilms grown in flow cells for 3 days (Table 3.1). The expression of the other 2/3 was detected in at 
least one of the conditions tested but a high proportion of these genes (25 out of 29) were 
expressed at the early stages of colony formation (including wspR). Only the expression of two 
genes, PA3177 encoding a putative DGC and PA4801 encoding a known PDE, was detected in all the 
conditions tested. All together, this and the relatively low number of hits in the MTP screen are 
supportive of a model whereby c-di-GMP constitutes a highly regulated signalling network that 
operates with a high degree of specificity.  
From the subset of transposon mutants in genes encoding proteins with a C-terminal GGDEF 
domain, mutants in siaD, PA0338 and PA4843 had a hypobiofilm phenotype. This is consistent with a 
putative DGC catalytic activity of the proteins under the conditions tested. For siaD the observed 
phenotype is in agreement with a previous report where the protein was shown to be involved in a 
stress dependent auto-aggregative phenotype (Klebensberger et al., 2009). 
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From the subset of mutants in genes with C-terminal GGDEF and EAL domains, strains harbouring 
transposon insertions in PA1181, PA2072 and fimX exhibited a hypobiofilm phenotype whereas 
insertions in rbdA, bifA and dipA led to hyperbiofilm formation. These results suggest that in the 
hypobiofilm formers the GGDEF domain is likely to have DGC catalytic activity while in the 
hyperbiofilm formers, it is the EAL domain that may be enzymatically functional.  
Indeed, for RbdA, BifA and DipA, a PDE activity has already been confirmed (An et al., 2010; Kuchma 
et al., 2007; Roy et al., 2012). In the case of RbdA and DipA, the PDE activity was shown to be 
required for biofilm dispersal indicating that the observed hyperbiofilm phenotype is due to an 
inability of the mutant to disperse properly. In the case of BifA, the PDE activity was shown to 
counteract the effect of two DGCs in the regulation of biofilm formation and swarming motility.    
 
 
Table 3.1 Expression of the GGDEF, EAL and HD-GYP domain proteins in P. aeruginosa at different 
phases and growth conditions.*  
Gene Protein1 
Planktonic 
exponential 
Planktonic 
stationary 
Colony 
15h 
Colony 
40h 
Biofilm 
3 days 
PA0338  -- -- -- -- -- 
PA0847  -- -- -- -- -- 
roeA  -- -- -- -- -- 
PA1851  -- -- -- -- -- 
PA2072  -- -- -- -- -- 
PA2133  -- -- -- -- -- 
PA2771  -- -- -- -- -- 
arr  -- -- -- -- -- 
PA2870  -- -- -- -- -- 
pelD  -- -- -- -- -- 
PA3258  -- -- -- -- -- 
nbdA  -- -- -- -- -- 
PA3343  -- -- -- -- -- 
PA3825  -- -- -- -- -- 
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Gene Protein1 
Planktonic 
exponential 
Planktonic 
stationary 
Colony 
15h 
Colony 
40h 
Biofilm 
3 days 
PA5442  -- -- -- -- -- 
siaD    -- -- -- -- 
PA4843    -- -- -- -- 
PA4929  --   -- -- -- 
PA0285  -- --   -- -- 
PA0575  -- --   -- -- 
yfiN  -- --   -- -- 
PA1181  -- --   -- -- 
lapD  -- --   -- -- 
PA2200  -- --   -- -- 
PA2567  -- --   -- -- 
wspR  -- --   -- -- 
toxR  -- --   
  
-- 
mucR    --   -- -- 
rocR    --   -- -- 
morA    --   -- -- 
sadC    --   -- -- 
fimX    --   -- -- 
PA5295    --   -- -- 
PA4396    --   --   
bifA    --   
    
PA5487    --   
    
rbdA    
    
-- -- 
dipA    
    
-- -- 
PA0290  --   
    
-- 
PA2572  --   
    
-- 
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Gene Protein1 
Planktonic 
exponential 
Planktonic 
stationary 
Colony 
15h 
Colony 
40h 
Biofilm 
3 days 
PA4781  --   
      
PA3177    
        
PA4108    
        
Total  15 8 25 8 6 
*Based on the microarray data provided by Helga Mikkelsen.  
1 Blue boxes represent the GGDEF domain and pink boxes the EAL domain. Grey boxes indicate 
presence of additional domains as specified in Table 1.5. 
 
 
Similar hypobiofilm phenotypes for PA1181 and fimX have previously been identified in the PA14 
screen performed by of Kulasekara et al. (2006). Interestingly, it has been shown that instead of 
being catalytically active, FimX works as a c-di-GMP binding protein and is required for twitching 
motility at the early stages of biofilm formation (Jain et al., 2012).  
The severe hypobiofilm phenotype of the PA2072 transposon mutant was chosen for further analysis 
but subsequent experiments showed that the mutant had a growth defect and biofilm formation 
was visible at a later time point (Figure 3.5). Nevertheless, experiments where PA2072 was 
overexpressed suggested that it is the EAL domain of the protein that is catalytic active. This 
hypothesis was further supported by the inability of PA2072AAL to cause the same reduction in 
biofilm formation as the wild-type PA2072 and to be unable to bind c-di-GMP (Figure 3.6). However, 
the physiological role of this PDE remains unknown.     
To screen the transposon collection for mutants with a dispersal phenotype, addition of sodium 
nitrite as a nitric oxide donor was used. Only one hyperdispersive mutant affected in the PA0847 
gene was identified but a clean deletion of PA0847 failed to confirm the phenotype. This could have 
been because of polar effects caused by the transposon insertion and the hit was not studied 
further.  
The fact that the developed MTP assay failed to identify more hypo- or hyperdispersive mutants, 
prompted the question about its suitability. Addition of sodium nitrite was used as a dispersal trigger 
because it acts as a nitric oxide donor and this has been shown here (Figure 3.2 and 3.3) and in the 
work of Nicolas Barraud from the University of New South Wales, to induce biofilm dispersal 
(Barraud et al., 2006; Barraud et al., 2009). However, other unpredicted dispersal triggers such as 
oxygen availability may have been present during the execution of the experiments. Since the MTP 
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assay was performed under shaking conditions in an incubator of communal use and the dispersal 
treatment required a transient withdraw of the MTP from the incubator, it is quite possible that 
other uncontrolled dispersal triggers were being applied. Subsequent discussions and experiments 
conducted by Nicolas Barraud, have indeed shown that biofilm dispersal in MTPs may be induced by 
limiting oxygen availability through simple reduction of the rotation speed of a shaking incubator 
(Figure 3.8), questioning the reliability of the developed MTP assay in assessing biofilm dispersal.  
 
 
Figure 3.8 Oxygen-induced biofilm dispersal using MTPs.  
(A) PAO1 planktonic and biofilm biomasses after oxygen limitation induced by reducing the shaking 
speed of the incubator (200rpm to 60rpm). The assay was performed at 37oC for 6 h in M9 medium 
with 0.4% glucose. (B) Photograph showing CV staining of biofilms at the time when dispersal was 
induced (0 min) and after the dispersal treatment (5 min). Figure provided by Nicolas Barraud 
(unpublished). 
 
Recently, three proteins with PDE activity have been shown to be involved in biofilm dispersal in 
studies mainly conducted using flow tube reactor systems. These proteins were NbdA, RbdA and 
DipA. For the recently described NbdA the biofilm dispersal phenotype was shown to be induced by 
nitric oxide and it was postulated that nitric oxide can act at both the posttranscriptional and the 
posttranslational level (Li et al., 2013).  
Besides the MTP screen, the work presented here demonstrates that c-di-GMP is associated with the 
switch between a planktonic and a biofilm lifestyle and confirms the paradigm that high levels of c-
di-GMP promote biofilms whereas low levels promote motility. Notwithstanding the high specificity 
at which intracellular c-di-GMP signalling seems to operate under natural conditions, overexpression 
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of genes encoding active DGCs or PDEs seems to have a more general impact that saturates or 
depletes, respectively, the signalling mechanisms of c-di-GMP and dictates the bacterial lifestyle. 
Hence, when the active DGCs WspR or WspRR242A were produced, an increment of the biofilm 
biomass was observed and when the active PDE PA2133 was produced, the appearance of biofilms 
was inhibited (Figure 3.1).   
Strikingly, the constitutively active WspR** which had the I-site and the phosphorylation site 
mutated, inhibited bacterial growth.  This suggests that c-di-GMP at high levels can be toxic to the 
cells. A similar observation has previously been reported by Ryjenkov and co-workers who were 
unable to overexpress a wild-type DGC in a pET23a vector using an E. coli BL21 (DE3) strain 
(Ryjenkov et al., 2005). Interestingly, also for PDEs a toxic effect has been postulated when Lacey 
and co-workers were unable to overexpress the E. coli gene yfgF from a plasmid which drives the 
constitutive expression of the gene (Lacey et al., 2010).  
In summary, these results highlight the importance of the c-di-GMP regulatory network in 
controlling bacterial lifestyle and further emphasize the high specificity at which it operates to 
modulate an array of different biological attributes. In theory, this specificity may be achieve by 
many means, including (i) the temporal expression of specific genes, (ii) the activation of DGCs and 
PDEs under certain conditions, (iii) the subcellular co-localization of proteins with the effectors, or 
(iv) the differences in the c-di-GMP binding affinities of the effector proteins. For the majority of the 
c-di-GMP related proteins or c-di-GMP regulated functions, the precise mechanism by which their 
regulatory role is achieved remains to be elucidated. 
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4) Cyclic di-GMP control on Type 
III and Type VI secretion systems 
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Chapter 4 – Cyclic di-GMP control on Type III and Type VI secretion systems  
 
Bacteria can cause both acute and chronic infections. In the versatile P. aeruginosa pathogen, it is 
now well documented that the bacterium lifestyle strongly correlates to its mode of infection. In the 
motile lifestyle, bacteria exhibit flagella-driven swimming motility and produce toxins via the T2SS 
and T3SS that damage the host tissues and subvert host cells, causing an acute infection. In the 
sessile lifestyle, bacteria establish as a biofilm and express the T6SS, causing a chronic infection that 
is prevalent in the lungs of cystic fibrosis patients. 
A key determinant in the P. aeruginosa course of infection is the regulatory cascade comprising the 
central two-component system GacAS (Figure 1.6). Major findings in my work have resulted from the 
investigation of a link between the Gac regulatory cascade and c-di-GMP signalling, and 
subsequently, on how this link goes beyond the modulation of biofilm formation to also regulate the 
expression of T2SS, T3SS and T6SS. Part of the work presented here has been published and a reprint 
of the paper can be found in the appendices (Appendix 1 and 2). 
 
4.1 The retS hyperbiofilm mutant has high levels of c-di-GMP 
 
The sensor RetS is known to form heterodimers with GacS (Goodman et al., 2009) thus preventing 
the expression of the two sRNAs, RsmY and RsmZ, and favouring the motile lifestyle. A retS deletion 
mutant releases the central GacAS cascade from the RetS inhibition and displays a hyperbiofilm 
phenotype (Figure 4.1A).  
Considering that high levels of c-di-GMP are associated with hyperbiofilm formation, the levels of c-
di-GMP in the retS mutant were investigated. Two methods were employed to achieve this. Firstly, 
the intracellular c-di-GMP levels were measured by liquid chromatography tandem mass 
spectrometry (LC-MS/MS) using nucleotide extracts and in collaboration with Stephan Heeb and Paul 
Williams at the University of Nottingham. Secondly, c-di-GMP level was qualitatively assessed by 
using a transcriptional reporter fusion between a promoter that positively responds to an increase in 
c-di-GMP (the promoter of cdrA which encodes an adhesin) and the gfp gene (encoding for green 
fluorescent protein) (Rybtke et al., 2012). As shown in Figure 4.1B and C, when compared to the 
wild-type strain, the hyperbiofilm phenotype of the retS mutant coincided with an increase in the 
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intracellular levels of c-di-GMP (Moscoso et al., 2011), both using LC-MS/MS and the c-di-GMP 
reporter. 
 
 
Figure 4.1 A retS mutant is a hyperbiofilm former, has elevated levels of c-di-GMP and expresses 
the T6SS.  
(A) Biofilms formed at the air-liquid interface under static conditions are visualized by CV staining. 
(B) Intracellular levels of c-di-GMP measured by LC-MS/MS and compared to the PAK wild-type 
strain. Statistical Student’s t-test analysis with p<0.01 is based on three technical replicates and 
significant changes are indicated by asterisks. (C) Intracellular levels of c-di-GMP measured with the 
c-di-GMP transcriptional gfp reporter. The reporter was introduced in the P. aeruginosa strains 
specified by electroporation. Relative fluorescence units (RFU) are arbitrary fluorescence intensity 
units corrected for cell density. A snapshot of fluorescent ∆retS cells carrying the reporter was taken 
using a confocal microscope. (D) Western blot performed on whole cell lysates using antibodies 
directed against PcrV (T3SS) and Hcp1 (T6SS). T3SS was induced by calcium chelation.  
 
To investigate whether the elevated level of c-di-GMP was directly attributable to the retS mutation 
or a consequence of the formation of a hyperbiofilm, the levels of c-di-GMP were determined in a 
retS mutant that is unable to form biofilms due to the inability of producing the Pel 
exopolysaccharide (Moscoso et al., 2011). In this retS/pel mutant, the levels of c-di-GMP remained 
high (Figure 4.1B), therefore confirming that the deletion of retS per se increases the level of c-di-
GMP. 
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4.2 RetS antagonistically controls the T3SS and the T6SS 
 
Besides inducing biofilm formation, deletion of retS is also known to induce the expression of the 
T6SS and to repress the T3SS. This can be visualized by Western blot using antibodies against 
structural components of both secretion systems: PcrV which sits at the tip of the needle of the 
T3SS, and Hcp1 which is the main component of the H1-T6SS nanotube.  
As illustrated in Figure 4.1D, PcrV is strongly detected in the wild-type strain but not in the retS or 
retS/pel mutants. By contrast, the production of Hcp1 is high in the retS or retS/pel mutants and low 
in the wild-type (Moscoso et al., 2011).  
In conclusion, the retS mutation induces a switch in the expression of the T3SS and T6SS (referred to 
as T3SS/T6SS switch). This switch is independent of the formation of a hyperbiofilm and occurs in 
such a way that a retS mutant displays an up-regulated T6SS and a down-regulated T3SS. 
 
4.3 Increased levels of c-di-GMP up-regulate the T6SS 
 
If in the retS mutant the hyperbiofilm phenotype is associated with high levels of c-di-GMP, it was 
hypothesized that the same could apply to the T3SS/T6SS switch. To test this hypothesis, the pBBR1-
MCS4 and the derivative construct overexpressing wspRR242A were conjugated in a pel mutant strain. 
WspRR242A is an active DGC and the effect of an increase in c-di-GMP production on T3SS and T6SS 
expression was monitored. As presented in Figure 4.2A and B, production of WspRR242A resulted in a 
more than 2-fold increased level of c-di-GMP and this correlated with a clear T3SS/T6SS switch, i.e. 
down-regulation of the T3SS concomitant with an up-regulation of the T6SS (Moscoso et al., 2011).  
The c-di-GMP-dependent up-regulation of the T6SS was further shown not to be growth phase 
dependent (Figure 4.2C) and to also occur upon overproduction of YfiN (PA1120), another DGC 
(Figure 4.2D). This suggested that in these conditions, it is the global increase in c-di-GMP levels that 
induces the T6SS rather than a specific role of either one of the tested DGCs in the process. Finally, 
the expression of other structural components of the T6SS involved in the formation of the 
puncturing device, namely VgrG1a, VgrG1b and VgrG1c, was also up-regulated upon the 
overexpression of wspRR242A (Figure 4.2E). This confirms that the impact of increased levels of c-di-
GMP is on the whole T6SS and not particularly on some of the genes or transcription units. 
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Figure 4.2 Cyclic di-GMP inversely regulates T3SS and T6SS.  
The pBBR1-MCS4 vector control (pVC) and its derivatives overexpressing wspR (pwspR), wspRR242A 
(pwspRR242A), PA2133 (pPA2133) or yfiN (pyfiN) were introduced in PAK∆pel or PAK∆retS∆pel by 
conjugation. (A) Intracellular levels of c-di-GMP measured by LC-MS/MS and compared to PAK∆pel 
carrying pBBR1-MCS4. Statistical Student’s t-test analysis with p<0.01 is based on three technical 
replicates and significant changes are indicated by asterisks. (B) At low levels of c-di-GMP the T3SS is 
expressed whereas at high levels of c-di-GMP the T6SS is expressed. T3SS was induced by calcium 
chelation. (B), (C), (D) and (E) Western blot performed on whole cell lysates using antibodies 
directed against PcrV (T3SS) and Hcp1 (T6SS) or VgrG1 (T6SS). In (E) the three bands correspond, 
from top to bottom, to VgrG1b, VgrG1c and VgrG1a (Hachani et al., 2011).   
 
The T3SS, together with the T2SS, is associated with the development of acute infections via the 
secretion of toxins and hydrolytic enzymes. Since the increase of c-di-GMP is accompanied by a 
down-regulation of T3SS, the impact of c-di-GMP on T2SS was also checked. In this case, the 
expression of the secretion system was monitored by Western blot using an antibody against one of 
its substrates, the elastase LasB. Interestingly and similar to the impact on T3SS, elevated levels of c-
di-GMP obtained by overproduction of WspRR242A down-regulated the production of LasB (Figure 
4.3).  
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Figure 4.3 Elevated levels of c-di-GMP down-regulate the T2SS effector protein LasB.  
The pBBR1-MCS4 vector control (pVC) and its derivative overexpressing wspRR242A (pwspRR242A) were 
introduced in PAK∆pel or PAK∆retS∆pel  by conjugation. Western blot performed on whole cell 
lysates using antibodies directed against LasB (T2SS) and Hcp1 (T6SS).   
 
4.4 Decreased levels of c-di-GMP up-regulate the T3SS 
 
To determine if the observable T3SS/T6SS switch can be reverted by lowering the levels of c-di-GMP, 
the inverse approach was applied. In this case, a construct overexpressing PA2133 which encodes a 
protein with PDE activity was introduced in the retS/pel mutant. As previously described, the 
production of PcrV and Hcp1 was monitored. Remarkably, the effect of PA2133 mirrored the effect 
of WspRR242A, hence the T3SS was up-regulated whereas the T6SS was down-regulated (Figure 4.2A 
and B) (Moscoso et al., 2011).     
 
4.5 The Gac system is required for the c-di-GMP-dependent T3SS/T6SS 
switch 
 
RetS belongs to a signalling cascade that involves several components like the central GacAS two-
component system, the two RsmY and RsmZ sRNAs, and the additional LadS sensor. The fact that the 
Gac system and the c-di-GMP network exert a similar control on biofilm formation and the 
T3SS/T6SS switch prompted the question of whether this regulation runs in parallel or is interlinked. 
To address this question, the plasmid overexpressing wspRR242A was introduced in a series of mutants 
in which the Gac cascade is inactivated, i.e. the rsmY/rsmZ double mutant, the gacS and gacA 
mutants and the ladS mutant.  
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As illustrated in Figure 4.4A and B, even though overproduction of WspRR242A increased the levels of 
c-di-GMP in the rsmY/rsmZ double mutant, this was not accompanied by an induction of the T6SS or 
a reduction of the T3SS expression.  This suggests that the c-di-GMP levels per se are not sufficient to 
induce the T3SS/T6SS switch and full control requires the production of the sRNAs to sequester 
RsmA and drive the up-regulation of the T6SS and down-regulation of the T3SS (Moscoso et al., 
2011). Furthermore, the switch was not induced in any mutant affected in genes required for the 
expression of the sRNAs, gacS and gacA, or positively influencing their expression, ladS. 
Interestingly, when the levels of c-di-GMP were assessed in a retS mutant also lacking the rsmY and 
rsmZ genes, the strain displayed reduced c-di-GMP levels, indicating that the elevated levels of c-di-
GMP in the retS mutant is somehow dependent on the production of the two sRNAs (Figure 4.4C). 
Deletion of the sRNAs individually did not have an impact on the overall levels of intracellular c-di-
GMP, suggesting that for this phenotype they may have a redundant function.       
In conclusion, the expression of RsmY and RsmZ seems to be central for the c-di-GMP-dependent 
control of the T3SS/T6SS switch. Furthermore, in all the mutants tested the introduction of the 
vector control or the plasmid overproducing WspRR242 resulted in a wild-type phenotype with up-
regulated T3SS and down-regulated T6SS, indicating that LadS, GacS and GacA, acting upstream of 
RsmY and RsmZ, are also required to observe the c-di-GMP-induced T3SS/T6SS switch. 
 
4.6 Screen for c-di-GMP binding of the components of the Gac system 
 
The data provided so far introduces the notion that the Gac and c-di-GMP cascades are interlinked 
but does not give yet a clear mechanistic insight on how it happens. One possibility is that c-di-GMP 
acts as a signal for the expression or activation of components belonging to the Gac signalling 
cascade. Another possibility is that the production of c-di-GMP is controlled by the Gac system.  
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Figure 4.4 The c-di-GMP-dependent T3SS/T6SS switch requires the expression of the two sRNAs 
RsmY and RsmZ.  
The pBBR1-MCS4 vector control (pVC) and its derivative overexpressing wspRR242A (pwspRR242A) were 
introduced in PAK or the rsmY/rsmZ, gacS, gacA and ladS mutants by conjugation. (A) Western blot 
performed on whole cell lysates using antibodies directed against PcrV (T3SS) and Hcp1 (T6SS). T3SS 
was induced by calcium chelation. (B) Intracellular levels of c-di-GMP measured by LC-MS/MS and 
compared to PAK∆rsmY∆rsmZ carrying pBBR1-MCS4. Statistical Student’s t-test analysis with p<0.01 
is based on three technical replicates and significant changes are indicated by asterisks. (C) 
Intracellular levels of c-di-GMP measured with the c-di-GMP transcriptional gfp reporter. The 
reporter was introduced in the P. aeruginosa strains specified by electroporation. Relative 
fluorescence units (RFU) are arbitrary fluorescence intensity units corrected for cell density. An 
ANOVA analysis was performed with a p value of 0.05. Asterisks indicate statistically significant 
changes. One independent experiment was performed. 
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To test the first possibility, the ability of RetS, LadS, GacS, GacA and RsmA to allosterically bind c-di-
GMP was evaluated. For that reason, the corresponding genes were cloned into pET28a with an N-
terminal FLAG tag and expressed in E. coli BL21 (DE3) cells (for soluble proteins) or BL21 (DE3) C41 
cells (for membrane proteins). In collaboration with the group of Urs Jenal at the Biozentrum 
(University of Basel), whole cell lysates overexpressing these proteins were tested for c-di-GMP 
binding using a biochemical approach based on a c-di-GMP capture compound (Nesper et al., 2012). 
This capture compound was developed by a biotechnology company called Caprotec Bioanalytics 
and consists of a molecule with three domains: a selectivity domain which contains the c-di-GMP 
molecule, a reactivity domain that can be activated to cross-link the proteins that bind to the 
selectivity domain, and a sorting domain which allows the pull-down of the capture compound and 
any proteins cross-linked to it (Figure 4.5A). In this technique, whole cell lysates overexpressing 
FLAG-tagged versions of the protein of interest are incubated with the capture compound and 
proteins that bind c-di-GMP are cross-linked to the capture compound by excitation with UV light. 
After, the bound proteins are isolated using streptavidin magnetic beads that bind to the biotin in 
the sorting domain. Using antibodies directed against the FLAG-tag of the protein it is then possible 
to analyse by Western blot whether the proteins of interest are “captured” by the compound. In the 
event of binding, specific binding to c-di-GMP can be determined by prior incubation of the lysate 
with free c-di-GMP so that the protein is first saturated with c-di-GMP and later unable to bind to 
the capture compound. 
To carry out the assay, whole cell lysates containing the positive control DgrA, a soluble PilZ domain 
protein from C. crescentus known for binding c-di-GMP was used. Whereas DgrA could be specifically 
captured, the same was not true for the P. aeruginosa RsmA soluble protein (Figure 4.5B). As for 
GacA, it was observed that some of the protein was captured, but it was not possible to discriminate 
if this binding was specific as pre-incubation with free c-di-GMP did not prevent the binding of GacA 
to the capture compound. 
In relation to the membrane proteins, specific binding to c-di-GMP could not be conclusively 
detected for any of the proteins tested (Figure 4.5C), including for the known DGC protein YfiN. 
Similarly to GacA, YfiN and GacS were able to bind the capture compound but this binding was not 
prevented by pre-incubation with free c-di-GMP. For LadS and RetS, no interaction with the capture 
compound was detected. 
To further investigate the ability of GacA and GacS to bind c-di-GMP, an additional method was 
used. As explained in the previous chapter, the DRaCALA assay is another assay that allows the 
identification of c-di-GMP binding proteins and was performed in collaboration with Vincent Lee. As 
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shown in Figure 4.6, c-di-GMP binding was clear for DgrA but negligible for GacS, GacA, RetS and 
RsmA. However, for whole cell lysates overexpressing LadS a weak but reproducible c-di-GMP 
binding ability was detected, challenging the result obtained by the capture compound assay.   
In summary, the two methods employed here to determine whether RetS, LadS, GacS, GacA and 
RsmA components of the Gac system are able to bind c-di-GMP yielded inconclusive data and it 
remains to be determined if LadS, GacS or GacA have any binding affinity to c-di-GMP. In addition, 
the sensitivity of these methods is unclear and low affinity binders may be hard to identify. 
 
 
Figure 4.5 Assessment of the c-di-GMP binding ability of RetS, LadS, GacS, GacA and RsmA using 
the c-di-GMP capture compound.  
(A) Chemical structure and domain specification of the c-di-GMP capture compound developed by 
Caprotec Bioanalytics GmbH, Berlin. (B) Western Blot analysis of whole cell lysates overproducing 
the soluble proteins DgrA, GacA and RmsA or (C) the membrane proteins YfiN, RetS, LadS and GacS. 
All proteins were HIS- or FLAG-tagged and detected using anti-HIS or anti-FLAG antibodies. Lanes 1 
were loaded with the cell extracts. Lanes 2 were loaded with cell extracts incubated with 10 μM of 
capture compound. Lanes 3 were loaded with cell extracts pre-incubated with 100x excess of c-di-
GMP (specificity control). Lanes 4 were loaded with cell extracts incubated with the streptavidin 
beads (beads control).  
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Figure 4.6 Assessment of the c-di-GMP binding ability of RetS, LadS, GacS, GacA and RsmA by 
DRaCALA.  
Graph of 32P-c-di-GMP binding by E. coli whole cell lysates overproducing the indicated proteins. The 
average indicated by a horizontal bar. Asterisks indicate significant difference by Dunnet’s test (*** 
represents p<0.01). Figure provided by Vincent Lee (unpublished). 
 
4.7 Screen for putative DGCs and PDEs involved in the T3SS/T6SS switch 
 
To test if any c-di-GMP related protein is specifically associated with the regulation of the T3SS/T6SS 
switch, a screen using a PA14 transposon collection in genes encoding proteins with a GGDEF, EAL, 
HD-GYP or PilZ domains was performed. The PA14 strain was chosen in detriment of the PAO1 strain 
because in PAO1 the T3SS/T6SS switch is not as clearly identifiable as in PA14. Hence, the PA14 
collection was obtained from the laboratory of Frederick Ausubel (Liberati et al., 2006) and consisted 
of transposon insertion mutants in all the genes encoding proteins with the referred domains, 
including a mutant in the pvrR gene which encodes a protein with an EAL domain found only in 
PA14; and excluding PA2771 and PA2818 which are not found in PA14; PA0012 and PA2870 which 
are not available in the library; and pelD and toxR which were not available in the Filloux’s laboratory 
collection.  
The rationale of this screen was based on the overproduction of LadS, an antagonist of RetS which is 
able to induce the T3SS/T6SS switch, up-regulating T6SS and down-regulating T3SS. The collection 
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was thus tested for mutants unable to switch upon introduction of the pBBR1-MCS4 derivative 
carrying the ladS gene. The transposon mutants in PA2072, PA4781 and PA2989 were not 
considered in this evaluation because they were not able to incorporate the plasmid but among the 
remaining 43 transposon mutants, the wspR mutant was the only one unable to up-regulate T6SS 
and down-regulate T3SS upon overexpression of ladS (Figure 4.7A). However, subsequent attempts 
to confirm this phenotype by reconstructing a clean wspR deletion mutant did not confirm the 
phenotype and the T3SS/T6SS switch was perfectly effective (Figure 4.8) (Moscoso et al., 2012). 
In addition to this, another four mutants were partially affected for the T3SS/T6SS switch as LadS 
was able to induce the up-regulation of the T6SS but no down-regulation of the T3SS was 
observable. These were mutants in PA0290, PA3258, morA and PA2200 and suggest that these 
proteins are specifically involved in the regulation of the T3SS, but this line of investigation was not 
carried further. 
 
 
Figure 4.7 Screen of a PA14 transposon collection for loss of T3SS/T6SS switch. (Figure legend 
continues on the next page.) 
 145 
 
The pBBR1-MCS4 vector control (pVC) and its derivative overexpressing ladS (pladS) were introduced 
in all the strains by conjugation and Western blot was performed on whole cell lysates using 
antibodies directed against PcrV (T3SS) and Hcp1 (T6SS). Asterisks indicate strains that did not 
incorporated the pladS plasmid. (A) Overexpression of ladS induces the T3SS/T6SS in PA14 and 
mutants in genes encoding proteins with a GGDEF domain are shown. (B) Mutants in genes encoding 
proteins with GGDEF and EAL domains are shown. (C) Mutants in genes encoding proteins with EAL 
or HD-GYP domains (left) and in genes encoding proteins with PilZ domains (right) are shown.  
 
 
Figure 4.8 The T3SS/T6SS switch occurs in a ΔwspR mutant upon overproduction of LadS.  
Western blot analysis of P. aeruginosa PA14 and PA14ΔwspR mutant carrying pBBR1-MCS-4 (pVC) or 
its derivative overexpressing ladS (pladS). The antibodies used are directed against PcrV (T3SS) and 
Hcp1 (T6SS). 
  
4.8 Discussion 
 
The relation between the Gac system and the control of the P. aeruginosa mode of infection has 
been established in the last decade through numerous observations. In the course of an acute 
infection, the T3SS is activated upon host-cell contact and drives the injection of toxins directly in the 
cytosol of the host cells. In laboratory conditions, the T3SS can be induced in calcium depleted 
medium. In various animal models of acute infection (Hauser et al., 2002; Roy-Burman et al., 2001), 
including the cost-effective and easy to use Galleria mellonella caterpillar (Miyata et al., 2003), the 
T3SS has been shown to be required for full virulence. Moreover, isolates from chronically infected 
patients frequently do not have an active T3SS indicating that the secretion of T3SS effectors is not a 
requirement for the establishment of long-term chronic infections (Jain et al., 2004).  
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Interestingly, transcriptome analysis of a retS mutant has shown that RetS is required not only for 
the expression of the T3SS but also for the expression of other virulence factors such as T2SS and 
T4P (Goodman et al., 2004). In addition, in vivo studies with murine models for acute infections 
(Goodman et al., 2004; Zolfaghar et al., 2006) and G. mellonella (unpublished data, Figure 4.9) 
showed that the retS mutant is attenuated in virulence. In contrast, the retS mutant displays 
increased ability to adhere to surfaces, biotic or abiotic, and transcriptome analysis revealed an up-
regulation of the pel and psl exopolysaccharide genes together with an up-regulation of the genes in 
the H1-T6SS. Both the production of exopolysaccharides, an intrinsic characteristic of biofilms, and 
the expression of T6SS are traits that have been associated with P. aeruginosa chronic infections. In 
the lungs of cystic fibrosis patients, bacteria establish as a biofilm (Singh et al., 2000) and high titers 
of antibodies against the T6SS are detected in their serum (Mougous et al., 2006). Furthermore, in a 
murine chronic lung infection model, mutants in the HI-T6SS were identified as being attenuated in 
virulence (Potvin et al., 2003).  
RetS is an orphan sensor that belongs to the Gac signalling cascade. This cascade is known to 
coordinate the expression of more than 500 genes via the translational repressor RsmA (Figure 1.6). 
This is a sRNA-binding protein that inhibits the translation of 2/3 of its regulon by directly binding to 
mRNA, including the psl and T6SS mRNA (Brencic & Lory, 2009; Irie et al., 2010). Indirectly, RsmA 
positively impacts the expression of 1/3 of its regulon, including T3SS, T2SS and T4P genes. The 
function of RsmA is counteracted by the expression of two sRNAs that compete with the mRNA 
targets for RsmA binding. The expression of these sRNAs, RsmY and RsmZ, is induced by the central 
two-component system GacAS and positively affected by the additional orphan sensor LadS. 
Given that the Gac system plays a central role in the modulation of the two P. aeruginosa modes of 
infection, this work addressed the question of whether c-di-GMP is related to the Gac regulatory 
pathway. In other bacteria that have a conserved GacAS two-component system, such as E. coli and 
S. enterica, a connection between the Gac and c-di-GMP networks has been established in the 
regulation of the PGA exopolysaccharide production and the biogenesis of cellulose, respectively. In 
P. aeruginosa a link between c-di-GMP and the Gac system has never been explored experimentally 
although two reports provide hints on such a link. In the paper by Goodman et al. (2004), the GGDEF 
domain protein PA4332 (sadC) was identified in a transposon screen for suppressors of the retS 
mutant; and in the paper by Brencic & Lory (2009), the GGDEF domain proteins PA0338 and PA4929 
were identified as being part of the RsmA regulon, the former being up-regulated in a rsmA mutant 
whereas the latter is down-regulated.  
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Figure 4.9 G. mellonella killing is attenuated in the retS mutant.  
This experiment was performed together with Isabel Cortés. (A) Photograph of G. mellonella 
inoculated with 2.5x104 bacteria and incubated for 1 day. Dead larvae are black. (B) The PAK wild-
type strain and the retS mutant were injected into G. mellonella and the percentage of dead larvae 
after 1 day of incubation is shown.   
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The signalling molecule c-di-GMP is known to regulate the switch between motility and sessility, so 
the first thing to test was if the retS hyperbiofilm mutant was associated with high levels of c-di-
GMP. Although the overall intracellular concentrations of c-di-GMP varies between different species, 
the levels of c-di-GMP are typically very low, in the picomolar range (Simm et al., 2009), and its 
quantification is not trivial. Nevertheless, simple methods that allow the detection and relative 
quantification of c-di-GMP have become available recently (Table 4.1). By using LC-MS/MS and the c-
di-GMP reporter, it was possible to observe that the hyperbiofilm phenotype of the retS mutant was 
associated with elevated levels of c-di-GMP. Importantly, this was independent of the formation of 
biofilms as the retS/pel mutant displayed even higher levels of c-di-GMP than the retS mutant 
(Figure 4.1).  
The finding that c-di-GMP is involved in the hyperbiofilm phenotype of the retS mutant is consistent 
with the pre-established concept that high levels of c-di-GMP promote biofilm formation. Recently, 
in X. campestris, the rsmA hyperbiofilm mutant was also associated with increased levels of c-di-
GMP and three DGCs were identified as RsmA targets, providing an explanation on how the c-di-
GMP levels are elevated in the mutant (Lu et al., 2012).  
In P. aeruginosa the finding that the retS mutant has high levels of c-di-GMP left open the possibility 
that c-di-GMP could be involved in the inverse regulation of the T3SS and T6SS, two secretion 
systems that play a major role in determining the virulence status of P. aeruginosa. To investigate 
this question, the levels of c-di-GMP were artificially modulated by means of overexpression of a 
DGC, WspRR242A, and a PDE, PA2133 (see Chapter 3). It was observed that increased levels of c-di-
GMP caused the wild-type strain to switch from an up-regulated T3SS to an up-regulated T6SS, and 
low levels of c-di-GMP caused the retS mutant to switch from an up-regulated T6SS to an up-
regulated T3SS (Figure 4.2). In other words, low levels of c-di-GMP promoted the expression of T3SS 
while high levels of c-di-GMP were associated with the expression of the T6SS. Furthermore, the 
T2SS which is co-regulated with the T3SS in the retS mutant, was also shown to be down-regulated 
by high levels of c-di-GMP (Figure 4.3). 
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Table 4.1 Chemical and biochemical methods for detection of c-di-GMP and identification of c-di-
GMP binding proteins. 
Method Description References 
Detection/quantification of c-di-GMP 
2D-TLC 
Two-dimensional thin layer chromatography of 
nucleotide extracts 
Bochner & 
Ames, 1982; 
Merritt et al., 
2007 
Liquid chromatography 
coupled with mass 
spectrometry 
Following nucleotide extraction, the amount of c-di-GMP 
is determined by mass spectrometry after separation by 
reversed-phase high-performance liquid 
chromatography. 
Simm et al., 
2009; 
Spangler et 
al., 2010 
FRET 
Genetically engineered c-di-GMP binding protein fused to 
two fluorescent proteins. When c-di-GMP binds, 
fluorescence decreases. 
Christen et 
al., 2010 
Thiazole orange Fluorescent detection of c-di-GMP quadruplexes.  
Nakayama et 
al., 2011 
c-di-GMP-proflavine-
hemin complex 
Colorimetric assay based on the peroxidase activity of the 
complex.  
Nakayama et 
al., 2012 
c-di-GMP reporter  
(PcdrA-gfp) 
Fluorescence-based transcriptional reporter that uses the 
c-di-GMP-responsive promoter of the adhesin encoding 
gene cdrA. The presence of c-di-GMP activates 
transcription. 
Rybtke et al., 
2012 
Identification of c-di-GMP binding proteins 
c-di-GMP analog bound to 
sepharose beads 
The functional c-di-GMP analog 2’-aminohexylcarbamoyl-
c-di-GMP is covalently coupled to sepharose beads and 
proteins are isolated by affinity chromatography. 
Duvel et al., 
2012 
DRaCALA 
Differential radial capillary action of ligand assay. 
Radioactive labelled c-di-GMP is synthesized and 
diffusion of the ligand in a membrane is measured after 
contact with the protein. Diffusion is slower when c-di-
GMP* binds the protein. 
Roelofs et 
al., 2011 
c-di-GMP-capture 
compound 
Chemical molecule composed of c-di-GMP, UV cross-
linking domain and biotin. Proteins that bind c-di-GMP 
are covalently bound to the capture compound and 
isolated using streptavidin magnetic beads. 
Nesper et al., 
2012 
  
 150 
 
To elucidate the link between the c-di-GMP and Gac cascades in the regulation of biofilms and the 
secretion systems, the c-di-GMP levels were manipulated by overproducing WspRR242A in strains 
lacking genes of the Gac system that are required for the expression of the T6SS. In all the mutants 
tested, i.e. ladS, gacS, gacA and rsmY/rsmZ mutants, WspRR242A was unable to induce the T3SS/T6SS 
switch, indicating that the expression of the RsmA antagonists, RsmY and RsmZ, is required for the c-
di-GMP-dependent T3SS/T6SS switch (Figure 4.4). Furthermore, the levels of c-di-GMP in a 
retS/rsmY/rsmZ mutant were reduced in comparison to the retS mutant, suggesting that the 
increase on c-di-GMP levels is a consequence of the activity of the Gac pathway. Although it is not 
known how c-di-GMP impacts the T3SS or the T6SS, the fact that the up-regulation of the T6SS via c-
di-GMP is dependent on the sRNAs is indicative of an indirect role of c-di-GMP in the 
posttranscriptional regulation of the T6SS.  
This link between c-di-GMP and the regulation of the T2SS, T3SS and T6SS, together with the 
observation that the retS mutant displays high levels of c-di-GMP constitute a novel finding. At the 
same time that this research was carried out, a few publications correlating the expression of the 
T3SS and c-di-GMP started to appear and are in accordance with these findings. In the 
phytopathogen Dickeya dadantii (ex Erwinia chrysantemi), one PDE (EcpC) and one protein with 
GGDEF and EAL domains with putative PDE activity (EcpB) were positively correlated to the 
expression of T3SS and shown to be required for virulence in vivo (Yi et al., 2010). In S. enterica, 
overexpression of a DGC, AdrA, was shown to lead to reduced virulence and secretion of the T3SS 
effectors (Lamprokostopoulou et al., 2010). More recently, a mutant in STM2215, encoding a PDE, 
was also shown to be attenuated in virulence and to have reduced expression of T3SS effectors 
(Zheng et al., 2013). 
To understand the hierarchy between the two signalling networks i.e. if c-di-GMP influences the Gac 
system or if c-di-GMP variation is a consequence of the activity of the Gac system, two strategies 
were employed. Firstly, the ability of the Gac system components to bind c-di-GMP was assessed. 
Secondly, a screen to identify putative c-di-GMP related proteins specifically involved in the 
T3SS/T6SS switch was performed.  
Like for the detection of c-di-GMP, the identification of c-di-GMP binding proteins has been 
hampered by the lack of simple procedures and high throughput techniques to verify c-di-GMP 
binding ability. Until recently, the only proteins known to bind c-di-GMP were proteins with a PilZ 
domain and studies were quite limited to the conventional bioinformatic predictions for the 
presence of the domain. However, the disproportion between the number of proteins with a PilZ 
domain and the number of putative DGCs and PDEs has always suggested that other c-di-GMP 
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receptors ought to exist and other types of receptors have slowly started to be discovered (see 
Chapter 1, section 1.3.2). Recently, a few groups developed assays suitable for high throughput 
analysis of c-di-GMP binding proteins (Table 4.1). One of them is the DRaCALA assay previously 
described and another one is from the group of Urs Jenal in Switzerland who developed a technique 
based in the usage of a c-di-GMP capture compound. To test whether LadS, RetS, GacS, GacA or 
RsmA were able to bind c-di-GMP both the capture compound and the DRaCALA assays were used. 
For RetS and RsmA, none of the assays detected any c-di-GMP binding affinity but for GacS, GacA 
and LadS the results were inconclusive (Figure 4.5). This divergency between the two methods was 
not surprising as previous screens performed with the capture compound methodology and another 
technique developed by the group of Susanne Haussler (Table 4.1) (Duvel et al., 2012) also yielded a 
number of divergent results. Using the c-di-GMP capture compound, GacS and GacA were pulled-
down with the capture compound, but it was not possible to show that the binding was specific to c-
di-GMP. This could mean that there is no c-di-GMP binding affinity or, instead, it can reflect a weak 
affinity for c-di-GMP under the conditions tested. One explanation for this last hypothesis is that the 
tested proteins were expressed in E. coli so it is possible that additional factors required to increase 
GacS or GacA c-di-GMP binding affinity were missing. For instance, GacS is known to phosphorylate 
GacA, and it is possible that the phosphorylation of the proteins alters their c-di-GMP binding 
affinity. Using the DRaCALA assay, a weak c-di-GMP binding affinity was determined for LadS but 
until further validation with purified protein or an alternative assay, it remains questionable if this 
binding is real or physiologically relevant (Figure 4.6). Hence, with the results presented here, it 
cannot be concluded that any of the components of the Gac system tested are able to sense c-di-
GMP.  
Noteworthy, even if it is unlikely that c-di-GMP binds any of the sensors and response regulators of 
the Gac system, it is still conceivable that c-di-GMP binds to the two sRNAs or that c-di-GMP acts in 
the regulation of the Gac components at the transcriptional or posttranscriptional level.  
Although the RetS and LadS regulons do not entirely overlap, a subset of genes positively regulated 
by LadS corresponds to genes that are regulated negatively by RetS (Figure 1.7). This includes genes 
involved in biofilm formation, T3SS and T6SS, and a strain overproducing LadS displays an up-
regulated T6SS like the retS mutant does. Exploiting this fact, a screen of a collection of PA14 
transposon mutants was performed in search of mutants that did not switch upon overexpression of 
ladS but the screen did not identify any specific GGDEF, EAL, HD-GYP or PilZ domain proteins 
involved in the T3SS/T6SS switch (Figure 4.7 and 4.8) (Moscoso et al., 2011; Moscoso et al., 2012).  
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The regulation of the expression and activity of the T3SS in P. aeruginosa is known to be dependent 
on the transcriptional activator ExsA and on the production of cAMP. Briefly, ExsA (PA1713) binds 
the promoters of T3SS genes, including its own, and via ExsC, ExsD and ExsE, it couples the activity of 
the machinery with its transcription. When the T3SS is not active, ExsE (PA1711) accumulates in the 
cytoplasm and binds ExsC (PA1710), preventing the release of ExsA from the anti-activator ExsD 
(PA1714). When T3SS is active, ExsE is secreted and ExsC becomes available to bind the anti-
activator ExsD, allowing ExsA to bind its target promoters (Hauser, 2009). In addition to this, the 
nucleotide cAMP has been shown to be required for T3SS activation, probably by binding to the 
transcriptional regulator Vfr, but the precise mechanism linking cAMP and T3SS activation is not 
clearly understood (Wolfgang et al., 2003; Yahr & Wolfgang, 2006). Remarkably, mutants lacking 
cAMP have reduced expression of T2SS, T3SS and T4P, just like the retS mutant which has high levels 
of c-di-GMP. This suggests that there may be a balance between the intracellular concentrations of 
cAMP and c-di-GMP in such a way that high levels of c-di-GMP are correlated to low levels of cAMP 
and that these are involved, respectively, in inducing biofilm formation and repressing T3SS. 
Conversely, low levels of c-di-GMP may be correlated to high levels of cAMP, preventing biofilm 
formation and inducing the expression of the T3SS.   
On the other hand, the regulation of the T6SS varies greatly between different species and even 
between different clusters in a same species. In P. aeruginosa, the T6SS is regulated at different 
levels, i.e. transcriptional, posttranscriptional and posttranslational (Miyata et al., 2013; Silverman et 
al., 2012). Transcriptionally, two quorum sensing related transcriptional regulators, LasR and MvfR 
(PA1013), have been shown to repress the H1-T6SS and induce H2- and H3-T6SS (Lesic et al., 2009). 
Posttranscriptionally, H1-T6SS is known to be regulated directly by the translational repressor RsmA 
(Brencic & Lory, 2009) and in light of the data herein presented, indirectly by c-di-GMP. 
Posttranslationally, the H1-T6SS assembly and export is dependent on the phosphorylation of a T 
residue in Fha1 which is controlled by PpkA (kinase) and PppA (phosphatase) (Mougous et al., 2007). 
The precise mechanism by which Fha1 allosteric modification induces the T6SS is still unknown but 
Fha1 has been observed to form stable complexes with the ATPase ClpV1 and to be recruited to the 
T6SS machinery upon PpkA phosphorylation (Hsu et al., 2009). 
In conclusion, the results show that the regulation by c-di-GMP goes beyond the switch between 
motitlity and sessility as it also acts in the regulation of secretion machineries that are major 
determinants of the P. aeruginosa pathogenicity, namely the T2SS, T3SS and T6SS. Furthermore, it 
establishes a link to the Gac system, demonstrating that the c-di-GMP-dependent T3SS/T6SS switch 
does not bypass the regulation exerted by RsmA. Importantly, there are multiple possibilities by 
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which c-di-GMP can regulate the T3SS/T6SS switch and this deserves further investigation.  The 
mechanisms of action involving c-di-GMP signalling have proven to be very versatile and range from 
transcriptional regulation (e.g. FleQ in P. aeruginosa (Hickman & Harwood, 2008), 
posttranscriptional regulation (e.g. riboswitches in B. subtilis (Sudarsan et al., 2008)), regulation of 
protein activity (e.g. flagellar brake in E. coli (Boehm et al., 2010)), and cross-envelope inside-out 
signalling (e.g. LapD in P. fluorescens (Newell et al., 2011)) (Moscoso et al., 2011). Understanding 
how the molecular mechanism by which c-di-GMP is operating in the regulation of the different 
secretion systems may not only constitute a great leap on the understanding of bacterial signalling, 
but also help designing new drugs to efficiently combat infections by P. aeruginosa and many other 
pathogens. 
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5) Link between cyclic di-GMP   
and the Gac system 
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Chapter 5 – Link between cyclic di-GMP and the Gac system 
 
In the previous chapters it was shown that high levels of c-di-GMP promote hyperbiofilm formation 
and the expression of the T6SS, whereas low levels of c-di-GMP promote a motile lifestyle and the 
expression of the T3SS and T2SS. In addition, the intricate c-di-GMP signalling network within the cell 
that operates at high specificity in the regulation of a variety of cellular processes was presented. 
Subsequently, evidence on how the c-di-GMP network is linked to the Gac signalling cascade and 
how these two pathways can be important in determining the P. aeruginosa course of infection was 
provided.  
In this chapter, the previous observation that the retS hyperbiofilm mutant has elevated c-di-GMP 
levels sets the starting point of the investigation. Here, I looked for what protein is accountable for 
the elevated levels of c-di-GMP in the retS mutant and then for the downstream components that 
are involved in the specific c-di-GMP-dependent lifestyle switch orchestrated by the Gac system.   
 
5.1 Screen for up-regulated DGCs in the retS mutant 
 
The fact that the retS hyperbiofilm mutant displays high levels of c-di-GMP (Figure 4.1A, B and C) 
was not surprising as biofilm formation has been associated with elevated levels of the second 
messenger for quite some time now (Figure 1.10). However, because the c-di-GMP network 
operates at high specificity, this observation prompted the question of which protein, or proteins, 
are responsible for increasing the overall intracellular concentration of c-di-GMP in the retS mutant 
background. In theory, the elevated levels could be a consequence of (i) an up-regulation or 
activation of proteins with DGC activity, and/or (ii) a down-regulation or inactivation of proteins with 
PDE activity. In order to explore the first hypothesis, the mRNA levels of all the identified genes 
encoding putative DGCs, i.e. proteins with a GGDEF or a GGDEF/EAL domain, were analysed by qRT-
PCR (real time reverse transcription PCR).  
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Figure 5.1 PA0338 is up-regulated in the retS mutant.  
(A) Genes up- or down-regulated in the qRT-PCR screen of all the 34 proteins with a GGDEF domain 
found in P. aeruginosa PAO1 genome. Expression levels were normalized to gyrA. Data represents 
two independent experiments performed with three technical replicates each. Statistical Student’s t-
test analysis with p<0.01 is based on three replicates and significant changes are indicated by 
asterisks. (B) RNA secondary structures of the 5’ untranslated region of hsiA1 and PA0338 predicted 
by Mfold. GGA motifs are highlighted in red and the predicted start codon is in yellow.  
 
A total of 34 candidates (see list of primers/genes on Table 2.2) were assessed and the mRNA levels 
of a particular gene in the retS mutant were compared to the mRNA levels of the same gene in the 
PAK wild-type strain. With a cut off value of 1.5-fold change, only four out of the 34 genes tested 
were up- or down-regulated in the retS mutant (Figure 5.1A). These were PA0338, encoding a 
protein with a GGDEF domain which was ~3.8-fold up-regulated; and another three genes that were 
in average 2.8-fold down-regulated: PA3343 and PA4843 which encode proteins with a GGDEF 
domain, and PA3258 which encodes a protein with a GGDEF/EAL domain.   
In agreement with the up-regulation of PA0338 which suggests that PA0338 is a RsmA target, a 
putative RsmA binding site is recognizable in the 5’ untranslated region of the PA0338 mRNA (Figure 
5.1B). This is a GGA motif that sits in an exposed region of a putative stem-loop and overlaps with 
the predicted ribosome binding site, 12 nucleotides upstream of the start codon. 
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5.2 PA0338 is not responsible for the hyperbiofilm phenotype 
 
Since PA0338 was up-regulated in the retS mutant and encodes a protein with a C-terminal GGDEF 
domain harbouring conserved I- and A-sites, it was hypothesized that the elevated levels of c-di-
GMP in the retS mutant were due to the production and consequent DGC activity of PA0338. To 
investigate this hypothesis, the deletion of PA0338 was engineered in the retS mutant and the 
biofilm, swimming and T3SS/T6SS switch phenotypes were tested.   
As illustrated in Figure 5.2A, B and C, deletion of PA0338 did not have an effect on the retS 
phenotypes. Similarly to the retS mutant, the retS/PA0338 double mutant still exhibited enhanced 
Congo Red binding (indicative of hyperbiofilm formation), reduced swimming motility and 
expression of the T6SS in detriment of the T3SS.  
To check the levels of c-di-GMP in the retS/PA0338 double mutant, the c-di-GMP reporter described 
in the previous chapter was introduced by electroporation in the strains of interest and the 
produced fluorescence was measured. Consistent with the previous phenotypes, the retS/PA0338 
double mutant displayed high levels of c-di-GMP (Figure 5.2D), refuting the hypothesis that PA0338 
is a main player in the synthesis of c-di-GMP in the retS mutant background.      
 
5.3 PA3343 is encoded in the genetic region of hptB 
 
Among the genes that were down-regulated in the qRT-PCR screen, PA3343 stood out for being 
located close to hptB (PA3345). HptB is a protein with an Hpt domain that has been shown to be 
involved in a phosphorelay between RetS, PA1611 and HsbR, eventually contributing for the 
regulation of rsmY expression (Figure 1.6 and 1.8).  
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Figure 5.2 Phenotypes of the retS/PA0338 double mutant.  
(A) Congo Red binding. The photograph was taken after 2 days of incubation. (B) Swimming motility 
in 0.3% LB agar plates from one independent experiment. (C) T3SS/T6SS switch. Western blot 
performed on whole cell lysates using antibodies directed against PcrV (T3SS) and Hcp1 (T6SS). (D) 
Intracellular levels of c-di-GMP measured with the c-di-GMP transcriptional gfp reporter. The 
reporter plasmid was introduced in the P. aeruginosa strains specified by electroporation. Relative 
fluorescence units (RFU) are arbitrary fluorescence intensity units corrected for cell density. At least 
three independent experiments were performed. In (B) and (D) an ANOVA analysis was performed 
with a p value of 0.05. Asterisks indicate statistically significant changes.  
 
Given the proximity of PA3343 to hptB, RT-PCR (reverse transcription PCR) was performed to check if 
PA3343 was co-transcribed with hptB in the same polycistronic mRNA. To do this, a set of eight 
primer pairs were designed to amplify the intergenic regions between all the genes from PA3348 to 
PA3340 (Figure 5.3A). The products amplified by RT-PCR are shown in Figure 5.4B. By comparing the 
PCR products obtained from gDNA and cDNA, it is likely that hptB is encoded within an operon that 
extends from PA3347 to PA3341 and includes PA3343, the gene encoding a protein with known DGC 
activity (Kulasakara et al., 2006).   
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Despite this very interesting observation, the fact that the qRT-PCR data revealed a down-regulation 
of PA3343 in the retS mutant rather than an up-regulation can hardly explain how a deletion of retS 
leads to increased levels of c-di-GMP. Therefore, for the purpose of this study this was not 
investigated further. 
 
 
Figure 5.3 The genetic context of PA3343.  
(A) Gene map of the region harbouring PA3343. Thick arrows denote open reading frames and the 
different intergenic regions (IG) are numbered 1-8 and indicated by lines with closed circles. (B) RT-
PCR analysis of IG1-8 resolved on a 1.2% agarose gel. Lane 1 corresponds to PCR products from 
gDNA (positive control). Lane 2 corresponds to PCR products from the RNA extract (negative 
control). Lane 3 corresponds to PCR products from cDNA.  Asterisks indicate the PCR product of the 
expected size.  
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5.4 SadC is responsible for the hyperbiofilm phenotype of the retS mutant 
 
Since PA0338 was not responsible for the elevated levels of c-di-GMP in the retS mutant, another 
candidate was considered. According to the paper by Goodman et al. (2004) which characterized 
RetS, two sadC transposon insertion mutants were identified as suppressors of the retS hyperbiofilm 
mutant. SadC (PA4332) is a membrane protein and has a cytoplasmic C-terminal GGDEF domain with 
known DGC activity.  Although sadC (PA4332) was not found to be up-regulated in the retS mutant, 
the impact of deleting sadC in the retS mutant was analysed in a similar way to PA0338.  
 
Figure 5.4 Phenotypes of the retS/sadC double mutant.  
(A) Congo Red binding. The photograph was taken after 2 days of incubation. (B) Swimming motility 
in 0.3% LB agar plates from one independent experiment. (C) T3SS/T6SS switch. Western blot 
performed on whole cell lysates using antibodies directed against PcrV (T3SS) and Hcp1 (T6SS). (D) 
Intracellular levels of c-di-GMP measured with the c-di-GMP transcriptional gfp reporter. The 
reporter plasmid was introduced in the P. aeruginosa strains specified by electroporation. Relative 
fluorescence units (RFU) are arbitrary fluorescence intensity units corrected for cell density. At least 
three independent experiments were performed. In (B) and (D) an ANOVA analysis was performed 
with a p value of 0.05. Asterisks indicate statistically significant changes. 
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As shown in Figure 5.4A, the retS/sadC double mutant did not bind Congo Red like the retS mutant 
did, indicating that without sadC the hyperbiofilm phenotype induced by deletion of retS is lost. 
In accordance to the loss of the hyperbiofilm phenotype, the swimming ability of the retS/sadC 
double mutant was also recovered and even surpassed that of the PAK wild-type strain (Figure 5.4B). 
In addition, the wild-type T3SS/T6SS switch phenotype was partially restored so that the T3SS was 
up-regulated (Figure 5.4C). 
To check if the observed phenotypes were due to low levels of c-di-GMP, the c-di-GMP reporter was 
used. Indeed, the elevated c-di-GMP levels of the retS mutant were drastically reduced in the 
retS/sadC double mutant (Figure 5.4D). Taken together, these results strongly support the idea of 
SadC being responsible for the elevated levels of c-di-GMP in the retS mutant. 
 
5.5 SadC is central to the Gac signalling system 
 
Given that SadC was responsible for the elevated levels of c-di-GMP in the retS mutant, the 
requirement of SadC in the broader context of the Gac system was inspected. Besides deletion of 
retS, the deletion of another two components of the Gac signalling cascade, hptB and rsmA, also 
leads to hyperbiofilm formation. Inversely, overexpression of a RetS antagonist, LadS, or an HptB 
antagonist, HsbR, causes a similar hyperbiofilm outcome. 
As illustrated in Figure 5.5A and B, the hptB hyperbiofilm mutant displayed an intermediate Congo 
Red binding phenotype in relation to the wild-type and the retS mutant, and this correlated to an 
intermediate level of c-di-GMP. Strikingly, like deletion of sadC in the retS mutant, the hptB/sadC 
double mutant was unable to bind Congo Red and showed reduced c-di-GMP levels. Concomitantly, 
overexpression of the antagonists LadS and HsbR in a sadC deletion mutant was unable to induce 
Congo Red binding (Figure 5.5C and D). 
In relation to RsmA, a downstream target of both the HptB and RetS pathways, an rsmA/sadC double 
mutant was engineered and the Congo Red binding phenotype tested. As shown in Figure 5.6A, 
deletion of sadC in the rsmA mutant abrogated Congo Red binding, indicating that the production of 
SadC is also required for the hyperbiofilm phenotype of the rsmA mutant and further supporting a 
theory in which SadC is central to the Gac system and to signaling cascades converging onto RsmA.  
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Figure 5.5 SadC is required for the c-di-GMP-dependent biofilm phenotype regulated by the Gac 
system.  
(A) Congo Red binding. The photograph was taken after 2 days of incubation. (B) Intracellular levels 
of c-di-GMP measured with the c-di-GMP transcriptional gfp reporter. The reporter was introduced 
in the P. aeruginosa strains specified by electroporation. Relative fluorescence units (RFU) are 
arbitrary fluorescence intensity units corrected for cell density. An ANOVA analysis was performed 
with a p value of 0.05. Asterisks indicate statistically significant changes. Three independent 
experiments were performed. PAK and PAK∆sadC were conjugated with pBBR1-MCS4-ladS (pladS) 
(C) or pBBR1-MCS4-hsbR (phsbR) (D). Congo Red binding is from day 2 of incubation.   
 
To investigate the relation between SadC and the Gac system, the ability of SadC to induce biofilm 
formation in an rsmY/rsmZ mutant was checked. This mutant is unable to form biofilms because it 
lacks the two sRNAs that antagonize the repression exerted by RsmA. In order to induce biofilm 
formation via the activity of SadC, the sadC gene was cloned under the regulation of an arabinose 
inducible promoter into miniCTX1. This plasmid allows the integration of genes into the att site of 
the P. aeruginosa chromosome. Site-directed mutagenesis on sadC was carried out to release the 
DGC activity from the c-di-GMP feedback inhibition and rendered the I-site nonfunctional through 
the substitution to A of the R392 residue. As presented in Figure 5.6B, in the wild-type strain, 
overexpression of sadCR392A induced Congo Red binding as it was expected. However, in the 
rsmY/rsmZ double mutant the same was not true, demonstrating that SadC depends on the 
expression of the two sRNAs to induce biofilm formation.  
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All together, these results confirm that SadC plays a central role in the Gac signalling pathway and 
consolidates the notion that the Gac and c-di-GMP networks are interlinked. Moreover, the fact that 
overexpression of sadCR392A per se was not sufficient to induce biofilm formation in the absence of 
RsmY and RsmZ expression, indicates that SadC acts downstream of the two sRNAs.  
 
 
Figure 5.6 Interdependence of the Gac and c-di-GMP signalling cascades.  
Congo Red binding phenotypes visualized on day 2 of incubation. (A) The ∆rsmA mutant phenotype 
is lost upon deletion of sadC. (B) Overexpression of SadI-site in the wild-type strain but not in the 
PAK∆rsmY∆rsmZ induces Congo Red binding. SadI-site was cloned in miniCTX1-araC-PBAD and 
expressed using 0.4% arabinose after integration in the chromosome following conjugation. 
 
5.6 SadB is also required for the hyperbiofilm phenotype of the retS and 
hptB mutants  
 
Based on research performed by the group of George O’Toole, SadC was characterized for its role in 
reciprocally regulating biofilm formation and swarming motility (Merritt et al., 2007). This 
observation derived mainly from the fact that a sadC deletion mutant had a hyperswarming 
phenotype and was defective in the transition to irreversible attachment during biofilm formation. 
Hinted by the fact that a previously described sadB (PA5346) transposon mutant displayed a similar 
phenotype (Caiazza & O'Toole, 2004), and through a series of epistasis experiments, the authors 
were able to place sadB and sadC in the same genetic pathway and demonstrated that SadB acts 
downstream of SadC.  
In light of this, the effect of deleting sadB in the retS and hptB mutants was also investigated. If it is 
true that SadB is downstream of SadC, it is expected that deletion of sadB in the retS or hptB 
mutants causes a similar effect on biofilm formation as deletion of sadC does. As shown in Figure 
5.7A and B, deletion of sadB impairs the hyperbiofilm phenotype of both mutants, although this was 
not as pronounced as the impairment caused by deletion of sadC. Nonetheless, the results support 
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the concept of SadB being in the same genetic pathway as SadC and further indicate that SadB may 
not be the sole player in the signalling cascade that operates downstream of SadC.  
 
 
Figure 5.7 SadB is also required for the c-di-GMP-dependent biofilm phenotype regulated by the 
Gac system.  
Biofilms formed in a MTP under shaking conditions for 24 h in M9 medium with 0.4% glucose were 
quantified by CV staining from three technical replicates. Deletion of sadB in the retS (A) or the hptB 
(B) mutant backgrounds negatively impacts the hyperbiofilm phenotype. An ANOVA analysis was 
performed with a p value of 0.05. Asterisks indicate statistically significant changes. Two 
independent experiments were performed. 
 
 
5.7 The C-terminus of SadB has structural homology with the HD-GYP 
domain 
 
The biochemical function of SadB is unknown. SadB is a cytoplasmic protein with 469 amino acids. It 
is predicted to have two domains: an N-terminal YbaK domain which is a domain of unknown 
function found in prokaryotic cells and frequently associated with prolyl-tRNA synthetases; and a C-
terminal HD domain which typically harbours phosphohydrolase activity. For instance, in the YfbR 
protein from E. coli the HD domain works as a nucleotidase by dephosphorylating nucleoside 5′-
monophosphates (Zimmerman et al., 2008). 
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Due to the fact that the first crystal structure of the c-di-GMP related HD-GYP domain, a variant of 
the HD superfamily, was only recently solved (Lovering et al., 2011), the structural homology of the 
HD domain of SadB with the HD-GYP domain of Bd1817 from Bdellovibrio bacteriovorus was 
examined. To do this, the crystal structure of Bd1817 (PBD code 3TM8) was searched against the P. 
aeruginosa PAO1 genome by doing a BackPhyre analysis.  
 
Table 5.1 Proteins with a putative HD-GYP domain identified by Phyre2. 
Hit Alignment coverage (amino acids) Confidence (%) 
Previously identified 
PA4108 5-306 100 
PA4781 82-306 100 
PA2572 31-307 100 
Previously unidentified 
PA0758 148-306 99.4 
PA0356 148-306 99.1 
PA5346 (sadB) 148-306 98.7 
PA0267 148-287 98.3 
PA2804 118-238 97.6 
PA3043 150-266 97.3 
PA5241 150-270 97.1 
PA4955 148-269 96.2 
PA1124 150-266 96 
 
 
As expected, the first three hits of the BackPhyre analysis, predicted with a confidence of 100%, 
were the three HD-GYP domain proteins known for P. aeruginosa: PA2572, PA4106 and PA4781 
(Table 5.1). Strikingly, another nine proteins with structural homology to the HD-GYP domain were 
also identified with high levels of confidence (above 95%). Interestingly, the region encompassing 
the HD domain of SadB was one of them, despite the fact that the amino acid sequence of SadB 
displays a degenerated HD motif and an unrecognizable GYP motif (Figure 5.8).         
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Figure 5.8. Phyre2 alignment of the structure and sequence of Bd1817, an HD-GYP domain protein, 
and SadB.  
Alignment covers amino acids 148 to 307 of Bd1817 and amino acids 250 to 450 of SadB. Asterisks 
indicate HD and GYP motifs. Grey boxes indicate conserved residues and α-helices are indicated by 
the green helices.  
 
5.8 Screen for proteins that interact with SadC 
 
The idea that SadC signals via SadB left open the possibility that SadB could be interacting with SadC. 
To test this hypothesis, a bacterial two-hybrid approach was used. This method is based on the 
reconstitution of the AC catalytic domain of CyaA when two proteins that carry the T18 and T25 
subdomains interact (Battesti & Bouveret, 2012; Karimova et al., 1998). This can then be visualized 
as red colonies in MacConkey agar plates supplemented with maltose, IPTG and the appropriate 
antibiotics (Figure 5.9A).  
Firstly, the genes of interest were cloned into specially designed vectors that allow the production of 
chimeric proteins harbouring the T18 or T25 subdomains. Because SadC has N-terminal 
transmembrane domains, two versions were engineered: one expressing the full length protein 
(SadCfl) with a C-terminal T18 or T25 subunit, and another one expressing the cytoplasmic portion of 
the protein (SadCct) with N-terminal T18 or T25 subunits. For SadB, the engineered plasmid encoded 
an N-terminal T18 or T25 subunit. When E. coli DHM1 cells were co-transformed with the relevant 
plasmids and plated in MacConkey agar, positive interactions were observed for self-interactions of 
SadCfl, SadCct and SadB (Figure 5.9B). However, interactions between SadCfl and SadB or SadCct and 
SadB were not detected.       
To search for other potential interaction partners of SadC, a genome-wide screen was performed in 
collaboration with Christophe Bordi at the CNRS in Marseille. Recently, a bacterial two-hybrid 
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genome fragment library with an estimated 3-fold coverage of the whole P. aeruginosa PAO1 
genome was constructed (Houot et al., 2012) and SadCfl was used as a bait to probe against the 
library. In total, an estimated number of 30 000 clones was obtained and among these, 20 red 
colonies were identified in the course of one-week of incubation on MacConkey agar plates. After 
re-streaking to confirm positive interaction and sequencing, a total of 12 hits were recognized (Table 
5.2).  One of them, PA4379, was identified four times as a strong interaction that was apparent on 
the second day of incubation; another one, PilS (PA4546), was identified two times as a weaker 
interaction. Other identified hits were FimV (PA3115), PA3926 and PA4459 which appeared after 
two days of incubation only, and PA1378, PA1891, PA3403, CysE (PA3816), InaA (PA4378), PA4929 
and AtpF (PA5558) which appeared later. Noteworthy, both FimV and PilS are proteins that have 
previously been related to twitching motility. Also, InaA is predicted to be encoded in the same 
operon as PA4379, and PA4929 is a protein with a C-terminal GGDEF domain and an N-terminal 
7TMR_DISM domain (like RetS and LadS). 
 
Table5.2 Prey proteins in the bacterial two-hybrid screen using SadC as bait. 
Hit Comments Gene product 
Strong interactions (after 2 days of incubation) 
FimV (PA3115) Hits the N-terminus Membrane protein 
PA3926 Hits the C-terminus Transporter 
PA4379 Hit 4x Methyltransferase 
PA4459  Lipopolysaccharide assembly 
Weaker interactions (after 4-6 days of incubation) 
PA1378  Hypothetical 
PA1891  Membrane protein 
PA3403  Hypothetical 
cysE (PA3816) Hits the C-terminus O-acetylserine synthase 
InaA (PA4378) Same operon as PA4379 Lipopolysaccharide kinase 
PilS (PA4546) Hit 2x Two-component membrane sensor 
PA4929 Hits the C-terminus Diguanylate cyclase 
AtpF (PA5558)  ATP synthase B chain 
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In relation to PA4379, the gene encodes a protein of 227 amino acids with a putative 
methyltransferase domain. The detected interaction with SadC in the screen was further confirmed 
by cloning the full length PA4379 into pKT25 and pUT18C, the vectors allowing the expression of 
PA4379 chimeric proteins carrying the T25 or T18 subunit at the N-terminus. As shown in Figure 
5.9C, PA4379 was able to interact with SadCfl. Moreover, the interaction with PA4379 still occured 
with the cytoplasmic truncated SadCct version, indicating that the transmembrane portion of SadC is 
not essential for the interaction between SadC and PA4379. Like for SadC, an interaction between 
PA4379 and SadB was not observable. 
 
 
Figure 5.9 SadC interacts with PA4379.  
Bacterial two-hybrid analysis of possible interactions between SadC and SadB or SadC and PA4379 
visualized on MacConkey agar plates after 2 days at 30oC. The different pKT25/pKNT25 and 
pUT18C/pUT18 recombinant plasmids harboring the proteins of interest were co-transformed into E. 
coli DHM1. SadCfl indicates expression of the full length sadC and was cloned in pKNT25 or pUT18. 
All the other proteins of interest, including the cytoplasmic truncation of sadC (SadCct), were 
expressed from pKT25 or pUT18C. (A) Co-expression of the empty vectors encoding the T25 and T18 
subunits does not give an interaction but the positive control expressing recombinant zip leads to 
the appearance of red colonies. (B) SadCfl or SadCct do not seem to interact with SadB but the three 
are able to interact with the self. (C) PA4379 is able to interact with itself and with SadC but does not 
interact with SadB. The transmembrane N-terminal region of SadC is not essential for the interaction 
with PA4379.   
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5.9 Discussion 
 
Although the complexity of the Gac system varies between different species, the central GacAS two-
component system and its downstream targets, namely the sRNAs and the translational repressor, 
are conserved in the Gammaproteobacteria class (Lapouge et al., 2008). In some species, a link 
between the Gac system and the c-di-GMP network in the regulation of specific features became 
apparent in the past few years. In E. coli, the GacAS two-component system is known as BarA/UvrY 
and controls the expression of two sRNAs, CsrB and CsrC. These, in turn, modulate the activity of the 
CsrA translational repressor which targets, among many other genes, two genes encoding proteins 
with a GGDEF domain, YdeH and YcdT (Jonas et al., 2008). In S. enterica, the GacAS two-component 
system is known as BarA/SirA and modulates the CsrA translational repressor via CsrB and CsrC. In 
this case, CsrA is known to regulate eight genes encoding GGDEF, GGDEF/EAL or EAL domain 
proteins, five of which by direct binding to the mRNA (Jonas et al., 2010). In X. campestris, RsmA has 
been shown to control posttranscriptionally at least three GGDEF domain proteins (XC_1803, 
XC_2715 and XC_2866) among the 22 genes encoding GGDEF or EAL domain proteins. The three 
contribute additively for the elevated levels of c-di-GMP in the rsmA mutant (Lu et al., 2012).  
In P. aeruginosa, the first direct evidence that the Gac system and the c-di-GMP signalling were 
interlinked came from the observation that the retS mutant displays high levels of c-di-GMP and that 
the c-di-GMP-induced T3SS/T6SS switch is dependent on the two sRNAs, RsmY and RsmZ (see 
Chapter 4) (Moscoso et al., 2011). Here, the link between the Gac system and c-di-GMP was studied 
further and evidence is provided showing that if, on the one hand, PA0338 seems to be a direct 
target of RsmA, on the other hand, SadC is the DGC responsible for the elevated levels of c-di-GMP 
in the retS, hptB and rsmA mutants. Based on the published literature, these two proteins were 
considered of interest because PA0338 had been seen to be up-regulated in the rsmA mutant 
(Brencic & Lory, 2009) and a sadC transposon mutant had been identified as a suppressor of the retS 
mutant hyperbiofilm phenotype (Goodman et al., 2004).  
To confirm the up-regulation of PA0338, a qRT-PCR screen was performed to check the expression of 
all the proteins with a GGDEF domain in the retS mutant. Indeed, PA0338 was ~3.8-fold up-regulated 
and this was in good agreement with the result obtained by Brencic & Lory (2009) which also 
observed a 3-fold change in the rsmA mutant. RsmA is known to exert its repression by binding to 
consensus GGA motifs at or near the ribosome binding site and residing in a single-stranded region 
of a stem-loop structure of the target mRNAs (Lapouge et al., 2008). Noteworthy, taking into 
account this information and according to the secondary mRNA structure predicted by Mfold, a GGA 
 170 
 
motif in PA0338 mRNA was found and provided further ground to conclude that PA0338 is post-
transcriptionally regulated by RsmA (Figure 5.1). 
When PA0338 was deleted in the retS mutant background, the retS/PA0338 double mutant still 
displayed elevated levels of c-di-GMP. Hence, although being up-regulated, PA0338 does not seem 
to account for the production of c-di-GMP in the retS mutant (Figure 5.2). This may be because 
PA0338 (i) does not have DGC activity (despite having conserved I- and A-sites), (ii) is not catalytic 
active under the conditions tested, or (iii) has weak DGC activity and its contribution to the overall 
level of the second messenger is minimal. According to Tina Jaeger from the laboratory of Urs Jenal, 
overexpression of PA0338 causes a slight increase in the ability of PAO1 to form biofilms, indicating 
that PA0338 has some DGC acitivity. Interestingly, PA0338 is predicted to be encoded in an operon 
with two other upstream genes. PA0336 is homologous to the E. coli protein RppH (formerly 
NudH/YgdP) that has been shown to be involved in mRNA decay by 5' pyrophosphate removal 
(Deana et al., 2008) and PA0337 is homologous to the E. coli protein PstP which in P. putida has been 
shown to be a component of a phosphotranferase system important in the regulation of carbon and 
nitrogen metabolism (Velazquez et al., 2007). In P. aeruginosa it has also been reported that PstP is 
involved in pyocyanin production via the two quorum sensing systems las and rhl (Xu et al., 2005) 
and to be required, similarly to GacS and GacA, for virulence in various infection models (Tan et al., 
1999). 
In addition to the up-regulated PA0338, the qRT-PCR screen performed showed a down-regulation 
of PA3343, PA4843 and PA3258 in the retS mutant. PA3343 is known to have DGC activity and 
PA3258 is homologous to RapA from P. fluorescens which has PDE activity (Monds et al., 2007). As 
for PA4843, the protein harbours two N-terminal REC domains and a C-terminal GGDEF domain with 
conserved I- and A-sites, but its catalytic function has not been demonstrated. 
Due to the proximity to hptB, PA3343 was hypothesized to be encoded in the same operon as hptB. 
Previously, it had been demonstrated by Hsu et al. (2008) that hptB was forming an operon with 
PA3347 and PA3346. Although the data is preliminary, the RT-PCR analysis suggested that PA3343 
belongs to a seven gene operon starting with PA3347 and finishing with PA3341 (Figure 5.3). Besides 
the putative DGC, HptB, HsbR (phosphatase) and HsbA (anti-anti-sigma factor), the operon includes 
a putative helicase (PA3344), a putative transcriptional regulator (PA3341) and a protein of unknown 
function (PA3342). Curiously, next to PA3347 is PA3348, a putative chemotaxis methyltransferase 
that was identified in the screen by Nesper et al. (2012) and Duvel et al. (2012) as being able to bind 
c-di-GMP. Based on these observations, one can speculate that these proteins may converge in the 
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regulation of a common cellular function that is dependent on both the Gac and c-di-GMP signalling 
via HptB and PA3343.  
Contrary to PA0338, sadC was not up-regulated in the retS mutant (Figure 5.1) or the rsmA mutant 
(Brencic & Lory, 2009). However, when sadC was deleted from both backgrounds the levels of c-di-
GMP were reduced and the phenotypes reverted (Figure 5.4 and 5.6). Thus, SadC seems to be the 
DGC responsible for the elevated levels of c-di-GMP in the retS or rsmA mutants, but it is unclear 
how the Gac system influences SadC to promote the production of c-di-GMP. If sadC was a direct 
target of RsmA, it would be expected to observe an up-regulation in the qRT-PCR screen or it would 
be possible to recognise a RsmA binding motif in the 5’ untranslated region of the corresponding 
mRNA, but neither one of these were identified. In theory, the regulation of sadC by the Gac system 
at the transcriptional level, directly or indirectly, can be disregarded. At the posttranscriptional level, 
the results do not support a direct regulation by RsmA but it is still possible that RsmA regulates 
sadC expression indirectly. For instance, RsmA could bind to an unknown allosteric regulator of 
SadC. Although the molecular link between SadC and the Gac system remains elusive, the link 
between the Gac system and SadC is strengthened by the fact that the two sRNAs, RsmY and RsmZ, 
were required for the SadC-induced biofilm phenotype. Additionally, the hyperbiofilm phenotype of 
the hptB mutants was also dependent on SadC (Figure 5.5), positioning SadC as a central player of 
the Gac signalling pathway that acts downstream of the two sRNAs.  
Given that deletion of sadC in the retS mutant completely reverted the c-di-GMP, Congo Red or 
swimming phenotypes to levels that are similar or even greater than the wild-type strain, it is 
unlikely that other DGCs cooperate to increase the c-di-GMP level in the retS mutant. However, 
when analysing the T3SS/T6SS switch in the retS/sadC double mutant, only a partial switch was 
observed as T6SS did not appeared down-regulated (Figure 5.4). This raises a question about the 
stringency at which c-di-GMP is able to regulate T6SS. While the expression of the T3SS seems to 
rapidly respond to the levels of c-di-GMP in both up and down directions, the down-regulation of 
T6SS at low levels of c-di-GMP may be more complex and dependent on additional factors.   
SadC was previously characterized for its role in swarming motility and placed in the same genetic 
pathway as BifA, a PDE, and SadB, a protein of unknown function. In addition, RoeA, a DGC, has been 
shown to have an additive effect to SadC in P. aeruginosa PA14 strain (Merritt et al., 2010). Since 
SadB has been demonstrated to act downstream of SadC, the impact of its deletion in the retS and 
hptB mutants was also investigated and the results confirmed the requirement of SadB downstream 
of SadC (Figure 5.7).  
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How SadB acts in the SadC signalling is not clear. Previously, Caiazza & O'Toole (2004) have shown 
that both the N-terminal YbaK domain of SadB and the C-terminal HD domain of SadB are required 
for function and no PDE activity has been demonstrated (Caiazza et al., 2007). Hypothetically, it was 
considered that SadB could act upstream of the c-di-GMP synthesis, somehow assisting SadC in its 
DGC activity, or that SadB could function as a c-di-GMP receptor, somehow transmitting the c-di-
GMP signal to downstream targets. In light of the results presented here, the latter hypothesis is 
favoured. Firstly, because no direct interaction between SadC and SadB could be detected using the 
bacterial two-hybrid approach (Figure 5.9). Secondly, because the C-terminus HD domain of SadB 
was shown to actually have high structural homology to an HD-GYP domain (Table 5.1), suggesting 
that the protein may be able to bind c-di-GMP and act as a c-di-GMP receptor.  
 
 
Figure 5.10 Model for the role of SadC in modulating biofilms downstream of the Gac system.  
The Gac system is a complex signalling cascade that inversely regulates attributes related to the 
switch between acute and chronic infections. One of those traits is the development of biofilms. The 
proteins belonging to this cascade that negatively impact the formation of biofilms are indicated in 
red. All the proteins indicated in green have a positive impact on biofilm formation. The hyperbiofilm 
phenotype displayed by the deletion of retS, hptB and rsmA is dependent on the DGC activity of 
SadC. Although it cannot be conclusively ruled out that SadC is a direct target of RsmA, the activity of 
SadC is likely to be regulated indirectly by RsmA. SadB was hypothesized to be able to bind c-di-GMP 
via its newly recognized HD-GYP domain and to transmit the signal relayed by SadC. This signal may 
be further regulated by the putative methyltransferase activity of PA4379 and the confirmed PDE 
acitivity of BifA. SadB is known to act upstream of the Pil-Chp cluster which is related to T4P 
biogenesis, and SadC has also been identified as a putative interaction partner of the T4P-related 
genes FimV and PilS. Possibly, the Gac/SadC-dependent high c-di-GMP level and the subsequent 
biofilm modulation is closely related with the production of T4P.  
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In addition to this, SadB is known to act upstream of the Pil-Chp chemotactic cluster (Caiazza et al., 
2007). This cluster is required for the T4P biogenesis and interestingly, other T4P related genes, 
namely the peptidoglycan-binding FimV and the sensor PilS, were identified in this study as possible 
interaction partners of SadC (Table 5.2). Together this provides a strong indication that the Gac 
system and SadC may be interlinked in the regulation of the T4P which contributes for biofilm 
formation. 
In P. fluorescens, a link between SadB and the Gac system has recently been established for the 
negative regulation of flagella-driven motility during exponential phase (Martinez-Granero et al., 
2012). In this bacterium, the Gac system comprises three translational repressors, RsmA, RsmE and 
RsmI, and three sRNAs, RsmX, RsmY and RsmZ, but RsmI and RsmY do not participate in the motility 
regulation. In relation to SadB and the Gac system, the two signalling cascades were shown to 
intersect in the cooperative regulation of the σ22 sigma factor, also known as AlgT or AlgU. On the 
one hand, SadB is required for the transcription of σ22, and on the other hand, RsmA and RsmE act as 
translational repressors of σ22. Once produced, σ22 is necessary for the expression of the 
transcriptional regulator amrZ (also referred to as algZ) which functions to down-regulate fleQ, the 
master regulator of the flagellar components.  In P. aeruginosa, it is not known if σ22 is a member of 
the RsmA regulon, but AmrZ belongs to the σ22 regulon and has been shown to be involved in both 
the down-regulation of flagella and Psl exopolysaccharide, and the up-regulation of twitching 
motility and alginate production (Baynham et al., 2006; Jones et al., 2013; Tart et al., 2005; Wozniak 
et al., 2003). 
Another identified interaction partner of SadC was PA4379. PA4379 is a putative methyltransferase 
and may belong to an operon with PA4377, a small protein of unknown function, and PA4378, a 
putative lipopolysaccharide kinase. The biological role of PA4379 is unknown but one can speculate 
that PA4379, as a methyltransferase, may be involved in the allosteric modification of SadC. 
In summary, a model is proposed in which the biofilm lifestyle directed by the Gac system is 
dependent on the production of c-di-GMP by SadC. Subsequently, the synthesized c-di-GMP is likely 
to be perceived by SadB which relays the signal and modulates biofilm formation (Figure 5.10). 
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6) Conclusion 
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Chapter 6 – Conclusion  
 
Bacteria are able to adapt to the environment and progress during the biofilm developmental cycle 
due to multiple signal transduction pathways that operate to allow the integration of extracellular 
signals into intracellular messages and the concerted action of different biological functions. These 
signal transduction pathways can have different degrees of complexity, varying from the simplest 
mode which consists of the direct binding of a signal to an effector protein, to the more complex 
mode which encompasses cascades of reactions like the ones directing chemotaxis. 
Two important signalling pathways in P. aeruginosa are the Gac system, pivotal in the inverse 
regulation between acute and chronic infections; and the c-di-GMP network, central to the inverse 
regulation between a motile and a sessile lifestyle. Here, a link between these two pathways has 
been established. 
In Chapter 3, the complexity of the c-di-GMP network in P. aeruginosa was demonstrated. A total of 
51 proteins have identifiable GGDEF, EAL, HD-GYP or PilZ domains which are domains that can be 
involved in synthesizing (GGDEF domain), degrading (EAL or HD-GYP domains) or binding to c-di-
GMP (PilZ domain). In relation to the later, many more proteins are thought to exist but remain 
unknown. As for the proteins with a GGDEF, EAL or HD-GYP domains, not all of them seem to have 
catalytic activity and some of them, like MucR, may have both the DGC and PDE activities. 
Nonetheless, the numerous c-di-GMP related proteins seem to work in a concerted manner to 
regulate a variety of biological functions in a highly specific manner. From the proteins that have 
been characterized so far, attributes like biofilm formation and dispersal, flagella and T4P motility, or 
the production of exopolysaccharides have been shown to be c-di-GMP regulated (Figure 6.1). 
Overall, the paradigm of c-di-GMP signalling has been established based on the overexpression of 
DGCs or PDEs and dictates that high levels of c-di-GMP promote the sessile lifestyle of the bacteria 
whereas low levels of c-di-GMP promote motility (Figure 3.1). However, when the production of 
individual DGCs or PDEs is impaired, the impact on biofilm formation or dispersal is not uniform 
(Figure 3.4), reflecting the high level of specificity at which the c-di-GMP network functions. 
Despite the fact the substantial progress has been made in characterizing the GGDEF, EAL and HD-
GYP domain proteins found in P. aeruginosa during the last years, the physiolocally role of more 
than half remains elusive and should be the focus of future work. For instance, it was established in 
this work that PA2072 is likely to function as a PDE, but further demonstration of this catalytic 
activity with an in vitro assay would be necessary to make a solid conclusion. Moreover, since 
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PA2072 exhibits both a GGDEF and EAL domain, an in vitro biochemical assay would also allow the 
investigation of the catalytic function of the GGDEF domain. Additionally, the fact that over the last 
year at least three different proteins (NbdA, RbdA and DipA) were implicated in biofilm dispersal by 
three independent studies, raises the question of whether they are expressed under the same 
conditions (at least RbdA and DipA seem to, Table 3.1) and if so, if their function is redundant or 
additive. 
 
 
Figure 6.1 The c-di-GMP network operates at high specificity.  
The P. aeruginosa proteins that have been related to c-di-GMP so far are represented. PDEs are 
indicated in pink, DGCs in blue and c-di-GMP binding proteins in purple.  
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Although in P. aeruginosa the bacterial lifestyle is generally associated with the mode of infection, 
with the sessile lifestyle being related to the establishment of chronic infections, the virulence of the 
bacterium correlates closely to the expression of different secretion systems. In acute infections, the 
T2SS and T3SS are up-regulated and secrete toxins into the environment and host cells, and in 
chronic infections the T6SS is active and important for the colonization of the host. Crucial for this 
inverse regulation of the secretion systems is the Gac system. This signalling cascade comprises the 
central two-component system GacAS which leads to the expression of two sRNAs that antagonize 
the translational repressor RsmA. The function of RsmA can be antagonized by deleting or 
overexpressing, respectively, the additional sensors RetS or LadS. A retS mutant is a hyperbiofilm 
former and has an up-regulated T6SS and down-regulated T3SS. As shown in Chapter 4, by artificially 
modulating the levels of c-di-GMP with the overexpression of a DGC or a PDE, it was possible to 
induce the switch between the different secretion systems. At high levels of c-di-GMP the T6SS was 
up-regulated, whereas at low levels of c-di-GMP the T3SS was up-regulated (Figure 4.2). Hence, the 
regulation by c-di-GMP goes beyond the lifestyle switch to modulate other important virulence 
factors like the T3SS/T6SS switch (Figure 6.2). Moreover, the observations that the hyperbiofilm retS 
mutant displays high levels of c-di-GMP (Figure 4.1) and that the c-di-GMP-dependent T6SS up-
regulation relies on an active GacAS cascade and the production of the sRNAs (Figure 4.4), provide a 
direct evidence of the existence of a firm link between the Gac and c-di-GMP signalling networks.  
This unprecedent link between c-di-GMP and the T3SS and T6SS regulation leaves open the question 
on how the c-di-GMP-dependent T3SS/T6SS switch occurs at the molecular level. The mechanisms 
by which c-di-GMP signals in bacteria have proven to be very diverse and the possibilities for this 
regulation are many. For instance, something similar to what happens with the c-di-GMP control of 
the swimming motility velocity in E. coli (Chapter 1, section 1.4) could be happening to one of the 
two secretion systems and for that reason it would be appropriated to check if c-di-GMP also affects 
the secretion of the different effector proteins. Ideally, the specific DGCs, PDEs and c-di-GMP binding 
proteins involved in the regulation of the two secretion systems should be identified and this could 
be done by using an approach similar to the screen performed with the PA14 transposon collection 
upon overexpression of ladS (Figure 4.7). To elucidate the full regulatory cascade, methods like 
bacterial two-hybrid or ChIP-seq could be applied to further look for interactions between proteins 
or between proteins and DNA. 
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Figure 6.2 The c-di-GMP regulation of the T3SS/T6SS switch.  
Low levels of c-di-GMP promote the expression of the T3SS whereas high levels of c-di-GMP favour 
the expression of the T6SS.  
 
Finally, in Chapter 5 the DGC responsible for the elevated levels of c-di-GMP in the retS mutant was 
pinpointed. According to previously published papers, the genes PA0338 and sadC encoding proteins 
with a GGDEF domain were considered of interest for being, respectively, up-regulated in a rsmA 
mutant or identified as a suppressor mutation of the retS hyperbiofilm phenotype.  A qRT-PCR 
screen confirmed that PA0338 is up-regulated in the retS mutant and no other proteins with a 
GGDEF domain showed a similar profile (Figure 5.1). Despite being up-regulated, PA0338 was found 
to not be responsible for the elevated levels of c-di-GMP in the retS mutant (Figure 5.3). Instead, 
SadC was identified as being central in the c-di-GMP-dependent regulation exerted by the Gac 
system (Figure 5.4-6). Not only was SadC required for the hyperbiofilm phenotype of retS, it was also 
indispensable for the phenotypes observed in the rsmA and hptB deletion mutants, and the strains 
overexpressing ladS and hsbR. In addition, the SadC downstream partner SadB, a protein of 
unknown biochemical function, was shown to be partially required for the retS and hptB mutants 
hyperbiofilm phenotype (Figure 5.7). Based on structural homology, it was hypothesized that the N-
terminal HD domain of SadB is actually a HD-GYP domain and that SadB may act as a c-di-GMP 
binding protein, thus relaying SadC activity.  
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In order to elucidate this pathway further, the biochemical function of SadB needs to be determined. 
For instance, the DRaCALA assay could be used to assess the ability of SadB to bind c-di-GMP. In fact, 
the same applies for all the putative HD-GYP domains identified by the BackPhyre analysis. In 
addition, the PA4379 bacterial two-hybrid hit should be further validated by engineering a clean 
deletion of the gene in the retS and hptB mutants and assessing the impact of that deletion in 
biofilm formation. Since some of the other possible SadC interaction partners were proteins involved 
in T4P-mediated twitching motility, it would be interesting to make a careful analysis of this 
phenotype.  
The exact mechanism by which SadC is induced to produce c-di-GMP in a retS or rsmA deletion 
background is still unknown. While the DGC PA0338 seems to be a direct target of RsmA, the same 
evidence was not provided for SadC and ultimately, the RsmA ability to bind both mRNAs should be 
investigated. Also, the possibility that the DGC PA3343 is down-regulated in the RsmA mutant and 
encoded in the same operon as HptB is an interesting one and deserves to be explored. 
 
 
Figure 6.3 The Gac and c-di-GMP pathways are interlinked.  
The Gac system acts upstream of SadC and this is responsible for the synthesis of c-di-GMP when the 
pathway is activated. 
 
In summary, the Gac system and the c-di-GMP network have in common the regulation of several 
biological functions like the biofilm development and the production of different secretion 
machineries. At least in relation to biofilm formation, the two pathways seem to cooperate with the 
Gac system acting upstream of the c-di-GMP network (Figure 6.3). When the GacAS two-component 
system is active, the production of the sRNAs inhibits RsmA which, by a yet unknown mechanism, 
leads to the production of c-di-GMP by the DGC protein SadC. 
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Summary
Acute bacterial infections are associated with motility
and cytotoxicity via the type III secretion system
(T3SS), while chronic infections are linked to biofilm
formation and reduced virulence. In Pseudomonas
aeruginosa, the transition between motility and ses-
sility involves regulatory networks including the
RetS/GacS sensors, as well as the second messenger
c-di-GMP. The RetS/GacS signalling cascade con-
verges on small RNAs, RsmY and RsmZ, which
control a range of functions via RsmA. A retS muta-
tion induces biofilm formation, and high levels of c-di-
GMP produce a similar response. In this study, we
connect RetS and c-di-GMP pathways by showing
that the retS mutant displays high levels of c-di-GMP.
Furthermore, a retS mutation leads to repression of
the T3SS, but also upregulates the type VI secretion
system (T6SS), which is associated with chronic
infections. Strikingly, production of the T3SS and
T6SS can be switched by artificially modulating c-di-
GMP levels. We show that the diguanylate cyclase
WspR is specifically involved in the T3SS/T6SS
switch and that RsmY and RsmZ are required for the
c-di-GMP-dependent response. These results provide
a firm link between the RetS/GacS and the c-di-GMP
pathways, which coordinate bacterial lifestyles, as
well as secretion systems that determine the infection
strategy of P. aeruginosa.
Introduction
Pathogenic bacteria can adopt different lifestyles, both in
nature and during infection. In the planktonic phase, they
are motile and can cause acute infections associated with
production of toxins via the Type III secretion system
(T3SS). Conversely, bacteria in a biofilm tend to be less
virulent, more resistant to antibiotics and cause chronic
infections. Pseudomonas aeruginosa is a versatile bacte-
rial pathogen (Lyczak et al., 2000) that produces many
virulence factors, of which secretion systems are major
weapons required for colonization, survival, cytotoxicity
and evasion of the innate host immune system (Bleves
et al., 2010). Such a versatile organism has a wide range
of survival strategies and causes chronic as well as acute
infections (Roy-Burman et al., 2001; Hauser et al., 2002).
Pseudomonas aeruginosa chronic infections are a major
burden and cause of mortality in people suffering from
cystic fibrosis (CF). In the CF lungs, the bacteria establish
as a biofilm (Singh et al., 2000), which is difficult to
eradicate by the immune system or antibiotic therapy
(Costerton et al., 1999). Previous reports suggest
that P. aeruginosa chronic infections are associated
with expression of the type VI secretion system (T6SS)
(Potvin et al., 2003; Mougous et al., 2006).
It has been shown in P. aeruginosa that the decision-
making process to adopt a chronic/biofilm or acute/
planktonic lifestyle depends on a regulatory network
involving two sensors, RetS and LadS (Goodman et al.,
2004; Ventre et al., 2006; Bordi et al., 2010; Vincent et al.,
2010; Mikkelsen et al., 2011). These sensors act antago-
nistically to inversely control motility and the T3SS versus
biofilm formation and the T6SS (Goodman et al., 2004).
The RetS sensor displays a unique mechanism of action
that is based on modulating the activity of another sensor
kinase, GacS (Goodman et al., 2009). GacS has long
been known for its crucial role in P. aeruginosa virulence
and biofilm formation (Tan et al., 1999; Parkins et al.,
2001). Briefly, the formation of heterodimers between
RetS and GacS prevents GacS autophosphorylation and
thus phosphotransfer-dependent activation of the cognate
response regulator GacA. The exclusive targets for
GacA are the genes encoding two small regulatory
RNAs (sRNAs), RsmY and RsmZ (Brencic et al., 2009).
The function of these sRNAs is to sequester the
post-transcriptional regulator RsmA, which profoundly
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influences P. aeruginosa biology and lifestyle (Brencic
and Lory, 2009). Among the transcripts that are directly
repressed by RsmA are the pel and psl genes that are
important in biofilm development (Irie et al., 2010). The
pel genes are proposed to encode a yet uncharacterized
exopolysaccharide (Coulon et al., 2010), while the psl
gene products direct the synthesis of a repeating pen-
tasaccharide containing D-mannose, D-glucose and
D-rhamnose (Byrd et al., 2009). Both exopolysaccharides
contribute to the biofilm architecture (Friedman and
Kolter, 2004; Vasseur et al., 2005; Colvin et al., 2011).
Other genes directly controlled by RsmA are encoding the
T6SS (H1-T6SS) (Brencic and Lory, 2009). In contrast,
the genes encoding the T3SS are positively regulated by
RsmA, likely in an indirect manner (Brencic and Lory,
2009). These observations highlight the antagonistic
regulation of the various components of the T3SS and the
T6SS. Furthermore, the co-regulation of the T6SS and
biofilm-related genes (pel and psl) support the notion that
the T6SS is important in chronic infections.
In a number of bacterial species, including P. aerugi-
nosa, the second messenger c-di-GMP is utilized as a
signal for transition between the planktonic and sessile
lifestyles (Tamayo et al., 2007; Jonas et al., 2009). High
c-di-GMP levels promote biofilm formation and chronic
infections, while low c-di-GMP levels favour swimming
and virulence. The intracellular levels of c-di-GMP are
controlled by the antagonistic activity of diguanylate cycla-
ses, such as WspR, and phosphodiesterases, such as
PA2133 (Hickman et al., 2005). The P. aeruginosa WspR
is part of a chemosensory pathway that is involved in
bacterial cell aggregation and wrinkly colony morphology
(D’Argenio et al., 2002). Hickman and colleagues showed
that WspR is an active diguanylate cyclase that is
involved in upregulation of the pel genes with a concomi-
tant decrease in flagellar motility (Hickman et al., 2005). In
the same study, it was shown that a P. aeruginosa phos-
phodiesterase, PA2133, counteracts the activity of the
wsp pathway by degrading c-di-GMP. This activity
resulted in a drastic loss of biofilm formation.
In the present study, we show that the P. aeruginosa
RetS/GacS regulatory network is linked to the c-di-GMP
signalling network. We present evidence that c-di-GMP
inversely controls the T3SS and the T6SS expression in a
RetS-independent manner and show that this control is
dependent on the WspR diguanylate cyclase and the two
sRNAs, RsmY and RsmZ.
Results
The retS mutant displays elevated levels of c-di-GMP
A P. aeruginosa retS mutant is known to overproduce
exopolysaccharides and has a hyperbiofilm phenotype as
shown using a crystal violet staining assay (Fig. 1A). Con-
sidering that c-di-GMP has been associated with the
switch between the planktonic and biofilm lifestyles, we
hypothesized that the hyperbiofilm phenotype of a retS
mutant could be linked to a variation in c-di-GMP. We
compared the levels of intracellular c-di-GMP between the
P. aeruginosa PAK wild-type strain and the isogenic retS
mutant (PAKDretS) by LC-MS/MS (see Experimental pro-
cedures). The hyperbiofilm phenotype of PAKDretS coin-
cided with a ~1.4-fold increase in c-di-GMP levels as
compared with the parental strain (Fig. 1B). This obser-
vation is in agreement with the established notion that
high c-di-GMP levels promote biofilm formation. To inves-
tigate whether the elevated level of c-di-GMP was directly
attributable to the retS mutation, or a consequence of the
development of a biofilm, the c-di-GMP concentration was
Fig. 1. Phenotypes of P. aeruginosa PAK and selected deletion
mutants. Strains are indicated in (A).
A. Biofilm formation in static growth conditions visualized by crystal
violet staining.
B. Intracellular c-di-GMP levels measured by LC-MS/MS. The
levels of c-di-GMP in the wild-type were set to 1, and statistically
significant changes (Student’s t-test, P < 0.01) are indicated by
asterisks. Statistical analysis is based on three replicates.
C. Western blot using antibodies directed against PcrV (T3SS) and
Hcp1 (T6SS).
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determined in a retS mutant unable to form biofilms due to
a pel gene mutation (PAKDretSDpel) (Fig. 1A). Interest-
ingly, the c-di-GMP levels remained high (~twofold
increase) in the double mutant (Fig. 1B). We therefore
concluded that a retS mutation increases intracellular
c-di-GMP levels, and that this is independent of biofilm
formation.
RetS signalling antagonistically controls the type III
and type VI secretion systems
In addition to repressing Pel and Psl exopolysaccharide
production, RetS inversely regulates the genes encoding
the T3SS and the T6SS (Goodman et al., 2004; Mougous
et al., 2006). Since c-di-GMP signalling seems to play a
role in the RetS pathway, we hypothesized that, if the
regulation of biofilm formation by RetS is c-di-GMP-
dependent, the same could apply to the T3SS and the
T6SS. The production of these secretion systems can be
monitored by the detection of specific structural compo-
nents of the machineries: PcrV is located at the tip of the
T3SS needle (Lee et al., 2007), whereas Hcp1 is the main
component of the T6SS nanotube (Ballister et al., 2008).
Western blot analysis using specific antibodies directed
against these components showed that Hcp1 was readily
detected in a retS mutant, whereas the parental strain
displayed low Hcp1 levels (Fig. 1C). Conversely, PcrV
production was observed in the parental strain but not in
the retS mutant (Fig. 1C). Furthermore, the production of
the secretion systems was shown to be independent of
biofilm formation, since a retS/pel double mutant dis-
played the same profile as the retS mutant (Fig. 1C). Our
data therefore confirmed that a retS mutation switches the
activity of the T6SS and the T3SS, leading to the hypoth-
esis of an inverse correlation between the secretion
profile and c-di-GMP levels.
The type III and type VI secretion systems are
controlled by c-di-GMP
Several studies have shown that overproduction of active
diguanylate cyclases results in high intracellular levels of
c-di-GMP and enhances biofilm formation. (Kulasakara
et al., 2006). Of the 17 GGDEF domain-containing pro-
teins encoded on the P. aeruginosa PAO1 genome, WspR
is perhaps the most extensively characterized (Hickman
et al., 2005; Ude et al., 2006; De et al., 2008). We first
confirmed that wspR overexpression increased biofilm
formation in P. aeruginosa PAK (Fig. S1A and B). The
diguanylate cyclase activity of WspR is tightly feedback-
controlled, but replacement of a critical residue in the
I-site (WspRR242A) renders the enzyme highly active (De
et al., 2008). The corresponding mutation in wspR was
therefore engineered (pBBR1MCS-4-wspRR242A), and
overproduction of WspRR242A resulted in further elevated
biofilm formation (Fig. S1A and B), enhanced polysaccha-
ride production (Fig. S1C) and reduced swimming motility
(Fig. S1D).
Since the control of biofilm formation by RetS is c-di-
GMP-dependent, we hypothesized that artificial manipu-
lation of c-di-GMP levels by overproducing WspR should
not only impact biofilm formation but also the T3SS and
the T6SS. We therefore used a pel mutant (PAKDpel) to
test the influence of c-di-GMP variation on the T3SS/
T6SS switch, independently of both biofilm formation and
of a retS mutation. The recombinant plasmid overproduc-
ing WspRR242A was introduced into PAKDpel, which
resulted in a > twofold increase in c-di-GMP levels when
compared with a strain carrying the empty vector
(Fig. 2A). Interestingly, this increase was concomitant with
a reduction in PcrV production (T3SS) and an increase in
Hcp1 production (T6SS) (Fig. 2B).
Another diguanylate cyclase, PA1120, identified as YfiN
(Malone et al., 2010) or TpbB (Ueda and Wood, 2009),
has previously been shown to influence biofilm formation
in P. aeruginosa. The PA1120 gene was also cloned into a
broad host range vector (pBBR1MCS-4-PA1120) and
Fig. 2. c-di-GMP inversely controls the T3SS and the T6SS.
Relationship between c-di-GMP levels and secretion systems in
PAKDpel or PAKDretSDpel carrying either the empty vector, or
overproducing proteins that modulate c-di-GMP levels as indicated
in (B).
A. Relative intracellular levels of c-di-GMP measured by
LC-MS/MS. The levels of c-di-GMP in PAKDpel carrying the vector
control were set to 1, and statistically significant changes (Student’s
t test, P < 0.01) are indicated by asterisks. ‘ns’ indicates changes
that are not statistically significant.
B. Western blot using antibodies directed against PcrV (T3SS) and
Hcp1 (T6SS).
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introduced into PAKDpel. Overexpression of PA1120 in
this strain resulted in a switch between the T3SS and the
T6SS (Fig. 3), similar to the one observed upon overex-
pression of wspRR242A (Fig. 2B).
These results show that an artificial increase in c-di-
GMP levels, upon overproduction of an active diguanylate
cyclase, controls the T3SS and the T6SS in an inverse
manner. This T3SS/T6SS switch is similar to what was
previously observed in a strain with a retS mutation
(Fig. 1C).
Overproduction of the PA2133 phosphodiesterase
reverts the T3SS/T6SS switch
Overproduction of phosphodiesterases has been shown
to revert the biofilm-related phenotypes associated with
high levels of c-di-GMP. Several putative phosphodi-
esterases encoded on the P. aeruginosa genome have
been shown to be enzymatically active. One example of
this is PA2133, the overproduction of which reduces
biofilm formation in P. aeruginosa PAO1 (Hickman et al.,
2005). We confirmed that overexpression of the PA2133
gene in PAKDretS reverted the hyperbiofilm and Congo
red binding phenotype (Fig. S2) and hypothesized that
reduction of c-di-GMP levels in a retS mutant would revert
the expression profiles of the T3SS and the T6SS. Indeed,
introduction of PA2133 into PAKDretSDpel resulted in a
~twofold decrease in c-di-GMP levels (Fig. 2A) and coin-
cided with a switch in the production of secretion systems
(Fig. 2B).
Taken together, these data show that artificial modula-
tion of c-di-GMP levels leads to a reciprocal change in the
production of the T3SS and the T6SS (Fig. 2). We there-
fore conclude that c-di-GMP is a central signalling mol-
ecule in the regulation of these two key protein secretion
systems involved in P. aeruginosa virulence.
WspR is required for the switch between the T3SS
and the T6SS
In this study it has been shown that the T3SS/T6SS switch
that occurs in a retS mutant is dependent on c-di-GMP
levels. This switch can also be observed by an artificial
and global increase in c-di-GMP levels. We therefore
assessed whether any specific diguanylate cyclases
could be associated with the RetS/LadS/GacS signalling
cascade. This investigation exploited the fact that ladS
overexpression activates the Gac/Rsm cascade and
gives the same phenotype as a retS mutation (Goodman
et al., 2004; Ventre et al., 2006). Fifteen mutants in genes
encoding diguanylate cyclases were selected from a pre-
viously published P. aeruginosa PA14 library (Kulasakara
et al., 2006; Liberati et al., 2006) and the ladS gene
carried on a broad host range plasmid (pBBRladS) was
introduced into these strains. The data revealed that over-
expression of ladS in the PA14 wild-type induced the
T6SS, compared with the vector control, which expressed
the T3SS (Fig. 4, first two lanes). Furthermore, all the
tested transposon mutants retained the ability to switch to
the T6SS apart from one, namely the wspR mutant. Inter-
estingly, although overexpression of the gene encoding
PA1120 could induce the switch (Fig. 3), the mutant in this
gene was not affected. This strongly supports the notion
Fig. 3. The diguanylate cyclase PA1120 induces the T3SS/T6SS
switch. Western blot analysis of PAKDpel carrying either empty
vector or overproducing the diguanylate cyclases WspRR242A or
PA1120 as indicated. Antibodies are directed against PcrV (T3SS)
and Hcp1 (T6SS).
Fig. 4. WspR is required for the LadS-induced T3SS/T6SS switch. Western blot analysis of PA14 wild-type carrying the empty vector or
overexpressing ladS, as well as transposon mutants in GGDEF-domain proteins, all overexpressing ladS as indicated. Antibodies are directed
against PcrV (T3SS) and Hcp1 (T6SS).
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that the switch involves a specific set of enzymes, and
that WspR is one of them. Interestingly, one of the other
mutants (PA0290) was moderately affected in the switch
and displayed low levels of both the T3SS and the T6SS.
We concluded that there is a level of specificity in the role
that various diguanylate cyclases play in the T3SS/T6SS
switch, and that WspR is one of the major players.
RsmY and RsmZ are required for the
c-di-GMP-dependent T3SS/T6SS switch
RetS is part of a signalling cascade that converges on the
sRNAs, RsmY and RsmZ. Given the link between RetS
and c-di-GMP levels, and the regulation of the T3SS/
T6SS switch by both RetS and c-di-GMP, we investigated
whether the two signalling networks act in parallel or
whether there was a direct link between them. Whereas
wspRR242A overexpression in the wild-type resulted in a
clear T3SS/T6SS switch, the same was not observed in a
mutant that lacked the sRNAs RsmY and RsmZ
(PAKDrsmYDrsmZ) (Fig. 5A). This was not due to a lack of
increase in c-di-GMP, since wspRR242A overexpression
resulted in a ~1.6-fold increase in c-di-GMP levels in this
strain as compared with the vector control (Fig. 5B). This
is a clear indication that the c-di-GMP-dependent switch
between the T3SS and the T6SS requires the presence of
the sRNAs to counteract the activity of the post-
transcriptional regulator RsmA.
Discussion
During colonization of a susceptible host, several bacte-
rial species utilize complex regulatory pathways that
control the switch between planktonic and biofilm lif-
estyles and consequently influence whether they cause
acute or chronic infections. In P. aeruginosa, the regula-
tory cascade associated with the switch between the two
infections strategies has been shown to involve the RetS
and LadS signalling pathways (Goodman et al., 2004;
Ventre et al., 2006). RetS and LadS are both orphan
hybrid sensors that modulate the activity of the GacS/
GacA two-component system to control the levels of the
sRNAs RsmY and RsmZ. While RetS negatively influ-
ences the regulatory cascade by direct inhibition of the
GacS sensor (Goodman et al., 2009), LadS has the oppo-
site effect and activates rsmY and rsmZ expression via a
currently unknown mechanism. When levels of RmsY and
RsmZ are elevated, the post-trancriptional regulator
RsmA is sequestered from target transcripts to allow
translation.
Among the genes under direct negative control of
RsmA are the pel and psl genes (Brencic and Lory, 2009;
Irie et al., 2010), which are essential for biofilm formation,
whereas genes involved in motility, such as type IV pili
and flagellar genes, are positively regulated by RsmA
(Brencic and Lory, 2009). In addition to the switch
between biofilm formation and motility, the RetS/LadS/
Gac/Rsm cascade tightly controls the production of viru-
lence factors. A retS mutation is known to result in
reduced mammalian cell cytotoxicity because of a down-
regulation of the T3SS. This suggests that RsmA posi-
tively and indirectly influences the expression of these
genes (Goodman et al., 2004; Brencic and Lory, 2009).
The expression of the P. aeruginosa T6SS was shown to
be directly and negatively controlled by RsmA (Brencic
and Lory, 2009). Interestingly, the T6SS has been asso-
ciated with CF patients chronically infected with P. aerugi-
nosa (Mougous et al., 2006). Since P. aeruginosa very
likely grows in biofilm communities in the CF lungs, this
observation highlights the survival strategy of this organ-
ism by coordinating the expression of biofilm-related
genes with those encoding the T6SS, both of which are
associated with the chronic mode of infection. Collectively,
these findings suggest that the RetS/LadS/Gac/Rsm sig-
nalling network plays a central role in a switch between
acute virulence and chronic persistence.
Fig. 5. The c-di-GMP-dependent T3SS/T6SS switch requires
RsmY and RsmZ.
A. Western blot analysis of PAK or PAKDrsmYDrsmZ carrying either
empty vector or overexpressing wspRR242A. Antibodies are directed
against PcrV (T3SS) and Hcp1 (T6SS).
B. Relative c-di-GMP levels of PAKDrsmYDrsmZ carrying either the
empty vector or overexpressing wspRR242A as indicated. The
c-di-GMP level of the strain carrying the empty vector has been set
to 1, and statistically significant changes (Student’s t test, P < 0.01)
are indicated by asterisks.
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Although RetS and LadS appear to be restricted to
Pseudomonads (Records and Gross, 2010), GacS/GacA-
like systems have been identified in several other bacte-
ria. Different RsmA homologues have been identified in
Escherichia coli (UvrY/BarA and CsrA) and in Salmonella
enterica serovar Typhimurium (SirA/BarA and CsrA), and
some of them are involved in the motility/sessility switch.
In E. coli, CsrA represses the pga genes, which are
involved in polysaccharide production (Wang et al., 2005),
and also positively regulates the expression of flagellar
genes (Wei et al., 2001). In S. typhimurium, CsrA down-
regulates the production of fimbriae, which are required
for biofilm formation, and upregulates flagellar genes
(Teplitski et al., 2006). In both bacteria, the activity of CsrA
is antagonized by two sRNAs, CsrB and CsrC. Although
only few direct CsrA targets are identified in E. coli and
S. typhimurium, these proteins are likely to govern a
central switch between motility and sessility.
In addition to the GacS/GacA signalling cascade, c-di-
GMP has emerged as a widespread second messenger
that controls the switch from motility to sessility in many
bacteria (Hengge, 2009). This control is exerted on many
different levels and has been shown to target a wide
range of functions, including polysaccharide production
and motility. c-di-GMP is known to influence the produc-
tion of Pel exopolysaccharides in P. aeruginosa (Hickman
et al., 2005; Lee et al., 2007; Starkey et al., 2009), cellu-
lose and curli fimbriae production in S. typhimurium
(Garcia et al., 2004; Romling and Amikam, 2006) and the
VPS polysaccharide in Vibrio cholera (Casper-Lindley and
Yildiz, 2004; Tischler and Camilli, 2004). This control
occurs at least partly at the transcriptional level. Further-
more, c-di-GMP was shown to exert post-transcriptional
control of the swimming velocity of E. coli and Salmonella
by binding to YcgR, which acts as a molecular brake that
interacts with proteins of the flagellar motor and slows
down its rotation (Boehm et al., 2010; Paul et al., 2010).
The fact that both c-di-GMP and RetS signalling con-
verge on pel gene expression prompted us to investigate
whether the two pathways were linked by measuring intra-
cellular c-di-GMP levels in a retS mutant. Indeed, our
results showed that a retS mutant displays a 1.4-fold
elevation in c-di-GMP levels compared with wild-type
P. aeruginosa, which increased to a twofold elevation in a
retS/pel double mutant that is unable to form biofilms. This
overlap between the RetS and the c-di-GMP network was
indirectly suggested by previous work, where Goodman
and collaborators found that the retS phenotype could be
suppressed by secondary mutations in the diguanylate
cyclase-encoding gene sadC (PA4322) (Goodman et al.,
2004; Merritt et al., 2007). In order to investigate whether
the overlap of the two regulatory systems went beyond
the pel genes, we used the diguanylate cyclase activity of
WspRR242A and the phosphodiesterase activity of PA2133
to artificially modulate c-di-GMP levels in the parental
strain and the retS mutant. We monitored the presence of
the T3SS and T6SS and found that increased c-di-GMP
levels caused the wild-type to switch from the T3SS to the
T6SS, while decreased c-di-GMP levels caused the retS
mutant to do the opposite and switch from the T6SS to the
T3SS. The regulation of the T6SS and the T3SS by c-di-
GMP therefore mimics the regulation by RetS, which
further confirms the link between these two pathways and
highlights that they have several target functions in
common (Fig. 6).
Previous studies in other bacteria have also suggested
a link between c-di-GMP and certain virulence functions.
In S. typhimurium and Dickeya dadantii (formerly Erwinia
chrysantemi), recent research has shown that increased
c-di-GMP levels not only promote biofilm formation, but
also downregulate the T3SS (Lamprokostopoulou et al.,
2010; Yi et al., 2010). Furthermore, although no link to the
Gac system was suggested in D. dadantii, CsrA in S. ty-
phimurium has been shown to downregulate the diguany-
late cyclases STM4551 and STM1987, as well as
upregulate the phosphodiesterase STM3611 (Jonas
et al., 2010). Similarly, CsrA in E. coli has been found to
Fig. 6. Schematic representation of regulatory networks that switch
P. aeruginosa lifestyles. The retS and c-di-GMP signalling pathways
act on the same targets to inversely control functions involved in
motility versus biofilm formation, or in acute versus chronic
infection. The RetS/LadS signalling network converges on the
post-transcriptional regulator RsmA to inversely regulate the T3SS
and the T6SS. The same regulation can be achieved by artificially
modulating c-di-GMP levels upon overproduction of a diguanylate
cyclase (DGC) or a phosphodiesterase (PDE). The dotted arrows
indicate an unknown mechanism of action.
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directly repress the diguanylate cyclases YcdT and YcdE
(Jonas et al., 2008). A connection between the two path-
ways might therefore be suggested in these bacteria.
While the inverse control exerted by RsmA on the T3SS
and the T6SS in P. aeruginosa has been well established
(Brencic and Lory, 2009), the c-di-GMP-dependent
switching of these secretion systems is a novel finding. It
is clear that overproduction of WspRR242A or PA1120
results in a substantial increase in c-di-GMP levels that
might saturate many c-di-GMP-dependent processes in a
non-specific manner. This has been observed in S. typh-
imurium upon overproduction of the diguanylate cyclase
AdrA (Simm et al., 2004). We therefore investigated the
specificity of this switch in a system that does not require
overexpression of diguanylate cyclases or phosphodi-
esterases. To achieve this, we took advantage of the fact
that ladS overexpression activates the Gac/Rsm signal-
ling cascade and gives the same phenotype as a retS
mutation (i.e. a switch from the T3SS to the T6SS). We
then took fifteen PA14 transposon mutants in selected
diguanylate cyclases-encoding genes from a previously
published library (Liberati et al., 2006) and overexpressed
ladS in trans in all these strains. In these conditions, the
expected switch occurred in all strains apart from the
wspR mutant, suggesting that WspR is required for the
switch to occur. Conversely, mutations in the previously
mentioned PA4322 (sadC), or in PA0338, which has been
identified as an RsmA target (Brencic and Lory, 2009), did
not prevent the switching, suggesting that these compo-
nents are not required for the process in this experimental
set-up. However, the mutant in PA0290 was moderately
affected and displayed reduced levels of both secretion
systems, suggesting that WspR might not be the only
player involved.
We next addressed the question whether c-di-GMP-
variation influences the Gac/Rsm signalling cascade, or
whether it is a consequence of its activity. As discussed
above, diguanylate cyclases and phosphodiesterases are
targets of RsmA/CsrA in a number of bacteria. However,
in the case of P. aeruginosa, the known RsmA targets
were shown to not be required for the c-di-GMP-
dependent switch between the secretion systems, at least
in our experimental set-up. In order to further investigate
the hierarchy between these regulatory systems, we
tested whether the presence of the Gac/Rsm signalling
cascade was required for c-di-GMP-dependent switching
to occur. This was done by overexpressing wspRR242A in
an rsmY/rsmZ double mutant. Although c-di-GMP levels
were twofold higher in this strain than in the vector control,
it still produced the T3SS and not the T6SS (Fig. 5). This
clearly indicates that c-di-GMP alone cannot relieve
RsmA repression in the absence of the sRNAs.
The c-di-GMP-dependent switching from motility and
T3SS to sessility and T6SS therefore requires the pres-
ence of the Gac/Rsm signalling cascade. However, the
exact level at which c-di-GMP influences the cascade is
still unclear. One hypothesis could be that c-di-GMP
serves as a signal influencing the activity of one of the
three sensors, RetS, LadS or GacS. Alternatively, the
second messenger could be a co-regulator influencing the
activity of the sRNAs. A third option is that the activity of
the cascade depends on a pool of available c-di-GMP, and
that this pool is partly controlled by direct RsmA-targets
(e.g. PA0388) and partly by other diguanylate cyclases/
phosphodiesterases that respond to alternative signals.
This may be the reason for the ‘half switch’ observed in
the PA0290 mutant (Fig. 4).
A number of different mechanisms of action for c-di-
GMP have so far been demonstrated in bacteria. These
have proven to be very versatile, and well known
examples range from transcriptional regulation (e.g. FleQ
in P. aeruginosa) (Hickman and Harwood, 2008), transla-
tional regulation (riboswitches in V. cholerae and Bacillus
subtilis) (Sudarsan et al., 2008), regulation of protein
activity (alg44 in P. aeruginosa and the flagellar brake in
E. coli and Salmonella) (Boehm et al., 2010; Paul et al.,
2010), and cross-envelope signalling (e.g. LapD in
Pseudomonas fluorescens) (Navarro et al., 2011; Newell
et al., 2011). With this in mind, there are multiple possi-
bilities of c-di-GMP control of the switch between the
T3SS and the T6SS, and these could involve direct
control of activity, as well as production of machinery
components, as observed in this study.
In conclusion, there is growing evidence that versatile
pathogens are able to switch their lifestyle or infection
mode by sensing environmental conditions. The switch is
driven by sophisticated regulatory networks, which often
modulate the levels of small molecules that in turn influ-
ence bacterial gene expression and physiology. The
present work demonstrates that, in P. aeruginosa, two
types of such molecules, c-di-GMP and sRNAs, function
in a concerted manner to coordinate a switch between two
secretion machineries, the T3SS and the T6SS. This
study therefore clearly demonstrates that c-di-GMP plays
a major role in controlling secretion machineries that are
essential in P. aeruginosa pathogenicity. Future work will
aim to further elucidate the molecular mechanisms of this
regulation and the specific components involved. This will
provide important information on perhaps the most impor-
tant regulatory cascade controlling the virulence strate-
gies of P. aeruginosa in the face of dwindling efficiency of
currently available antibiotics.
Experimental procedures
Strains, plasmids and growth conditions
The bacterial strains and plasmids used in this study are
listed in Table S1. Bacteria were cultured at 37°C with
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shaking in Luria–Bertani (LB) medium or M9 minimal medium
containing 22 mM glucose, 2 mM MgSO4 and 0.1 mM CaCl2.
Culture media were supplemented with antibiotics at the
following concentrations, when appropriate. For E. coli:
50 mg ml-1 ampicillin (Ap) and 50 mg ml-1 kanamycin (Km).
For P. aeruginosa: 500 mg ml-1 carbenicillin (Cb) for selection
of transconjugants or 300 mg ml-1 Cb for maintenance of plas-
mids and 15 mg ml-1 gentamicin (Gm). The T3SS was
induced by adding 5 mM EGTA-20 mM MgCl2 to the growth
medium in the experiments shown in Figs 1, 2 and 5. Congo
red staining assay was performed at 30°C on tryptone
(10 g l-1) agar (1%) plates supplemented with 40 mg ml-1
Congo red and 20 mg ml-1 Coomassie brilliant blue. Swim-
ming plates were prepared using 0.3% agar and incubated at
30°C as described previously (Mikkelsen et al., 2009).
Escherichia coli OmniMAX and TOP10 were used for stan-
dard genetic manipulations.
The wspR gene was amplified by PCR using primers
WspRF (CGTGGAACAGCATTCAATTT) and WspRR (AA
AGATACCCCCGAATGGTC). The PA2133 gene was ampli-
fied using primers PA2133F (TCACACAGGAAACTACA
GTGAACGGTTCCCCAC) and PA2133R (GGAAGGCTG
ATTGCTCTGTT). The PA1120 gene was amplified using
primers PA1120F (TTCACACAGGAAACCGTGATGAACCG
TCGTC) and PA1120R (AACAGCACCTTGCTCGACAT).
PCR products were cloned into pCR2.1-TA and sub-cloned
into pBBR1MCS-4.
The R252A-wspR allele was generated in pCR2.1 by site-
directed mutagenesis using the QuickChange Site-Directed
Mutagenesis Kit (Stratagene) following the supplier’s
protocol. Primers used were WspRmutR242F (CGAGGGC
TGCAGTGCCTCCTCGGACCTG) and WspRmutR242AR
(CAGGTCCGAGGAGGCACTGCAGCCCTCG). All con-
structs were confirmed by sequencing.
Transfer of plasmids into P. aeruginosa strains was carried
out by triparental mating using the conjugative properties
of plasmid pRK2013. Transconjugants were isolated on
Pseudomonas Isolation Agar (Difco) supplemented with
appropriate antibiotics.
Biofilm assays
Visualization of biofilm formation was carried out in 14 ml
borosilicate tubes. Briefly, LB (3 ml) supplemented with
appropriate antibiotics was inoculated to a final OD600 of 0.1
and incubated at 37°C. Biofilms were stained with 0.1%
crystal violet (CV) and tubes were washed with water to
remove unbound dye. Quantification of biofilm formation was
performed in 24-well polystyrene microtiter plates. M9
medium (1 ml per well) supplemented with appropriate anti-
biotics was inoculated to a final OD600 of 0.01 and incubated
at 37°C with shaking for 8 h. Biofilms were stained and
washed as above, and CV was solubilized in 96% ethanol
before measuring the absorbance at 600 nm. For each
biofilm assay three independent experimental repetitions
were performed.
Western blots
Cultures were inoculated into LB medium to an OD600 of 0.1
and incubated at 37°C with shaking for 6 h. Whole-cell
lysates were loaded (0.1 OD600 equivalent unit) on SDS-
PAGE and proteins transferred on nitrocellulose membranes.
Primary antibodies, anti-Hcp1 and anti-PcrV were used at
dilutions of 1:500 and 1:1000 respectively. Secondary anti-
body (horseradish peroxidase-conjugated goat anti-rabbit
IgG) was used at 1:5000 dilution. Visualization was achieved
using the SuperSignal West Pico Chemiluminescent Sub-
strate Kit (Thermo) and a LAS3000 Imaging System (Fuji).
For each Western blot three independent experimental rep-
etitions were performed.
Extraction and measurement of c-di-GMP levels
Intracellular c-di-GMP levels were determined by LC-MS/MS
as previously described (Simm et al., 2009), with the follow-
ing modifications. Bacterial pellets from 100 ml overnight
liquid cultures (M9 medium supplemented with nutrients and
appropriate antibiotics) were resuspended in 0.19% ice-cold
formaldehyde at a concentration of 300 mg wet weight per
ml, incubated on ice for 10 min and centrifuged at 10 000 g
for 15 min. The pellet was then resuspended in 300 ml of
water and when required, c-di-GMP (BIOLOG LifeScience
Institute, Bremen, Germany) was spiked at a concentration of
1.7 mM. After the ethanol extraction of nucleotides (Simm
et al., 2009), samples were dried under vacuum, reconsti-
tuted in 50 ml H2O by vigorous vortexing and sonication for
5 min, centrifuged for 15 min at 10 000 g and the superna-
tants were analysed using an Agilent 1200 HPLC system with
aC18 ACE 3 AQ 150 ¥ 2.1 mm column with a matching guard
maintained at 55°C. The mobile phase consisted of 0.1%
formic acid run in an H2O-acetonitrile gradient at a flow rate of
300 ml min-1, reaching 50% acetonitrile in 14 min. MS analy-
sis was then performed by negative ion electrospray from the
Agilent HPLC system into a Bruker HCT Plus ion trap in
multiple reaction mode. Using SmartFrag (HyStar software),
the trap was set to isolate from full scan and then fragment
ions at m/z 688.9, with a monitored mass range of m/z 450–
700. DataAnalysis v3.3 was used to interrogate the acquisi-
tions, and extracted ion chromatograms of m/z 538 were
produced from the negative ion MS/MS of m/z 688.9. Reten-
tion times and peak spectra were matched to the standard
injected at intervals throughout the run. Peak areas and rela-
tive c-di-GMP levels were normalized to the levels obtained
with the reference strains. Each extraction and quantification
was performed in triplicate.
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Fig. S1. Overexpression of wspR or wspRR242A influences
biofilm-related phenotypes. PAK wild type carrying either
empty vector or overexpressing wspR or wspRR242A, as indi-
cated in (A).
A. Biofilm formation in static growth conditions visualized by
crystal violet staining.
B. Biofilm formation in shaking growth conditions quantified
by crystal violet staining.
C. Bacterial colony on Congo red agar.
D. Swimming motility determined in 0.3% agar.
Fig. S2. Overproduction of a phosphodiesterase suppresses
the hyperbiofilm phenotype of a retS mutant. Biofilm forma-
tion in glass tubes, visualized by crystal violet staining (left
panel), and Congo red binding (right panel) of PAKDretS
carrying either empty vector or overproducing the phosphodi-
esterase PA2133.
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Appendix 2 
Corrigendum
The Pseudomonas aeruginosa sensor RetS switches
Type III and Type VI secretion via c-di-GMP signallingemi_2723 1088..1089
Joana A. Moscoso,1 Helga Mikkelsen,1 Stephan Heeb,2 Paul Williams2 and Alain Filloux1*
1Imperial College London, Division of Cell and Molecular Biology, Centre for Molecular Microbiology and Infection,
South Kensington Campus, Flowers Building, London SW7 2AZ, UK.
2School of Molecular Medical Sciences, Centre for Biomolecular Sciences, University Park, University of Nottingham,
Nottingham NG7 2RD, UK.
In the article ‘The Pseudomonas aeruginosa sensor RetS switches Type III and Type VI secretion via c-di-GMP
signalling’ (Moscoso et al., 2011), we showed that a P. aeruginosa PAKDretS mutant displays increased levels
of c-di-GMP, which explains, at least in part, why it has a hyperbiofilm phenotype. We further showed that expression
of the type VI secretion system (T6SS) and type III secretion system (T3SS), which are antagonistically controlled
by RetS, could clearly be switched in a RetS-independent manner upon manipulation of c-di-GMP levels by over-
expressing the diguanylate cyclase-encoding genes, wspR or PA1120 in a wild-type strain. We also showed that
overexpression of these diguanylate cyclases (DGC) in an rsmYZ mutant, although increasing levels of c-di-GMP is not
sufficient to induce the T3SS/T6SS switch indicating that an increase in c-di-GMP alone cannot relieve RsmA-mediated
repression.
In the last part of the paper, and in an attempt to demonstrate DGC specificity, we tried to demonstrate that the switch
involved a specific DGC. We showed that overexpression of ladS results in the same phenotype as a retS mutant with
respect to the T3SS/T6SS switch. Our strategy has thus been to use the PA14 collection of transposon mutants
(http://ausubellab.mgh.harvard.edu/cgi-bin/pa14/home.cgi) and to overexpress ladS in the individual DGC mutants avail-
able from the collection. By doing so we observed that the wspR mutant no longer responded to ladS overexpression and
no T3SS/T6SS switch was observed (fig. 4 in Moscoso et al., 2011).
We have now reconstructed a clean wspR deletion mutant (see Experimental procedures) and observed that upon
overexpression of ladS, the T3SS/T6SS switch is perfectly effective (see Fig. 1), i.e. the T6SS is highly expressed whereas
the T3SS is downregulated. This result rules out our initial observation that WspR is specifically involved in the T3SS/T6SS
switch and leaves open the notion of specificity. Whereas none of the tested single mutations in genes encoding DGCs
affects the T3SS/T6SS switch, it remains a possibility that the switch could only be affected when multiple DGC-encoding
genes are deleted together.
We apologize for the confusion resulting from the use of two different wspR mutant strains.
*For correspondence. E-mail a.filloux@imperial.ac.uk, Tel. (+44) 20 7594 9651, Fax (+44) 20 7594 3069.
Fig. 1. Western blot analysis of P. aeruginosa PA14 and PA14DwspR mutant (indicated as DwspR) carrying the empty vector (pBBR1-MCS-4
indicated as vector) or overexpressing ladS (pBBR1-MCS-4-ladS indicated as ladS). The antibodies used are directed against PcrV (T3SS)
and Hcp1 (T6SS) as indicated on the left of each panel.
Environmental Microbiology (2012) 14(4), 1088–1089 doi:10.1111/j.1462-2920.2012.02723.x
© 2012 Society for Applied Microbiology and Blackwell Publishing Ltd
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Experimental procedures
The PA14DwspR strain was obtained by using the suicide vector pKNG101 carrying a mutator fragment homologous to the
flanking regions of wspR. The mutator fragment was obtained using primers 5′-GCAGCATGTCGACGAGGTAT-3′,
5′-TCAGGCCCAGTTGTGCATGTTTCTCTCCGG-3′, 5′-ATGCACAACTGGGCCTGATGGAACAGCCG-3′ and 5′-GATGTCC
AGGTAGGCGTTGT-3′. Clones in which the double recombination events occurred, resulting in the deletion of wspR, were
selected on sucrose-containing plates as described elsewhere (Kaniga et al., 1991; Vasseur et al., 2005).
Deletion of wspR was confirmed using the external primers 5′-GAGGATCGGAATCGTCAATG-3′ and 5′-CTGCATTT
CCAGCTCGTACA-3′.
The ladS gene carried on a broad-host-range plasmid (pBBRladS) or the cloning vector was introduced into the wild-type or
wspR mutant strains (see Moscoso et al., 2011). Bacterial growth, preparation of whole cell extracts and Western blot analysis
were performed as previously described.
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Chapter 49 
 
Methods for studying biofilm dispersal in Pseudomonas 
aeruginosa 
Nicolas Barraud, Joana A. Moscoso, Jean-Marc Ghigo and Alain Filloux 
 
 
Summary 
Biofilm dispersal is the last and least understood stage of the biofilm life cycle. 
Several recent studies have characterised dispersal events in response to various cues 
and signals. Here we describe a range of methods useful for the investigation of 
dispersal in the biofilm model organism and opportunistic pathogen Pseudomonas 
aeruginosa. 
 
Key words: Biofilm, dispersal, environmental cues, nitric oxide, batch culture, 
crystal violet staining, continuous culture, microfermenters.  
___________________________________________________________________ 
1. Introduction 
In most environments bacteria adopt a biphasic life cycle, with a sessile surface-
attached biofilm phase and a motile free-living planktonic phase. Biofilm bacteria, 
compared to their planktonic counterparts, often show increased resistance to 
environmental stress and antimicrobials. While the mechanisms for attachment of 
bacteria on surfaces and the onset of biofilm formation have been well documented in 
many species, the reverse transition, at the end of the biofilm development that 
involves the release into the bulk liquid of cells that were once strongly attached is 
still poorly understood. Biofilm dispersal appears to be a programmed, highly 
regulated process, which can be triggered by specific cues such as nutrients, oxygen 
and nitric oxide (NO) levels as well as bacterial derived signal molecules. The 
population of dispersal bacteria often comprises high levels of phenotypic and genetic 
variants, which are thought to provide an ecological advantage by facilitating 
colonisation of new surfaces (1). 
Elucidating the mechanisms of biofilm dispersal is of primary importance in order 
to better understand the maintenance, evolution and dissemination of biofilm 
infections. It may also lead to the identification of potential new targets for the control 
of biofilm by inducing their natural detachment in a non-toxic, non-resistant manner. 
The successful study of this phenomenon presents several challenges: (i) one needs to 
grow a functional, mature biofilm, (ii) then the biofilm needs to be exposed to a 
dispersal cue in a controlled fashion, and (iii) finally the remaining biofilm needs to 
be analysed for evidence of dispersal events. Since nutrients and oxygen availability 
can trigger dispersal, sudden changes in growth conditions during biofilm treatment or 
analysis may result in an uncontrolled detachment of portions of biofilm, 
compromising interpretation of the data. This paper describes two complementary 
systems that are useful to study dispersal in Pseudomonas aeruginosa (2). First, a 
microtitre-based batch system was designed for high throughput screening of 
dispersal in response to various cues. Second, a microfermenter-based system allows 
for varying a wide range of parameters, with minimum uncontrolled disturbance to 
the biofilm. These procedures can be useful to screen for compounds that may induce 
dispersal or for mutant strains that may be defective in dispersal. The use of 
microfermenters, by generating abundant biomass and allowing for the extraction of 
nucleic acids and proteins from the attached biofilm bacteria, can also support the 
examination of cellular changes that regulate dispersal. Further, because the dispersal 
population is readily collected in the biofilm runoff effluent, it is also possible to 
study the phenotypic and genotypic changes associated with biofilm dispersal. 
____________________________________________________________________ 
 
2. Materials 
2.1. Microtitre plate assay 
1. Luria Bertani (LB) medium with 1% NaCl. 
2. Modified M9 minimal medium (freshly made, see Note 1): M9 1X salts 
consisting of 48 mM Na2HPO4, 22 mM KH2PO4, 9 mM NaCl, 19 mM NH4Cl, 
pH 7.2, supplemented with the nutrients 2 mM MgSO4, 100 µM CaCl2 and 
glucose at 2 mM or 20 mM for continuous or batch culture experiments, 
respectively. 
3. Tissue-culture-treated 24-well plates (BD). 
4. Dispersal agents. For NO donors: sodium nitroprusside (SNP, Sigma) solution 
in water made fresh on the day; or NONOate disodium 1-[2-
(carboxylato)pyrrolidin-1-yl]diazen-1-ium-1,2-diolate (Proli, Cayman 
Chemicals) solution in 10 mM NaOH and stored at -20 ºC for no more than 
one week. 
5. Vacuum station made using a vacuum pump (Fisherbrand) connected to a side 
arm flask with a venting cap/stopper linked to a Pasteur pipette. 
6. Repeater pipettor (Eppendorf). 
7. Phosphate-buffered saline (PBS): 137 mM NaCl, 2.7 mM KCl, 10 mM 
Na2HPO4, 1.8 mM KH2PO4, pH 7.4. 
8. Crystal violet stain 0.2% crystal violet prepared by diluting with PBS a 2% 
crystal violet solution in 1.9% ethanol and 0.08% ammonium oxalate. 
Alternatively, a commercial stain, Gram crystal violet 0.3% in 1:1:18 
isopropanol:ethanol/methanol:water (BD), may be used. 
9. 100% ethanol. 
10. Sonication bath (e.g. 150 W, Unisonics). 
 
2.2. Microfermenter assay 
11. Microfermenters equipped with glass spatula (Institut Pasteur, Paris). 
12. Silastic silicone tubing internal diameter (ID)-outside diameter (OD) 1.0-2.6 
mm (Cole Parmer) for upstream sterile medium flow; Tygon tubing ID-OD 
2.4-4.0 mm (Saint Gobain) for peristaltic pump; silicone microbore tubing ID-
OD 1.0-2.9 mm (Cole Parmer) for downstream biofilm effluent runoff flow. 
13. Polypropylene adapters and connectors (Cole Parmer): female luer  1/8” hose 
barb; male luer  1/8” hose barb; barbed reducer 1/8”  1/16”; barbed T-
connector 4 mm. 
14. Polypropylene 10-20 l carboys autoclavable equipped with a filling/venting 
cap (Cole Parmer). 
15. Peristaltic pump (e.g. model 205S, Watson Marlow). 
16. Water bath consisting of a 5-6 l tank and a thermostat with circulator (Cole 
Parmer). 
17. Source of compressed air at 40 kPa. 
18. Sterile filters with 0.2 µm pore size (Millipore). 
____________________________________________________________________ 
3. Methods 
2.3. Batch culture microtitre plate assay 
In the batch assay, P. aeruginosa PAO1 wild type biofilms are grown in microtitre 
plates and dispersal is assessed as a concomitant increase in planktonic biomass and a 
decrease in biofilm biomass (Fig. 1). 
1. Grow a P. aeruginosa PAO1 culture overnight in LB medium to an OD600 of 
2.5. 
2. Make a 1:200 dilution in M9 minimal medium with 20 mM glucose and 
aliquot 1 ml per well of a 24-well plate.  
3. Put the plate on a platform shaker at 37 °C and incubate with shaking at 180 
rpm (see Note 2).  
4. After 6 h growth (see Note 3), induce dispersal by adding 10 µl per well of a 
solution at the appropriate concentration in less than 1 min per plate (see Note 
4). For instance, add 10 µl of a 10 mM solution of NO donor Proli to make a 
final concentration of 100 µM (Fig. 1C and 1D). Dispersal can also be 
induced by reducing the shaking speed to 60 rpm (Fig. 1A and 1B), which is 
known to induce a decrease in oxygen tension in the culture within minutes (3).  
5. Incubate for a further 15 min to 1 h. 
6. The planktonic biomass is assessed by measuring the OD600 or colony-forming 
units (CFU) count of the supernatant. 
7. Finally the biofilm biomass is assessed by performing either crystal violet 
staining (4) or CFU count of biofilm cells. 
 
2.4. Crystal violet staining  
Crystal violet provides a fast and highly reproducible method to quantify biofilm 
biomass.  
1. Use the vacuum device for suction of the supernatant liquid from the wells. 
2. To remove loosely attached biofilm cells, wash each well once by adding 1 ml 
PBS using a repeater pipettor and then removing the liquid using the vacuum 
device. 
3. Stain with 1 ml crystal violet solution for 20 min. 
4. Using the same vacuum device, remove the crystal violet dye from each well. 
5. Wash twice with 1 ml PBS as in step 2.  
6. Photograph the distribution of crystal violet dye on the walls of microtitre 
wells by using a digital camera (Fig. 1B and 1D).  
7. Add 1 ml of 100% ethanol to each well to re-elute the crystal violet dye and 
shake gently until all crystal violet is dissolved. 
8. Measure the OD550. The absorbance of an uninoculated well serves as a 
negative control and should be subtracted from the value of the inoculated 
wells. 
 
2.5. CFU enumeration of biofilms  
CFU count is a sensitive method that allows for detection of much lower numbers of 
biofilm bacteria compared to crystal violet staining. Further, CFU count is useful to 
assess the efficacy of biofilm control measures when dispersal treatments are 
combined with bactericidal agents. 
1. Equip the vacuum device with a sterile Pasteur pipette and suction liquid from 
the cultures, briefly flaming the Pasteur pipette between each well. 
2. Wash each well twice with 1 ml of sterile PBS. Drain all the wells. 
3. Add 1 ml sterile PBS and resuspend biofilms on the bottom and walls of the 
well by swabbing with a sterile cotton bud and incubating in a sonication bath 
for 2 min.  
4. Perform a serial dilution of resuspended biofilm cells and plate on LB agar. 
5. Enumerate CFU after 24 h incubation at 37 °C. After 6 h incubation under 
these growth conditions, control biofilms that were not treated harboured 19.6 
± 2.6  106 CFU / cm2. 
 
2.6. Continuous culture microfermenter assay 
In the continuous flow assay, P. aeruginosa PAO1 biofilms are grown under flow-
through conditions in glass microfermenters (5) and dispersal is assessed by 
monitoring the biofilm effluent (Fig. 3). At the end of the assay, the remaining 
biofilm can be quantified or further analysed for gene or protein expression. 
1. Prepare the microfermenter system as described in Fig. 2, and sterilise all 
components by autoclaving. Autoclave the Tygon pump tubing separately with 
both extremities free of any connector and wrapped in aluminium foil. 
2. Prepare a 10-20 l M9 1X salts solution and sterilise by autoclaving at 121 ºC, 
15 psi for 45 min instead of the usual 15 min. After cooling down, add 2 mM 
MgSO4, 100 µM CaCl2 and 2 mM glucose to the M9 1X salts solution, 
preferably under sterile conditions. Mix well to dissolve any calcium 
precipitate. 
3. Connect the microfermenter to the medium inlet via a piece of Tygon tubing 
pinched to the roller of a peristaltic pump. Put the microfermenter upright in a 
water bath heated at 37 ºC. Close the air supply line with a clamp and rinse the 
whole system by pumping through each microfermenter 200 ml of fresh sterile 
M9 medium. 
4. Stop the medium flow, open the microfermenter cap under sterile conditions 
and in each microfermenter containing 40 ml of M9 medium inoculate 1 ml of 
an overnight culture of P. aeruginosa PAO1 grown in LB at 37 ºC. Close the 
cap tightly. 
5. Allow cells to attach with medium flow and airflow turned off for 1 h. 
6. Turn on liquid medium flow at a rate of 0.8 ml / min. Unclamp the air supply 
line and turn on the aeration at 40 kPa, 100 ml / min (see Note 5). When air 
and medium flows are turned on, the volume of medium inside the 
microfermenter is ~20 ml, thus making a residence time of 25 min. 
7. Grow for 24 h without interruption or disturbance (see Note 6). 
8. After 24 h, switch the medium inlet to separate containers bearing fresh media 
with specific treatment; e.g. NO donors SNP at 1 mM or NaNO2 at 10 mM 
(Fig. 3), no carbon source (starvation), or 20 mM glucose (nutrient increase). 
For oxygen depletion-induced dispersal, switch aeration to nitrogen or argon 
gas (see Note 7). This procedure ensures minimal physical disruption of the 
biofilm growing inside the microfermenters. 
9. Collect the biofilm effluent in separate 15 ml Falcon tubes (BD) every 10 min 
and monitor the release of dispersal cells by measuring the OD600 (see Note 8). 
10. To assess the remaining biofilm biomass after dispersal has been induced, 
remove the spatula aseptically and resuspend the biofilm cells in 5 ml PBS by 
swabbing with a sterile cotton bud. Measure the OD600 of the suspension. This 
procedure could also be used to extract proteins or nucleic acids from biofilm 
cells after dispersal was induced.  
11. For microscopy analysis of biofilm structures, remove the spatula and rinse 
once by dipping briefly in sterile PBS. Add an appropriate stain (e.g. live/dead 
bacterial viability kit, Invitrogen), put a cover slip on top and visualise under a 
microscope. 
____________________________________________________________________ 
4. Notes 
4.1. For the batch microtitre plate assay: 
1. Complete M9 medium needs to be made fresh on the day by adding MgSO4 
(from 1 M stock autoclaved), glucose (from 20 % stock sterilised by passing 
through a 0.2 µm-filter) and CaCl2 (from 1 M stock autoclaved) to the 1X salts 
solution. Autoclave the 1X salts solution beforehand (this can be kept on the 
bench for long periods). 
2. To minimize variations in biofilm growth due to heaters and air fans that may 
induce variable evaporation/aeration (edge effect), put plates on the same 
row/level, and preferably in the middle of the shaker. To check for possible 
variations, include control wells (not dispersed with any treatment) both on the 
edge and in the middle of the plate. 
3. Incubation time and inoculum may have to be adjusted according to the strain 
being used. For instance, when growing P. aeruginosa PA14 biofilms under 
these conditions, a 1:1,000 initial dilution in M9 and incubation for 18 h are 
recommended. 
4. Do not stop or open the incubator during the experiment and work quickly 
every time the plate is taken out of the incubator. Use only 12 wells in the 2 
middle rows of the 24-well plate in order to keep low number of wells, which 
should allow for processing each plate quickly enough every time the plate is 
removed from the shaker-incubator, i.e. for addition of treatments, 
quantification of supernatants, washing and crystal violet staining. If assessing 
biofilm biomass by crystal violet analysis rather than CFU count, the system 
does not need to be strictly sterile at the time of adding dispersal treatments, 
i.e. 15 min to 1 h before the end of incubation. It is recommended to start by 
performing the oxygen-induced dispersal assay in order to better grasp the 
dynamics of dispersal that may be potentially induced when the plate is taken 
out of the incubator. 
 
4.2. For the continuous flow microfermenter assay: 
5. Always apply a positive pressure to medium and air supplies or the 
supernatant will flow back, contaminate the growth medium and block air 
filters. Therefore, to turn the system on, first tighten the microfermenters caps, 
then switch on the air pump and finally the peristaltic pump. To turn off, first 
switch off the peristaltic pump, then the air pump and finally loosen the caps. 
6. Incubation time may have to be adjusted according to the strain being used. 
For instance, under these growth conditions P. aeruginosa PA14 form visible 
biofilms only after 3 days. Increased volumes of media may be necessary. 
7. Use three-way valves for aeration of microfermenters in order to allow for 
switching aeration with minimum disruption. Alternate aeration lines should 
be equipped with pressure gauge and flow meters as well as fine regulators to 
adjust the pressure quickly after switching the aeration source. 
8. Using a microbore tubing (e.g. 1 mm internal diameter) for the biofilm 
effluent ensures minimising biofilm growth in areas other than the 
microfermenter that could potentially interfere with the analysis of cells in the 
biofilm effluent that are expected to be exclusively released from the biofilm 
inside the microfermenter. A microbore tubing presents a small surface area 
and the flow velocity and shear stress are high. 
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Figure legends 
Fig. 1. Microtitre plate assay for biofilm dispersal. (A) Oxygen-depletion induced 
dispersal. P. aeruginosa PAO1 biofilms were grown for 6 h with shaking at 200 rpm, 
then at t = 0, the shaking speed was reduced to 60 rpm to reduce oxygen tension. At 
various time points, the planktonic biomass was assessed by measuring the OD600 of 
the supernatant and the biofilm biomass by performing crystal violet staining. (B) 
Stained biofilms before and after 5 min of incubation at a reduced shaking speed. (C) 
NO-induced dispersal. P. aeruginosa biofilms were grown for 6 h with shaking at 200 
rpm in the absence of NO donor. Then 10 µl of a Proli solution were added to the 
wells to make a final concentration of 100 µM and control wells were left untreated. 
Plates were incubated for a further 15 min before assessing dispersal by measuring the 
OD600 of the supernatant and performing crystal violet staining of the biofilm. (D) 
Stained biofilms untreated or treated with Proli for 15 min. 
 
 
Fig. 2. (A) Illustration of the microfermenter flow-through culture set up: (i) 10-20 l 
fresh medium autoclavable carboy equipped with venting cap; (ii) 40 cm-long Silastic 
tubing (in a system where multiple microfermenters are used, this tubing may be 
diverted by using T-connectors) connected with male and female luer lock connectors 
to a 30 cm-long Tygon pump tubing which is pinched to the roller of a peristaltic 
pump and connected on the other side via a luer connection to a 20 cm-long Silastic 
tubing; (iii) T-connector; (iv) Silastic tubing with 0.2 µm-filter connected to a source 
of compressed air at 40 kPa; (v) glass microfermenter with unused capillaries sealed 
and equipped with a removable glass spatula; (vi) 3 cm-long Silastic effluent tubing 
connected with reducing connector to 80 cm-long microbore effluent tubing 
connected with reducing connector to 3 cm long Silastic tubing; (vii) waste collection 
carboy capped with aluminium foil. (B) Microfermenters in a water bath. (C) Biofilm 
formed on the glass surfaces of microfermenter and spatula. (D) Theoretical dilution 
curve of a solute introduced at a concentration of 1 in the microfermenter at a time 
indicated by the arrow (illustrating a sudden dispersal event) and evacuated over time 
with the flow of fresh medium. 
 
Fig. 3. Dispersal of P. aeruginosa PAO1 biofilms in response to NO and oxygen 
depletion. (A) One day-old biofilms grown in microfermenters were treated (arrow) 
with the NO donor SNP at 1 mM (white circles), 10 mM sodium nitrite (white 
diamonds) or 1 mM potassium ferricyanide (FCN, black circles), the SNP ‘backbone’ 
that does not release NO. To deplete the biofilm of oxygen, aeration was switched to 
nitrogen gas (white squares). To monitor dispersal events, OD600 of the biofilm 
effluent was measured. (B) After 2.5 h, biofilm cells remaining on the microfermenter 
spatula were resuspended in PBS and quantified by measuring the OD600. 
  
  
  
Fig. 1. Microtitre plate assay for biofilm dispersal. (A) Oxygen-depletion induced 
dispersal. P. aeruginosa PAO1 biofilms were grown for 6 h with shaking at 200 rpm, 
then at t = 0, the shaking speed was reduced to 60 rpm to reduce the oxygen tension. 
At various time points, the planktonic biomass was assessed by measuring the OD600 
of the supernatant and the biofilm biomass by performing crystal violet staining. (B) 
Stained biofilms before and after 5 min of incubation at a reduced shaking speed. (C) 
NO-induced dispersal. P. aeruginosa biofilms were grown for 6 h with shaking at 200 
rpm in the absence of NO donor. Then 10 µl of a Proli solution were added to the 
wells to make a final concentration of 100 µM and control wells were left untreated. 
The plates were incubated for a further 15 min before assessing dispersal by 
measuring the OD600 of the supernatant and performing crystal violet staining of the 
biofilm. (D) Stained biofilms untreated or treated with Proli for 15 min. 
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 Fig. 2. (A) Illustration of the microfermentor flow-through culture set up: (i) 10-20 l 
fresh medium autoclavable carboy equipped with venting cap; (ii) 40 cm-long Silastic 
tubing (in a system where multiple microfermentors are used, this tubing may be 
diverted by using T-connectors) connected with male and female luer lock connectors 
to a 30 cm-long Tygon pump tubing which is pinched to the roller of a peristaltic 
pump and connected on the other side via a luer connection to a 20 cm-long Silastic 
tubing; (iii) T-connector; (iv) Silastic tubing with 0.2 µm-filter connected to a source 
of compressed air at 40 kPa; (v) glass microfermentor with unused capillaries sealed 
and equipped with a removable glass spatula; (vi) 5 cm-long Silastic effluent tubing 
connected with reducing connector to 80 cm-long microbore effluent tubing; (vii) 
waste collection carboy capped with aluminium foil. (B) Microfermentors in a water 
bath. (C) Biofilm formed on the glass surfaces of the microfermentor and spatula. (D) 
Theoretical dilution curve of a solute introduced at a concentration of 1 in the 
microfermentor at a time indicated by the arrow (illustrating a sudden dispersal event) 
and evacuated over time with the flow of fresh medium. 
 
 
 Fig. 3. Dispersal of P. aeruginosa PAO1 biofilms in response to NO and oxygen 
depletion. (A) One day-old biofilms grown in microfermentors were treated (arrow) 
with the NO donor SNP at 1 mM (white circles), 10 mM sodium nitrite (white 
diamonds) or 1 mM potassium ferricyanide (FCN, black circles), the SNP ‘backbone’ 
that does not release NO. To deplete the biofilm of oxygen the aeration was switched 
to nitrogen gas (white squares). To monitor dispersal events, the OD600 of the biofilm 
effluent was measured. (B) After 2.5 h, biofilms remaining on the microfermentor 
spatula were resuspended in PBS and quantified by measuring the OD600. 
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